UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One) |
|
x |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
SECURITIES EXCHANGE ACT OF 1934 |
For the Fiscal Year Ended December 31, 2006 Commission File No. 1-9328
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
ECOLAB INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
41-0231510
|
370 Wabasha Street North, St. Paul, Minnesota
|
|
55102
|
Registrants telephone number, including area code: (651) 293-2233
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
Common Stock, $1.00 par value |
|
New York Stock Exchange, Inc. |
Preferred Stock Purchase Rights |
|
New York Stock Exchange, Inc. |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
x YES o NO
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
o YES x NO
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x YES o NO
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer x |
Accelerated Filer o |
Non-Accelerated Filer o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
o YES x NO
Aggregate market value of voting and non-voting common equity held by non-affiliates of registrant on June 30, 2006: $10,187,562,612 (see Item 12, under Part III hereof), based on a closing price of registrants Common Stock of $40.58 per share.
The number of shares of registrants Common Stock, par value $1.00 per share, outstanding as of January 31, 2007: 250,634,287 shares.
DOCUMENTS INCORPORATED BY REFERENCE
1. Portions of the registrants Annual Report to Stockholders for the year ended December 31, 2006 (hereinafter referred to as Annual Report) are incorporated by reference into Parts I and II.
2. Portions of the registrants Proxy Statement for the Annual Meeting of Stockholders to be held May 4, 2007 and to be filed within 120 days after the registrants fiscal year ended December 31, 2006 (hereinafter referred to as Proxy Statement) are incorporated by reference into Part III.
TABLE OF CONTENTS
Except where the context otherwise requires, references in this Form 10-K to either Ecolab, Company, we and our are to Ecolab Inc. and its subsidiaries, collectively.
This Annual Report on Form 10-K, including Managements Discussion and Analysis of Financial Condition and Results of Operation incorporated by reference into Item 7 of this Form 10-K, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning business progress and expansion, business acquisitions, currency translation, cash flows, debt repayments, environmental and regulatory considerations, share repurchases, global economic conditions, pension expenses and potential contributions, income taxes and liquidity requirements. Without limiting the foregoing, words or phrases such as will likely result, are expected to, will continue, is anticipated, we believe, we expect, estimate, project (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Item 1A of this Form 10-K, entitled Risk Factors.
Item 1. Business .
Item 1(a) General Development of Business .
Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31.
During 2006, we continued to make business acquisitions to broaden our product offerings and expand our geographic coverage, consistent with our Circle the Customer Circle the Globe strategy. These transactions included the following:
In June 2006, the Company acquired Shield Medicare Ltd., a developer, manufacturer and marketer of contamination control products used in pharmaceutical, medical device and hospital clean rooms. Shield Medicare Ltd., located in the United Kingdom, has annual sales of approximately $19,000,000 and became part of our International operations beginning in the third quarter of 2006.
In September 2006, we acquired DuChem Industries, Inc. DuChem manufactures and markets cleaning and sanitizing products with a focus on the protein (meat and poultry) segment of the food and beverage market. Duchem is located in Newnan, Georgia and has annual sales of approximately $10,000,000 and became part of our United States Cleaning & Sanitizing operations in the third quarter of 2006.
In September 2006, we acquired Powles Hunt & Sons International Ltd.s commercial laundry business from Quill International Group. Powles Hunt is a leading supplier of professional laundry products in the United Kingdom with annual sales of approximately $5,000,000 and became part of our International operations beginning in the fourth quarter of 2006.
Additional details regarding certain of the above acquisition transactions are found in Note 5 located on pages 34 and 35 of the Annual Report, and incorporated into Item 8 of this Form 10-K.
Item 1(b) Financial Information About Operating Segments .
The financial information about reportable segments appearing under the heading Operating Segments in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.
2
Item 1(c) Narrative Description of Business .
General : Ecolab develops and markets premium products and services for the hospitality, foodservice, healthcare and industrial markets. We provide cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quick-service (fast-food and other convenience store) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry. A strong commitment to customer support is a distinguishing characteristic of our business. Additional information on our business philosophy is found below under the heading Additional Information Competition of this Item 1(c).
The following description of our business is based upon our three reportable segments as reported in our consolidated financial statements. However, we pursue a Circle the Customer Circle the Globe strategy by providing products, systems and services which serve our customer base, and do so on a global basis to meet the needs of our customers various operations around the world. Therefore, one customer may utilize the products or services of all three of the segments and there is interdependence among the operating segments. Revenues of our International segment include sales outside the United States by our Kay and Pest Elimination businesses.
The United States Cleaning & Sanitizing segment is comprised of seven business units which provide cleaning and sanitizing products and programs to United States markets.
Institutional : Our Institutional Division is our largest division and sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (warewashing), for on-premise laundries (typically used by hotel and health care customers) and for general housekeeping functions, as well as food safety products and equipment, dishwasher racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries, and water filters to the foodservice industry. The Institutional Division also provides pool and spa treatment programs for hospitality and other commercial customers. The Institutional Division manufactures and markets various chemical dispensing device systems, which are made available to customers, to dispense our cleaners and sanitizers. In addition, the Institutional Division markets a lease program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.
We believe we are the leading supplier of chemical warewashing products and programs to institutions in the United States.
The Institutional Division sells its products and programs primarily through company-employed field sales and service personnel. However, to a significant degree, we also utilize independent, third-party foodservice distributors to market and sell our products to smaller accounts or accounts which purchase through food distributors. We provide the same customer support to accounts supplied by food distributors as to direct customers.
Effective January 1, 2007, we integrated our former Professional Products division into the Institutional Division to deliver a broad range of cleaning and floor care products and programs to customers in hospitality, health care and commercial facilities. The Institutional sales force along with a network of independent, third-party distributors serving the commercial janitorial industry, market Professional Products proprietary offerings (detergents, general purpose cleaners, carpet care, stone care, furniture polishes, disinfectants, floor care products, hand soaps and odor counteractants).
Kay : Our Kay Division (which consists of certain wholly-owned subsidiaries of Ecolab Inc.) supplies chemical cleaning and sanitizing products primarily to national and regional quick-service restaurant chains and to the food retail (i.e., grocery store) industry. Kays products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and
3
assorted cleaning tools. Products are sold under the Kay brand or the customers private label. In addition, Kay supports its product sales with employee training programs and technical support designed to meet the special needs of its customers. Kays customized cleaning and sanitation programs are designed to reduce labor costs and product usage while increasing sanitation levels, cleaning performance, equipment life and safety levels.
Kay employs a direct field sales force which primarily calls upon national and regional quick-service restaurant, franchisee, and food retail chain headquarters, although the sales are made to distributors who supply the chain or franchisees units.
We believe that our Kay Division is the leading supplier of chemical cleaning and sanitizing products to the traditional quick-service restaurant industry in the United States. While Kays customer base has been growing, Kays business is largely dependent upon a limited number of major quick-service restaurant chains and franchisees. Kay continues to seek growth and diversification opportunities.
Food & Beverage : Our Food & Beverage Division addresses cleaning and sanitation at the beginning of the food chain to facilitate the production of products for human consumption. The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors. The Food & Beverage Division is also a leading developer and marketer of antimicrobial products used in direct contact with meat, poultry, seafood and produce during processing in order to reduce microbial contamination on those surfaces. The Division also designs, engineers and installs CIP (clean-in-place) process control systems and facility cleaning systems for its customer base. Farm products are sold through dealers and independent, third-party distributors, while plant products are sold primarily by our field sales personnel.
We believe that we are one of the leading suppliers of cleaning and sanitizing products to the dairy plant, dairy farm, food, meat and poultry, and beverage/brewery processor industries in the United States.
Textile Care : Our Textile Care Division provides chemical laundry products and proprietary dispensing systems, as well as related programs, to large industrial and commercial laundries. Typically these customers process a minimum of 1,000,000 pounds of linen each year and include free-standing laundry plants used by institutions such as hotels, restaurants and healthcare facilities as well as industrial and textile rental laundries. Products and programs include laundry cleaning and specialty products and related dispensing equipment, which are marketed primarily through a Company-employed sales force and, to a lesser extent, through independent, third-party distributors. The Divisions programs are designed to meet our customers need for exceptional cleaning, while extending the useful life of linen and reducing the customers overall operating cost.
Healthcare : Our Healthcare Division provides infection prevention and healthcare offerings to hospital, acute care and long-term care markets in the United States. Healthcares proprietary infection prevention/healthcare products (skin care, disinfectants and instrument cleaners) are sold primarily under the Ecolab and Huntington brand names.
Vehicle Care : Our Vehicle Care Division provides vehicle appearance products which include soaps, polishes, sealants, wheel and tire treatments and air fresheners. Products are sold to vehicle rental, fleet and consumer car wash and detail operations. Brand names utilized by the Vehicle Care Division include Blue Coral Ò , Black Magic Ò and Rain-X Ò .
4
Water Care Services : Water Care Services provides water and wastewater treatment products, services and systems for commercial/institutional customers (full service hotels, cruise ships, hospitals, healthcare, commercial real estate, government, and commercial laundries), food and beverage customers (dairies, meat, poultry, food processing and beverage) and other light industry. Water Care Services works closely with our Institutional, Textile Care and Food & Beverage Divisions to offer customized water care strategies to their accounts that have water care needs, primarily to treat water used in heating and cooling systems and manufacturing processes and to treat wastewater.
The United States Other Services segment is comprised of two business units: Pest Elimination and GCS Service. In general, these businesses provide service or equipment which can augment or extend our product offering to our business customers as a part of our Circle the Customer approach.
Pest Elimination : Our Pest Elimination Division provides services for the detection, elimination and prevention of pests to restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick-service restaurant and grocery operations and other institutional and commercial customers. These services are sold and performed by Company-employed sales and service personnel. In addition, through our EcoSure Food Safety Management business, the Division provides customized on-site evaluations, training and quality assurance services to foodservice operations.
GCS Service : GCS Service provides commercial cooking and refrigeration equipment repair and maintenance services for restaurant and other foodservice operations. Repair services are offered for in-warranty repair, acting as the Manufacturers Authorized Service Agent, as well as after warranty repair. In addition, GCS Service offers parts at a wholesale level to repair service companies and end users.
We conduct business in approximately 70 countries outside of the United States through wholly-owned subsidiaries or, in the case of Israel, the United Arab Emirates and Venezuela, through joint ventures with local partners. In other countries, selected products are sold by our export operations to distributors, agents or licensees, although the volume of those sales is not significant in terms of our overall revenues. Our largest International operations are located in Europe, Asia Pacific, Latin America and Canada, with smaller operations in Africa and the Middle East.
In general, the businesses conducted internationally are similar to those conducted in the United States but are managed on a geographic basis. The businesses which are similar to the United States Institutional and Food & Beverage businesses are the largest businesses in our International operations. They are conducted in virtually all our International locations and, compared to the United States, constitute a larger portion of the overall business. Kay also has sales in a number of International locations. A significant portion of Kays international sales are to international units of United States-based quick-service restaurant chains. Consequently, a substantial portion of Kays international sales are made either to domestic or internationally-located third-party distributors who serve these chains.
Our Pest Elimination business continues to expand its geographic coverage. Since 2001, we have entered markets in Brazil, Chile, the United Kingdom, Ireland, France and South Africa, primarily through acquisitions.
Our other businesses are conducted less extensively in our International locations. However, in general, most of the principal businesses conducted in the United States are operated in Canada.
International businesses are subject to the usual risks of foreign operations, including possible changes in trade and foreign investment laws, tax laws, currency exchange rates and economic and
5
political conditions abroad. The profitability of our International operations has historically been lower than the profitability of our businesses in the United States. This has been due to the smaller scale of the International operations as well as the additional cost of operating in numerous and diverse foreign jurisdictions.
Additional Information
Competition : Our business units have two significant classes of competitors. First, each business unit competes with a small number of large companies selling directly or through distributors on a national or international scale. Second, all of our business units have numerous smaller regional or local competitors which focus on more limited geographies, product lines and/or end-user segments.
Our objective is to achieve a significant presence in each of our business markets. In general, competition is based on customer support, product performance and price. We believe we compete principally by providing superior value, premium customer support and differentiated products. Value is provided by state-of-the-art cleaning, sanitation and maintenance products and systems coupled with high customer support standards and continuing dedication to customer satisfaction. This is made possible, in part, by our significant on-going investment in training and technology and by our standard practice of advising customers on means to lower operating costs and helping them comply with safety, environmental and sanitation regulations. In addition, we emphasize our ability to uniformly provide a variety of related premium cleaning and sanitation programs to our customers and to provide that level of customer support to multiple locations of chain customer organizations worldwide. This approach is succinctly stated in our Circle the Customer Circle the Globe strategy which is discussed above in this Item 1(c) under the heading General.
Sales and Service : Products, systems and services are primarily marketed in domestic and international markets by Company-trained sales and service personnel who also advise and assist our customers in the proper and efficient use of the products and systems in order to meet a full range of cleaning and sanitation needs. Independent, third-party distributors are utilized in several markets, as described in the business unit descriptions found under the discussion of the three reportable segments above.
Number of Employees : We have approximately 23,130 employees.
Customers and Classes of Products : We believe that our business is not materially dependent upon a single customer although, as described above in this Item 1(c) under the description of the Kay business, Kay is largely dependent upon a limited number of national and international quick-service chains and franchisees. Additionally, although we have a diverse customer base and no customer or distributor constitutes ten percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position. No material part of our business is subject to renegotiation or termination at the election of a governmental unit. We sell two classes of products which each constitute 10 percent or more of our sales. Sales of warewashing products in 2006, 2005 and 2004 approximated 21, 21 and 22 percent, respectively, of our consolidated net sales. In addition, through our Institutional and Textile Care businesses, we sell laundry products and provide customer support to a broad range of laundry customers. Sales of laundry products and services in 2006, 2005 and 2004 approximated 10, 11 and 10 percent, respectively, of our consolidated net sales.
Patents and Trademarks : We own and license a number of patents, trademarks and other intellectual property, including through a license agreement with Henkel KGaA. While we have an active program to protect our intellectual property by filing for patents or trademarks, and pursuing legal action, when appropriate, to prevent infringement, we do not believe that our overall business is materially dependent on any individual patent or trademark.
6
Seasonality : Overall our business does not have a significant degree of seasonality. However, we do experience variability in our quarterly operating results due to sales volume and business mix fluctuations in our operating segments. Note 17, entitled Quarterly Financial Data located on page 47 of the Annual Report, is incorporated herein by reference.
Working Capital : We have invested in the past, and will continue to invest in the future, in merchandising equipment consisting primarily of systems used by customers to dispense our cleaning and sanitizing products. Otherwise, we have no unusual working capital requirements.
Manufacturing and Distribution : We manufacture most of our products and related equipment in Company-owned manufacturing facilities. Some products are also produced for us by third-party contract manufacturers, including Henkel KGaA. Other products and equipment are purchased from third-party suppliers. Additional information on product/equipment sourcing is found in the segment discussions above and additional information on our manufacturing facilities is located beginning at page 15 of this Form 10-K under the heading Properties.
Deliveries to customers are made from our manufacturing plants and a network of distribution centers and public warehouses. We use common carriers, our own delivery vehicles, and distributors. Additional information on our plant and distribution facilities is located beginning at page 15 of this Form 10-K under the heading Properties.
Raw Materials : Raw materials purchased for use in manufacturing our products are inorganic chemicals, including phosphates, silicates, alkalis, salts and organic chemicals, including surfactants and solvents. These materials are generally purchased on an annual contract basis from a diverse group of chemical manufacturers. When practical, global sourcing is used so that purchasing or production locations can be shifted to control product costs at globally competitive levels. Pesticides used by our Pest Elimination Division are purchased as finished products under contract or purchase order from the producers or their distributors. We also purchase packaging materials for our manufactured products and components for our specialized cleaning equipment and systems. Most raw materials, or substitutes for those materials, used by us, with the exception of a few specialized chemicals which we manufacture, are available from several suppliers.
Research and Development : Our research and development program consists principally of devising and testing new products, processes, techniques and equipment, improving the efficiency of existing ones, improving service program content, and evaluating the environmental compatibility of products. Key disciplines include analytical and formulation chemistry, microbiology, process and packaging engineering and product dispensing technology. Substantially all of our principal products have been developed by our research, development and engineering personnel. At times, technology has also been licensed from third parties to develop offerings. Note 13, entitled Research Expenditures located on page 40 of the Annual Report, is incorporated herein by reference.
Environmental and Regulatory Considerations : Our businesses are subject to various legislative enactments and regulations relating to the protection of the environment and public health. While we cooperate with governmental authorities and take commercially practicable measures to meet regulatory requirements and avoid or limit environmental effects, some risks are inherent in our businesses. Among the risks are costs associated with transporting and managing hazardous substances, waste disposal and plant site clean-up, fines and penalties if we are found to be in violation of law, as well as modifications, disruptions or discontinuation of certain operations or types of operations including product recalls. Additionally, although we are not currently aware of any such circumstances, there can be no assurance that future legislation or enforcement policies will not have a material adverse effect on our consolidated results of operations, financial position or cash flows. Environmental and regulatory matters most significant to us are discussed below.
7
Ingredient Legislation : Various laws and regulations have been enacted by state, local and foreign jurisdictions pertaining to the sale of products which contain phosphorous, volatile organic compounds, or other ingredients that may impact human health or the environment. Under California Proposition 65, label disclosures are required for certain products containing chemicals listed by California. To date, we generally have been able to comply with such legislative requirements by reformulation or labeling modifications. Such legislation has not had a material negative effect on our consolidated results of operations, financial position or cash flows to date.
Pesticide Legislation : Various international, federal and state environmental laws and regulations govern the manufacture and/or use of pesticides. We manufacture and sell certain disinfecting and sanitizing products which kill or reduce microorganisms (bacteria, viruses, fungi) on hard environmental surfaces and on certain food products. Such products constitute pesticides or antimicrobial pesticides under the current definitions of the Federal Insecticide Fungicide and Rodenticide Act (FIFRA), as amended by the Food Quality Protection Act of 1996, the principal federal statute governing the manufacture, labeling, handling and use of pesticides. We maintain approximately 400 product registrations with the U.S. Environmental Protection Agency (EPA). Registration entails the necessity to meet certain efficacy, toxicity and labeling requirements and to pay on-going registration fees. In addition, each state in which these products are sold requires registration and payment of a fee. In general, the states impose no substantive requirements different from those required by FIFRA. However, California and certain other states have adopted additional regulatory programs, and California imposes a tax on total pesticide sales in that State. While the cost of complying with rules as to pesticides has not had a material adverse effect on our consolidated results of operations, financial condition, or cash flows to date, the costs and delays in receiving necessary approvals for these products continue to increase. Total fees paid to the EPA and the states to obtain or maintain pesticide registrations, and for the California tax, were approximately $3,400,000 in 2006 and $2,900,000 in 2005. In Europe, the Biocidal Product Directive (98/8/EC) is establishing a program to evaluate and authorize marketing of biocidal active substances and products. The Biocidal Product Directive requirements are transitioning into effect. In September 2006, certain biocidal active substances not notified to the European Chemicals Bureau were required to be withdrawn from the market. We are working with suppliers and industry groups to manage requirements associated with the Biocidal Products Directive. Anticipated registration costs are not expected to significantly affect our consolidated results of operations, financial position or cash flows.
In addition, our Pest Elimination Division applies restricted-use pesticides which it generally purchases from third parties. That Division must comply with certain standards pertaining to the use of such pesticides and to the licensing of employees who apply such pesticides. Such regulations are enforced primarily by the states or local jurisdictions in conformity with federal regulations. We have not experienced material difficulties in complying with these requirements.
FDA Antimicrobial Product Requirements : Various laws and regulations have been enacted by federal, state, local and foreign jurisdictions regulating certain products manufactured and sold by us for controlling microbial growth on humans, animals, foods, and medical devices. In the United States, these requirements generally are administered by the U.S. Food and Drug Administration (FDA). However, the U.S. Department of Agriculture and EPA also may share in regulatory jurisdiction of antimicrobials applied to food. The FDA also has been expanding requirements applicable to such products, including proposing regulations in a Tentative Final Monograph for Healthcare Antiseptic Drug Products dated June 17, 1994 that may impose additional requirements associated with antimicrobial hand care products and associated costs when finalized by the FDA. To date, such
8
requirements have not had a material adverse effect on our consolidated results of operations, financial position or cash flows.
Europe : The European Union is developing a new regulatory framework for the Registration, Evaluation and Authorization of Chemicals (REACH). The European Parliament and Council adopted the REACH regulation in December 2006, and it will enter into force in June 2007. REACH will establish a new European Chemicals Agency in Helsinki, Finland. The Agency would be responsible for evaluating data to determine hazards and risks and to manage this program for authorizing chemicals for sale and distribution in Europe. All new and existing chemicals produced or imported into the European Union in quantities above one ton per year must be registered in a central database. For chemicals deemed to be of most concern, industry must gain specific authorization for particular uses which have been demonstrated to be safe. Other uses would be prohibited. To manage this new program, we are simplifying our product line and working with chemical suppliers to comply with registration requirements. The eventual impact of REACH will also be felt by our competitors. Potential costs to us are not yet fully quantifiable.
Other Environmental Legislation : Our manufacturing plants are subject to federal, state, local or foreign jurisdiction laws and regulations relating to discharge of hazardous substances into the environment and to the transportation, handling and disposal of such substances. The primary federal statutes that apply to our activities are the Clean Air Act, the Clean Water Act and the Resource Conservation and Recovery Act (RCRA). We are also subject to the Superfund Amendments and Reauthorization Act of 1986, which imposes certain reporting requirements as to emissions of hazardous substances into the air, land and water. We make capital investments and expenditures to comply with environmental laws and regulations, to ensure employee safety and to carry out its announced environmental stewardship principles. To date, such expenditures have not had a significant adverse effect on our consolidated results of operations, financial position or cash flows. Our capital expenditures for environmental health and safety projects world-wide were approximately $6,410,000 in 2006 and $4,230,000 in 2005. Approximately $9,370,000 has been budgeted globally for projects in 2007.
Environmental Remediation and Proceedings : Along with numerous other potentially responsible parties (PRPs), we are currently involved with waste disposal site clean-up activities imposed by the federal Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) or state equivalents at 22 sites in the United States. Additionally, we have similar liability at eight sites outside the United States. In general, under CERCLA, we and each other PRP which actually contributes hazardous substances to a Superfund site are jointly and severally liable for the costs associated with cleaning up the site. Customarily, the PRPs will work with the EPA to agree and implement a plan for site remediation. Pursuant to an Environmental Agreement dated December 7, 2000 with Henkel KGaA, Henkel agreed to indemnify us for certain environmental liabilities associated with the parties former joint venture in Europe. Reimbursement from Henkel has been requested for 647,924 euro (or approximately $855,000) spent for such environmental liabilities prior to December 31, 2006.
Based on an analysis of our experience with such environmental proceedings, our estimated share of all hazardous materials deposited on the sites referred to in the preceding paragraph, and our estimate of the contribution to be made by other PRPs which we believe have the financial ability to pay their shares, we have accrued our best estimate of our probable future costs relating to such known sites. Unasserted claims are not reflected in the accrual. In establishing accruals, potential insurance reimbursements are not included. The accrual is not discounted. It is not feasible to predict when the amounts accrued will be paid due to the uncertainties inherent in the environmental remediation and associated regulatory processes.
9
Our worldwide net expenditures for contamination remediation were approximately $950,000 in 2006 and $1,240,000 in 2005. Including the ChemLawn matters described below, our worldwide accruals at December 31, 2006 for probable future remediation expenditures totaled approximately $4,900,000. We review our exposure for contamination remediation costs periodically and our accruals are adjusted as considered appropriate. While the final resolution of these issues could result in costs below or above current accruals and, therefore, have an impact on our consolidated financial results in a future reporting period, we believe the ultimate resolution of these matters will not have a material effect on our consolidated results of operations, financial condition or liquidity. In addition, we have retained responsibility for certain sites where our former ChemLawn business is a PRP. Currently there are five such locations and, at each, ChemLawn is a de minimis party. Anticipated costs currently accrued for these matters were included in our loss from our discontinued ChemLawn operations in 1991. The accrual remaining reflects our best estimate of probable future costs.
Item 1(d) Financial Information About Geographic Areas .
The financial information about geographic areas appearing under the heading Operating Segments in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.
Our Internet address is www.ecolab.com. Copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports, are available free of charge on our website at www.ecolab.com/investor as soon as reasonably practicable after such material is filed with, or furnished to, the Securities and Exchange Commission.
In addition, the following governance materials are available on our website at www.ecolab.com/investor/governance and the same information is available in print to any requesting persons, free of charge, by writing to the Corporate Secretary at our headquarters address, or by submitting an e-mail request to investor.info@ecolab.com: (i) charters of the Audit, Compensation, Finance and Governance Committees of our Board of Directors; (ii) our Boards Corporate Governance Principles; and (iii) our Code of Conduct and Code of Ethics for Senior Officers and Finance Associates.
Executive Officers of the Company
The persons listed in the following table are our current executive officers. Officers are elected annually. There is no family relationship among any of the directors or executive officers, and no executive officer has been involved during the past five years in any legal proceedings described in applicable Securities and Exchange Commission regulations.
10
Name |
|
|
|
Age |
|
Office |
|
Positions Held Since
|
|
Douglas M. Baker, Jr. |
|
48 |
|
Chairman of the Board, President and Chief Executive Officer |
|
May 2006 - Present |
|
||
|
|
|
|
President and Chief Executive Officer |
|
Jul. 2004 - Apr. 2006 |
|
||
|
|
|
|
President and Chief Operating Officer |
|
Aug. 2002 - Jun. 2004 |
|
||
|
|
|
|
President Institutional Sector |
|
Mar. 2002 - Jul. 2002 |
|
||
|
|
|
|
Senior Vice President Institutional Sector |
|
Jan. 2002 - Feb. 2002 |
|
||
Lawrence T. Bell |
|
59 |
|
Senior Vice President, General Counsel and Secretary |
|
Jul. 2002 - Present |
|
||
|
|
|
|
Senior Vice President Law and General Counsel |
|
Jan. 2002 - Jun. 2002 |
|
||
Steven L. Fritze |
|
52 |
|
Executive Vice President and Chief Financial Officer |
|
Feb. 2004 - Present |
|
||
|
|
|
|
Senior Vice President and Chief Financial Officer |
|
Mar. 2002 - Jan. 2004 |
|
||
|
|
|
|
Senior Vice President Finance and Controller |
|
Jan. 2002 - Feb. 2002 |
|
||
Robert K. Gifford |
|
49 |
|
Senior Vice President Global Supply Chain |
|
Oct. 2005 - Present |
|
||
|
|
|
|
Vice President Supply Chain Management |
|
Sep. 2004 - Sep. 2005(1) |
|
||
Thomas W. Handley |
|
52 |
|
Executive Vice President-Specialty Sector |
|
Jan. 2004 - Present |
|
||
|
|
|
|
Senior Vice President Strategic Planning |
|
Aug. 2003 - Dec. 2003(2) |
|
||
Michael A. Hickey |
|
45 |
|
Senior Vice President Global Business Development |
|
Jan. 2006 - Present |
|
||
|
|
|
|
Senior Vice President Global / Corporate Accounts |
|
Nov. 2005 - Dec. 2005 |
|
||
|
|
|
|
Vice President Global/Corporate Accounts, Institutional Division |
|
Jan. 2002 - Oct. 2005 |
|
||
Diana D. Lewis |
|
60 |
|
Senior Vice President Human Resources |
|
Jan. 2002 - Present |
|
11
Phillip J. Mason |
|
56 |
|
Executive Vice President Asia Pacific and Latin America |
|
Dec. 2004 - Present |
|
|
|
|
|
Senior Vice President Strategic Business Development |
|
May 2004 - Nov. 2004(3) |
|
James A. Miller |
|
50 |
|
Executive Vice President Institutional Sector North America |
|
Jan. 2004 - Present |
|
|
|
|
|
Vice President and General Manager Institutional |
|
Sept. 2002 - Dec. 2003 |
|
|
|
|
|
Institutional Vice President-Marketing North America |
|
Jan. 2002 - Aug. 2002 |
|
Susan K. Nestegard |
|
46 |
|
Senior Vice President-Research, Development and Engineering and Chief Technical Officer |
|
Dec. 2004 - Present |
|
|
|
|
|
Vice President-Research, Development and Engineering and Chief Technical Officer |
|
Mar. 2003 - Nov. 2004(4) |
|
Daniel J. Schmechel |
|
47 |
|
Senior Vice President and Controller |
|
Dec. 2005 - Present |
|
|
|
|
|
Vice President and Controller |
|
Apr. 2002 - Nov. 2005 |
|
|
|
|
|
Vice President and Treasurer |
|
Jan. 2002 - Mar. 2002 |
|
C. William Snedeker |
|
61 |
|
Executive Vice President Global Services Sector |
|
Mar. 2006 - Present |
|
|
|
|
|
Senior Vice President Global Pest Elimination |
|
May 2003 - Feb. 2006 |
|
|
|
|
|
Vice President and General Manager Pest Elimination |
|
Jan. 2002 - Apr. 2003 |
|
Robert P. Tabb |
|
55 |
|
Vice President and Chief Information Officer |
|
Sep. 2003 - Present(5) |
|
1. Prior to joining Ecolab in September 2004, Mr. Gifford served as Vice President, World Logistics and Program Manager of Hewlett Packard Corporation for three years. Prior to Hewlett Packard, Mr. Gifford was employed by Compaq and Tandem.
2. Prior to joining Ecolab in August 2003, Mr. Handley was employed by the Procter & Gamble Company for 22 years in various management, marketing and executive positions including assignments in Japan and Mexico. Mr. Handleys last position at P&G was Vice President - Feminine Care Strategic Planning.
3. Mr. Mason re-joined Ecolab in May 2004, where he formerly served 23 years in various management and executive positions, most recently as Vice President Asia Pacific. Prior to re-joining Ecolab, Mr. Mason was employed by HAVI Group, LP, serving as President, HPR Partners from 1997-2004.
4. Prior to joining Ecolab in March 2003, Ms. Nestegard was employed by 3M Company for 20 years, most recently as Business Director of Optical Components. Ms. Nestegards experience includes product and process development and technical management as Director Engineering Systems Technology Center and as Technical Director of the Electronic Products Division of 3M in Austin, Texas.
5. Prior to joining Ecolab in September 2003, Mr. Tabb held various executive positions in the systems technology industry, most recently with Focus IT Group, a consulting firm. From 1997 2000 Mr. Tabb was employed by CNF Transportation, Inc. as Vice President and Chief Information Officer. From 2000 2001 Mr. Tabb served as Vice President, Global Information Technology at Nike, Inc.
12
The following are important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-K. See the section entitled Forward-Looking Statements located on page 2 of this Form 10-K.
We may also refer to this disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conference and/or webcasts open to the public.
Except as may be required under applicable law, we undertake no duty to update our Forward-Looking Statements.
Our results depend upon the continued vitality of the markets we serve: Economic downturns, and in particular downturns in the foodservice, hospitality, travel, health care and food processing industries, can adversely impact our end-users who are sensitive to changes in travel and dining activities. During such downturns, these end-users typically reduce their volume of purchases of cleaning, hygiene and appearance products, which would likely in turn have an adverse impact on our consolidated results of operations, financial condition, or cash flows.
Our growth depends upon our ability to successfully compete with respect to value, product offerings and customer support: Our competitive market is made up of numerous national, regional and local competitors. Our ability to compete depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize innovative, high value-added products for niche applications. There can be no assurance that we will be able to accomplish this or that technological developments by our competitors will not place certain of our products at a competitive disadvantage in the future. In addition, certain of the new products that we have under development will be offered in markets in which we do not currently compete, and there can be no assurance that we will be able to compete successfully in those new markets. If we fail to timely introduce new technologies, we may lose market share and our consolidated results of operations, financial condition, or cash flows could be adversely affected.
We enter into multi-year contracts with customers that can impact our results. We enter into multi-year contracts with some of our customers which include terms affecting our pricing flexibility. There can be no assurance that these restraints will not have an adverse impact on our margins and operating income.
Consolidation of our customer and vendors can affect our results: Customers and vendors in the foodservice, hospitality and lodging industry have been consolidating in recent years and that trend may continue. This consolidation could have an adverse impact on our ability to retain customers and on our margins and operating income.
Our results can be adversely affected by fluctuations in the cost of raw materials: The prices of raw materials used in our business can fluctuate significantly from time to time, and have increased in recent years. Changes in oil or raw material prices, unavailability of adequate and reasonably priced raw materials or substitutes for those raw materials, or the inability to obtain or renew supply agreements on favorable terms can adversely affect our consolidated results of operations, financial position or cash flows.
13
If we are unsuccessful in integrating acquisitions, our business could be adversely affected : As part of our long-term strategy, we seek to acquire complementary businesses. There can be no assurance that we will find attractive acquisition candidates or succeed at effectively managing the integration of acquired businesses into existing businesses. If the expected synergies from such transactions do not materialize or we fail to successfully integrate new businesses into our existing businesses, our consolidated results of operations, financial position or cash flows could be adversely affected.
Our business depends on our ability to comply with governmental regulations: Our business is subject to numerous regulations relating to the environment and to the manufacture, storage, distribution, sale and use of our products. Compliance with these regulations, as well as changes in tax, fiscal, governmental and other regulatory policies expose us to potential financial liability and increase our operating costs. Regulation of our products and operations continues to increase with more stringent standards, causing increased costs of operations and potential for liability if a violation occurs. The potential cost to us relating to environmental and product registration laws and regulations is uncertain due to factors such as the unknown magnitude and type of possible contamination and clean-up costs, the complexity and evolving nature of laws and regulations, and the timing and expense of compliance. In addition, changes in accounting standards, including the adoption effective January 1, 2007 of FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109, could increase the volatility of our quarterly tax rate.
Our results are impacted by general worldwide economic factors: Economic factors such as the worldwide economy, interest rates and currency movements including, in particular, our exposure to foreign currency risk have affected our business in the past and may have a material adverse impact on our consolidated results of operations, financial condition, or cash flows in the future.
Extraordinary events may significantly impact our business: The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war (including acts of terrorism or hostilities which impact our markets), (d) natural or manmade disasters, or (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries may have a significant, adverse impact on our business.
Defense of litigation, particularly certain types of actions such as antitrust, patent infringement and class action lawsuits, can be costly and time consuming even if ultimately successful, and if not successful could have a material adverse impact on our consolidated results of operations, financial position or cash flows.
While we have a diverse customer base and no customer or distributor constitutes ten percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on our consolidated results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position.
War (including acts of terrorism or hostilities), natural or manmade disasters or severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries cause a downturn in the business of restaurants, motels and hotels and other of our customers, which in turn can have a material adverse impact on our business, financial condition, results of operations and cash flows.
14
We depend on key personnel to lead our business: Our continued success will largely depend on our ability to attract and retain a high caliber of talent and on the efforts and abilities of our executive officers and certain other key employees. Our operations could be adversely affected if for any reason such officers or key employees did not remain with us.
Our manufacturing philosophy is to manufacture products wherever an economic, process or quality assurance advantage exists or where proprietary manufacturing techniques dictate internal production processes. Currently, most products sold by us are manufactured at our facilities.
Our manufacturing facilities produce chemical products or equipment for all of our businesses, although the businesses constituting the United States Other Services segment purchase the majority of their products and equipment from outside suppliers. Our chemical production process consists primarily of blending and packaging powders and liquids and casting solids. Our equipment manufacturing operations consist primarily of producing chemical product dispensers and injectors and other mechanical equipment and dishwasher racks and related sundries.
The following chart profiles our main manufacturing facilities with ongoing production activities. In general, manufacturing facilities located in the United States serve the United States Cleaning & Sanitizing segment and facilities located outside of the United States serve the International segment. However, certain of the United States facilities do manufacture products for export and which are used by the International segment. The facilities having export involvement are marked with an asterisk(*).
Location |
|
|
|
Size (Sq. Ft.) |
|
Types of Products |
|
Majority
|
|
UNITED STATES |
|
|
|
|
|
|
|
||
Joliet, IL * |
|
610,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
||
South Beloit, IL * |
|
313,000 |
|
Equipment |
|
Owned |
|
||
Garland, TX * |
|
239,000 |
|
Solids, Liquids |
|
Owned |
|
||
Martinsburg, WV |
|
228,000 |
|
Liquids |
|
Owned |
|
||
Hebron, OH |
|
196,000 |
|
Liquids |
|
Owned |
|
||
Greensboro, NC |
|
193,000 |
|
Liquids, Powders |
|
Owned |
|
||
San Jose, CA |
|
175,000 |
|
Liquids |
|
Owned |
|
||
McDonough, GA* |
|
141,000 |
|
Solids, Liquids |
|
Owned |
|
||
Eagan, MN * |
|
133,000 |
|
Solids, Liquids, Emulsions, Powders |
|
Owned |
|
||
Huntington, IN * |
|
127,000 |
|
Liquids |
|
Owned |
|
||
City of Industry, CA |
|
125,000 |
|
Liquids |
|
Owned |
|
||
Elk Grove Village, IL * |
|
115,000 |
|
Equipment |
|
Leased |
|
||
Fort Worth, TX |
|
101,000 |
|
Equipment |
|
Leased |
|
||
Carrollton, TX |
|
70,000 |
|
Liquids |
|
Owned |
|
||
St. Louis, MO |
|
37,000 |
|
Equipment |
|
Leased |
|
||
City of Industry, CA |
|
30,000 |
|
Equipment |
|
Leased |
|
15
Location |
|
|
|
Size (Sq. Ft.) |
|
Types of Products |
|
Majority
|
|
INTERNATIONAL |
|
|
|
|
|
|
|
||
Chalons, FRANCE |
|
280,000 |
|
Liquids, Powders |
|
Owned |
|
||
Nieuwegein, NETHERLANDS |
|
168,000 |
|
Powders |
|
Owned |
|
||
Tessenderlo, BELGIUM |
|
153,000 |
|
Solids, Liquids |
|
Owned |
|
||
Melbourne, AUSTRALIA |
|
145,300 |
|
Liquids, Powders |
|
Owned |
|
||
Rozzano, ITALY |
|
126,000 |
|
Liquids |
|
Owned |
|
||
Mississauga, CANADA |
|
120,400 |
|
Liquids |
|
Leased |
|
||
Johannesburg, SOUTH AFRICA |
|
100,000 |
|
Liquids, Powders |
|
Owned |
|
||
Hamilton, NEW ZEALAND |
|
96,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
||
Mullingar, IRELAND |
|
74,300 |
|
Liquids |
|
Leased |
|
||
Valby, DENMARK |
|
70,000 |
|
Liquids |
|
Owned |
|
||
Sao Paulo, BRAZIL |
|
62,325 |
|
Solids, Liquids |
|
Leased |
|
||
Shika, JAPAN |
|
60,000 |
|
Liquids |
|
Owned |
|
||
Santiago, CHILE |
|
60,000 |
|
Liquids, Powders |
|
Leased |
|
||
Revesby, AUSTRALIA |
|
59,200 |
|
Liquids, Powders |
|
Owned |
|
||
Cheadle (Hulme), UNITED KINGDOM |
|
52,575 |
|
Liquids |
|
Leased |
|
||
Guangzhou, CHINA |
|
50,230 |
|
Liquids, Powders |
|
Leased |
|
||
Noda, JAPAN |
|
49,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
||
Siegsdorf, GERMANY |
|
42,000 |
|
Equipment |
|
Owned |
|
||
Mexico City, MEXICO |
|
40,000 |
|
Liquids, Powders |
|
Owned |
|
||
Maribor, SLOVENIA |
|
39,000 |
|
Liquids, Powders |
|
Owned |
|
||
Leeds, UNITED KINGDOM |
|
35,000 |
|
Liquids |
|
Owned |
|
||
Pilar, ARGENTINA |
|
30,000 |
|
Liquids, Powders |
|
Owned |
|
||
Shanghai, CHINA |
|
27,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
||
Perth, AUSTRALIA |
|
26,900 |
|
Liquids, Powders |
|
Owned |
|
||
Dorado, PUERTO RICO |
|
25,000 |
|
Liquids, Powders |
|
Leased |
|
||
Singapore, SINGAPORE |
|
25,000 |
|
Liquids, Powders |
|
Owned |
|
||
Dar es Salaam, TANZANIA |
|
22,900 |
|
Liquids, Powders |
|
Leased |
|
||
Seoul, SOUTH KOREA |
|
22,160 |
|
Liquids, Powders |
|
Owned |
|
||
Racibor, POLAND |
|
20,000 |
|
Liquids |
|
Leased |
|
||
Mandras, GREECE |
|
18,000 |
|
Liquids |
|
Owned |
|
||
San Jose, COSTA RICA |
|
11,000 |
|
Liquids, Powders |
|
Owned |
|
||
Cikarang, INDONESIA |
|
10,000 |
|
Solids, Liquids, Powders |
|
Owned |
|
||
Bangkok, THAILAND |
|
10,000 |
|
Liquids, Powders |
|
Owned |
|
||
Manilla, PHILIPPINES |
|
7,600 |
|
Liquids, Powders |
|
Owned |
|
16
We believe our manufacturing facilities are in good condition and are adequate to meet our existing production needs, except that a new manufacturing facility in Wales, U.K. is being constructed to support continued growth in Europe.
Most of our manufacturing plants also serve as distribution centers. In addition, we operate distribution centers around the world, all of which are leased, and utilize various public warehouses to facilitate the distribution of our products and services. In the United States, our sales and service associates are located in approximately 90 leased offices. Additional sales offices are located internationally.
Our corporate headquarters is comprised of three adjacent multi-storied buildings located in downtown St. Paul, Minnesota. The main 19-story building was constructed to our specifications and is leased through 2008. Thereafter, it is subject to multiple renewals at our option. The second building is leased through 2011 with additional options available. The third building is owned. The corporate headquarters includes an employee training center. In April 2004, we purchased a 90 acre campus in Eagan, Minnesota to provide for future growth. The acquired facility houses the research and development and data center requirements as well as several of our administrative functions. Renovations of the buildings on this property, comprising approximately 500,000 square feet, have been completed and more than 800 associates now work at this site. Our former research center in Mendota Heights, Minnesota and the data center in St. Paul were sold in 2005.
The Company and certain of our subsidiaries are defendants in various lawsuits and claims arising out of the normal course of business. Accruals have been established reflecting our best estimate of probable future costs relating to such matters.
As previously reported, the New York State Department of Environmental Conservation issued a Notice of Violation in 2006 alleging that two products had been sold by us with phosphorous levels exceeding New York State requirements for certain household cleansing products. We have provided information to the State resolving allegations relating to one of the products that is not in violation of the relevant statute, have suspended sales of the other product, and are in discussions with the State attempting to resolve the matter.
As previously reported, in June 2006 Ecolab received notice from the Connecticut Department of Environmental Protection alleging violations of state regulatory requirements for the business of commercial pesticide applications. This matter relates mainly to supervisory issues relative to application procedures. In December 2006 Ecolab signed an Administrative Order on Consent (AOC) that resolved the states pest elimination enforcement action. Under the terms of the AOC, Ecolab will pay a $145,750 penalty and fund three supplemental environmental improvement projects worth a total of $437,250.
Other matters arising under laws relating to protection of the environment are discussed at Item 1(c) above, under the heading Environmental and Regulatory Considerations.
Item 4. Submission of Matters to a Vote of Security Holders .
No matters were submitted to a vote of our security holders during the fourth quarter of 2006.
17
Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities .
Market Information : Our Common Stock is listed on the New York Stock Exchange under the symbol ECL. The Common Stock is also traded on an unlisted basis on certain other United States exchanges. The high and low sales prices of our Common Stock on the consolidated transaction reporting system during 2006 and 2005 were as follows:
|
|
2006 |
|
2005 |
|
||||||||||
Quarter |
|
|
|
High |
|
Low |
|
High |
|
Low |
|
||||
First |
|
$ |
40.50 |
|
$ |
33.64 |
|
$ |
35.08 |
|
$ |
31.20 |
|
||
Second |
|
$ |
41.20 |
|
$ |
37.00 |
|
$ |
34.23 |
|
$ |
30.68 |
|
||
Third |
|
$ |
45.44 |
|
$ |
39.57 |
|
$ |
34.14 |
|
$ |
30.75 |
|
||
Fourth |
|
$ |
46.40 |
|
$ |
42.17 |
|
$ |
37.15 |
|
$ |
30.93 |
|
||
The closing Common Stock price on January 31, 2007 was $43.90.
Holders : On January 31, 2007, we had 5,222 holders of Common Stock of record.
Dividends : We have paid Common Stock dividends for 70 consecutive years. Quarterly cash dividends of $0.0875 per share were declared in February, May and August 2005. Cash dividends of $0.10 per share were declared in December 2005, and February, May and August 2006. A dividend of $0.115 per share was declared in December 2006.
Issuer Purchases of Equity Securities :
Period |
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
|
|
October 1-31, 2006 |
|
256,733 |
|
$ |
43.8163 |
|
199,900 |
|
13,312,500 |
|
||
November 1-30, 2006 |
|
215,309 |
|
$ |
45.1004 |
|
200,000 |
|
13,112,500 |
|
||
December 1-31, 2006 |
|
204,885 |
|
$ |
44.6910 |
|
186,500 |
|
12,926,000 |
|
||
Total |
|
676,927 |
|
$ |
44.4895 |
|
586,400 |
|
12,926,000 |
|
(1) In addition to programs under publicly announced plans, column (a) includes 90,527 shares reacquired from employees and/or directors as swaps for the cost of stock options, shares surrendered to satisfy minimum statutory tax obligations, under our stock incentive plans, or forfeitures of unvested shares of restricted stock.
(2) The average price paid per share includes brokerage commissions associated with publicly announced plan purchases plus the value of such other reacquired shares.
(3) As announced on December 9, 2004, our Board of Directors authorized the repurchase of up to 10,000,000 additional shares of Common Stock, including shares to be repurchased under Rule 10b5-1. As announced on October 26, 2006, our Board of Directors authorized the repurchase of up to 10,000,000 additional shares of Common Stock, including shares to be repurchased under Rule 10b5-1. We intend to repurchase all shares under this authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions.
18
Item 6. Selected Financial Data .
The comparative data for the years ended December 31, 2006, 2005, 2004, 2003 and 2002 inclusive, which are set forth under the heading entitled Summary Operating and Financial Data located on pages 50 and 51 of the Annual Report, are incorporated herein by reference.
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operation .
The material appearing under the heading entitled Financial Discussion, located on pages 17 through 26 of the Annual Report, is incorporated herein by reference.
The material appearing under the heading entitled Market Risk, located on page 26 of the Annual Report, is incorporated herein by reference.
Item 8. Financial Statements and Supplementary Data .
The financial statements and material which are an integral part of the financial statements listed under Item 15.I(1). below and located on pages 27 through 51 of the Annual Report, are incorporated herein by reference.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure .
None.
Disclosure Controls and Procedures : As of December 31, 2006, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board, President and Chief Executive Officer and the Executive Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 as amended). Based upon that evaluation, our Chairman of the Board, President and Chief Executive Officer and the Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures are effective.
Internal Control Over Financial Reporting : Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, including our Chairman of the Board, President and Chief Executive Officer and Executive Vice President and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2006.
Our managements assessment of the effectiveness of our internal control over financial reporting as of December 31, 2006 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm. PricewaterhouseCoopers LLP has issued an attestation report on our controls over financial reporting. Their report, and our management reports, can be found in our Annual Report, the relevant portion of which has been filed as Exhibit (13) to this Form 10-K and is incorporated into Item 8 of this Form 10-K.
19
During the period October 1 - December 31, 2006, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
The following disclosures would otherwise be filed on Form 8-K under the heading Item 5.02(e) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In the paragraphs below describing certain of our executive compensation plans and programs, the Named Executive Officers or NEOs refer to our Principal Executive Officer and Principal Financial Officer during 2006 and the next three most-highly compensated executive officers who were serving in those capacities at December 31, 2006, and the Committee refers to the Compensation Committee of the Board of Directors.
General : The components of the overall compensation program for the Companys executive officers include base salary, long-term incentives in the form of annual stock option awards, cash-based annual bonus incentives, participation in deferred compensation and retirement plans, and certain perquisites. Information regarding the compensation awarded to the NEOs in respect of and during the year ended December 31, 2006 will be provided in the definitive proxy statement for the Companys 2007 annual meeting of stockholders, which is expected to be filed with the Securities and Exchange Commission on or around March 30, 2007.
Base Salary : For the 2007 fiscal year, base salaries for the NEOs, other than the CEO, are scheduled to increase on an annualized basis by an average of 7.1%. The salary of the CEO has been established at $900,000, representing an increase of $100,000 over 2006. The base salaries established for the 2007 fiscal year for the NEOs are included as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)U to this Form 10-K and incorporated by reference herein.
Establishment of 2007 Non-Equity Incentive Plan Compensation Criteria : The Company maintains annual cash incentive programs for executives referred to as the Management Incentive Plan or MIP and Management Performance Incentive Plan or MPIP. The Companys stockholders approved the current version of the MPIP in 2004, an annual incentive plan under which awards should qualify as performance based under Internal Revenue Code Section 162(m). On February 22, 2007, as required under the terms of the MPIP, the Committee selected the CEO and CFO and one other NEO to participate in the MPIP for 2007, established the 2007 performance goal based upon the performance criteria of diluted earnings per share (EPS), set an EPS performance target of a designated earnings per share, and designated a cash award of 300% of the base salary of each such officer for 2007 to the extent the goal is achieved. The award is subject to and interpreted in accordance with the terms and conditions of the MPIP and no amount will be paid under the MPIP unless and until the Committee has determined the extent to which the performance goal has been met and the corresponding amount of the award earned by the participant. The MPIP permits the Committee to exercise downward discretion so as to pay an amount which is less than the amount of the award earned by the participant. In applying this downward discretion, the Committee considers underlying operable metrics communicated to the participant, which are described as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)U to this Form 10-K and incorporated by reference herein. Two other NEOs will participate in the MIP in 2007 and the operating metrics with respect to such NEOs participation are similarly included as a part of Exhibit (10)U.
Adoption of Form of Restricted Stock Award Agreement : On February 22, 2007, the Committee approved the form of Agreement for restricted stock awards granted under our 2005 Stock Incentive Plan (2005 Plan). Each restricted stock award will vest at such times and in such installments as may be determined by the Committee and, until such award vests, will be subject to restrictions on transferability and the possibility of forfeiture. An unvested restricted stock award will become fully
20
vested upon the termination of employment due to death or disability of the holder of such award or if we have a change-in-control (as such term is defined in the 2005 Plan). Such an award will be terminated and forfeited upon such holders termination of employment for any other reason. A holder will have all voting, liquidation and other rights with respect to the shares covered by a restricted stock award. A holder will have no right to receive dividends or distributions with respect to unvested shares, however, the Committee may distribute special dividends or distributions paid on such unvested shares or direct that such special dividends or distributions be held subject to the award restrictions.
The foregoing summary of the restricted stock award agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which is attached as Exhibit (10)W(iii) to this Form 10-K and incorporated by reference herein.
Information about our directors is incorporated by reference from the discussion under the heading Proposal to Elect Directors located in the Proxy Statement. Information about compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, is incorporated by reference from the discussion under the heading Section 16(a) Beneficial Ownership Reporting Compliance located in the Proxy Statement. Information about our Audit Committee, including the members of the Committee, and our Audit Committee financial experts, is incorporated by reference from the discussion under the heading Corporate Governance, and sub-headings Board Committees and Audit Committee, located in the Proxy Statement. Information about our Code of Conduct is incorporated by reference from the discussion under the heading Corporate Governance Materials and Code of Conduct located in the Proxy Statement. Information regarding our executive officers is presented under the heading Executive Officers of the Company in Part I on pages 10 through 12 of this Form 10-K, and is incorporated herein by reference.
Item 11. Executive Compensation .
Information appearing under the headings entitled Executive Compensation and Director Compensation located in the Proxy Statement is incorporated herein by reference. However, pursuant to Instructions to Item 407(e)(5) of Securities and Exchange Commission Regulation S-K, the material appearing under the sub-heading Compensation Committee Report shall not be deemed to be filed with the Commission, other than as provided in this Item 11.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters .
Information appearing under the heading entitled Security Ownership located in the Proxy Statement is incorporated herein by reference. The holdings of Henkel KGaA and Henkel Corporation are subject to certain limitations with respect to our voting securities as more fully described in our Proxy Statement under the heading Stockholder Agreement, and is incorporated herein by reference.
A total of 494,715 shares of Common Stock held by our directors and executive officers, some of whom may be deemed to be affiliates of the Company, have been excluded from the computation of market value of our Common Stock on the cover page of this Form 10-K. This total represents that portion of the shares reported as beneficially owned by our directors and executive officers as of June 30, 2006, which are actually issued and outstanding.
21
Equity Compensation Plan Information : The following table presents, as of December 31, 2006, compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance.
Plan Category |
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
|
Equity compensation plans approved by security holders |
|
21,778,635 |
(1)(2) |
$ |
29.74 |
(2) |
11,689,435 |
(3) |
||
Equity compensation plans not approved by security holders |
|
-0- |
|
|
|
-0- |
|
|||
Total |
|
21,778,635 |
(1)(2) |
$ |
29.74 |
(2) |
11,689,435 |
(3) |
(1) Includes 125,492 Common Stock equivalents under our 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. These Common Stock equivalents represent deferred compensation earned by non-employee directors and are excluded from the calculation of weighted average exercise price of outstanding options, warrants and rights in column (b) of this table.
(2) Includes 14,343 shares of our Common Stock subject to stock options with a weighted-average exercise price of $26.97, which we assumed in connection with our acquisition of Alcide Corporation effective July 30, 2004. These assumed options are deemed exempt from shareholder approval under Rule 303A.08 of the New York Stock Exchange in accordance with our notice to the NYSE dated August 18, 2004. The respective Alcide plans were amended to prohibit future grants.
(3) Includes 1,100,000 shares restored to reserves as part of a refueling feature of our 2002 Stock Incentive Plan. The refueling feature permits the restoration of shares repurchased on the open market using proceeds from options exercised under the Plan.
Item 13. Certain Relationships and Related Transactions .
Information appearing under the heading entitled Director Independence Standards and Determinations and Related Person Transactions located in the Proxy Statement as well as the biographical material pertaining to Messrs. Stefan Hamelmann, Kasper Rorsted and Hans Van Bylen, located in the Proxy Statement under the heading Proposal to Elect Directors are incorporated herein by reference.
Information appearing under the heading entitled Audit Fees located in the Proxy Statement is incorporated herein by reference.
22
Item 15. Exhibits and Financial Statement Schedules .
I(1). The following financial statements of the Company, included in the Annual Report, are incorporated into Item 8 hereof.
(i) Consolidated Statement of Income for the years ended December 31, 2006, 2005 and 2004, Annual Report page 27.
(ii) Consolidated Balance Sheet at December 31, 2006 and 2005, Annual Report page 28.
(iii) Consolidated Statement of Cash Flows for the years ended December 31, 2006, 2005 and 2004, Annual Report page 29.
(iv) Consolidated Statement of Comprehensive Income and Shareholders Equity for the years ended December 31, 2006, 2005 and 2004, Annual Report page 30.
(v) Notes to Consolidated Financial Statements, Annual Report pages 31 through 47.
(vi) Report of Independent Registered Public Accounting Firm, Annual Report page 49.
I(2). The following financial statement schedule to the Companys financial statements listed in Item 15.I(1). for the years ended December 31, 2006, 2005 and 2004 located on page 33 hereof, and the Report of Independent Registered Public Accounting Firm on Financial Statement Schedule at page 32 hereof, are filed as part of this Report.
(i) Schedule II Valuation and Qualifying Accounts for the years ended December 31, 2006, 2005 and 2004.
All other schedules, for which provision is made in the applicable regulations of the Securities and Exchange Commission, are not required under the related instructions or are inapplicable and therefore have been omitted. All significant majority-owned subsidiaries are included in the filed consolidated financial statements.
II. The following documents are filed as exhibits to this Report. We will, upon request and payment of a fee not exceeding the rate at which copies are available from the Securities and Exchange Commission, furnish copies of any of the following exhibits to stockholders.
(3)A. Restated Certificate of Incorporation of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006 Incorporated by reference to Exhibit (3)A of our Form 10-K Annual Report for the year ended December 31, 2005.
B. Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006 Incorporated by reference to Exhibit (3)C of our Form 10-K Annual Report for the year ended December 31, 2005.
C. By-Laws, as amended through February 18, 1999 - Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report for the year ended December 31, 1998.
(4)A. Common Stock - see Exhibits (3)A and (3)C.
B. Form of Common Stock Certificate effective February 28, 2007.
C. Rights Agreement, dated as of February 24, 2006, between Ecolab Inc. and Computershare Investor Services, LLC, as Rights Agent, which includes the following exhibits thereto: (i) Exhibit A Form of Certificate of Designation,
23
Preferences and Rights of Series A Junior Participating Preferred Stock and (ii) Exhibit B Form of Rights Certificate Incorporated by reference to Exhibit (4)C of our Form 10-K Annual Report for the year ended December 31, 2005.
D. Second Amended and Restated Stockholders Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001 - Incorporated by reference to Exhibit (4) of our Form 8-K dated November 30, 2001.
E. Amended and Restated Indenture, dated as of January 9, 2001, between Ecolab Inc. and Bank One, NA (formerly known as The First National Bank of Chicago) as Trustee - Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001.
F. Officers Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011 - Incorporated by reference to Exhibit 4(B) of our Form 8-K dated January 23, 2001.
G. Form of 6.875% Note due February 2, 2011 - Incorporated by reference to Exhibit 4(c) of our Form 8-K dated January 23, 2001.
Copies of other constituent instruments defining the rights of holders of our long-term debt are not filed herewith, pursuant to Section (b)(4)(iii) of Item 601 of Regulation S-K, because the aggregate amount of securities authorized under each of such instruments is less than 10% of our total assets on a consolidated basis. We will, upon request by the Securities and Exchange Commission, furnish to the Commission a copy of each such instrument.
(10)A. Multicurrency Credit Agreement, dated as of September 29, 1993, as amended and restated as of June 1, 2006, among Ecolab Inc., the financial institutions party thereto as Banks from time to time, the financial institutions party thereto as Issuing Banks from time to time, Citibank, N.A., as administrative agent for the Banks and Issuing Banks thereunder, Citibank International PLC, as agent for the Banks in connection with certain of the Eurocurrency Advances, and JPMorgan Chase Bank, N.A., as syndication agent Incorporated by reference to Exhibit (10) of our Form 8-K dated June 1, 2006.
B. Documents comprising global Commercial Paper Programs
(i) U.S. $200,000,000 Euro-Commercial Paper Programme
(a) Amended and Restated Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers), Ecolab Inc., Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank International plc and Credit Suisse First Boston (Europe) Limited (as Dealers). Incorporated by reference to Exhibit (10)B(i)(a) of our Form 10-K Annual Report for the year ended December 31, 2005.
(b) Amended and Restated Note Agency Agreement dated as of 2 December 2005 between Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank, N.A. as Issue and Paying Agent. Incorporated by reference to Exhibit (10)B(i)(b) of our Form 10-K Annual Report for the year ended December 31, 2005.
(c) Deed of Covenant made on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH. Incorporated by reference to Exhibit (10)B(i)(c) of our Form 10-K Annual Report for the year ended December 31, 2005.
(d) Deed of Guarantee made on 2 December 2005. Incorporated by reference to Exhibit (10)B(i)(d) of our Form 10-K Annual Report for the year ended December 31, 2005.
(ii) U.S. $450,000,000 U.S. Commercial Paper Program
(a) Form of Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc - Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003.
24
(b) Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent - Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003.
C. (i) Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000 -
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000.
(ii) Non-Statutory Stock Option Agreement as in effect for grants through May 12, 2000 Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended June 30, 2004.
(iii) Non-Statutory Stock Option Agreement as in effect for grants beginning May 13, 2000 through May 10, 2002 Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended June 30, 2004.
D. (i) 1995 Non-Employee Director Stock Option Plan.
(ii) Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000 - Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K Annual Report for the year ended December 31, 2000.
(iii) Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001 - Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2003.
E. (i) Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan as amended
effective May 1, 2004 Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2003.
(ii) Amendment No. 1 adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended and restated effective May 1, 2004, with respect to the American Jobs Creation Act of 2004 Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
(iii) Master Agreement Relating to Options (as in effect through May 7, 2004) Incorporated by reference to Exhibit (10)D(i) of our Form 10-Q for the quarter ended June 30, 2004.
(iv) Master Agreement Relating to Periodic Options, as amended effective as of May 1, 2004 Incorporated by reference to Exhibit (10)D(ii) of our Form 10-Q for the quarter ended June 30, 2004.
F. Note Purchase Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the Purchasers party thereto Incorporated by reference to Exhibit (10) of our Form 8-K dated July 26, 2006.
G. Form of Director Indemnification Agreement. Substantially identical agreements are in effect as to each of our directors Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2003.
H. (i) Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994. See also Exhibit
(10)N hereof.
(ii) Amendment No. 1 to Ecolab Executive Death Benefits Plan Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 1998.
(iii) Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998 - Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K Annual Report for the year ended December 31, 1998.
25
(iv) Amendment No. 3 to the Ecolab Executive Death Benefits Plan, effective August 12, 2005 Incorporated by reference to Exhibit (10)B of our Form 8-K dated December 13, 2005.
I. Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994. See also Exhibit (10)N hereof Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2004.
J. Ecolab Executive Financial Counseling Plan Incorporated by reference to Exhibit (10)J of our Form 10-K Annual Report for the year ended December 31, 2004.
K. (i) Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003
Incorporated by reference to Exhibit (10)M of our Form 10-K Annual Report for the year ended December 31, 2003.
(ii) Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Supplemental Executive Retirement Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 Incorporated by reference to Exhibit (10)K(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
L. (i) Ecolab Mirror Savings Plan, as amended and restated effective as of March 1, 2002 - Incorporated by
reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002.
(ii) Amendment No. 1 adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended and Restated Effective as of March 1, 2002) With Respect to the American Jobs Creation Act of 2004 Incorporated by reference to Exhibit (10)L(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
(iii) Amendment No. 2 to the Ecolab Mirror Savings Plan, effective January 1, 2005 Incorporated by reference to Exhibit (10)A of our Form 8-K dated December 13, 2005.
M. (i) Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003 - Incorporated by
reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003. See also Exhibit (10)N hereof.
(ii) Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Mirror Pension Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 Incorporated by reference to Exhibit (10)M(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
N. (i) Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective
as of January 1, 2003 Incorporated by reference to Exhibit (10)P of our Form 10-K Annual Report for the year ended December 31, 2003.
(ii) Amendment No. 1 adopted December 16, 2004 to the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004 Incorporated by reference to Exhibit (10)N(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
O. (i) Ecolab Inc. Management Performance Incentive Plan, as amended and restated on February 28, 2004
Incorporated by reference to Exhibit (10)A of our Form 10-Q for the quarter ended March 31, 2004.
(ii) Amendment No. 1 adopted February 26, 2005 to the Ecolab Inc. Management Performance Incentive Plan Incorporated by reference to Exhibit (10)O(ii) of our Form 10-K Annual Report for the year ended December 31, 2004.
26
P. Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002 - Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2001.
Q. (i) Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA - Incorporated
by reference to Exhibit 18 of HC Investments, Inc.s and Henkel KGaAs Amendment No. 5 to Schedule 13D dated December 14, 2000.
(ii) Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA - Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001.
(iii) Intellectual Property Agreement dated November 30, 2001, between Ecolab and Henkel KGaA - Incorporated by reference to Exhibit (10) of our Form 8-K dated November 30, 2001.
R. (i) Ecolab Inc. 2002 Stock Incentive Plan - Incorporated by reference to Exhibit (10) of our Form 10-Q for the
quarter ended June 30, 2002.
(ii) Non-statutory Stock Option Agreement as in effect for grants beginning May 11, 2002 through August 12, 2003 Incorporated by reference to Exhibit (10)A(i) of our Form 10-Q for the quarter ended June 30, 2004.
(iii) Non-statutory Stock Option Agreement as in effect for grants beginning August 13, 2003 Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q for the quarter ended June 30, 2004.
S. (i) Transition Agreement effective February 28, 2004 by and between Ecolab Inc. and Allan L. Schuman
including related arrangements Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended March 31, 2004.
(ii)
Amendment
No. 1 to Transition Agreement by and between Ecolab Inc.
and Allan L. Schuman Incorporated by reference to Exhibit (10) of our Form
8-K dated January 1, 2006.
(iii) Non-statutory Stock Option Agreement Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended March 31, 2004.
(iv) Mutual Release by Allan L. Schuman and Ecolab Inc. Incorporated by reference to Exhibit (10)B(iii) of our Form 10-Q for the quarter ended March 31, 2004.
(v) Employment Agreement (Management) dated December 19, 1994 Incorporated by reference to Exhibit (10)B(iv) of our Form 10-Q for the quarter ended March 31, 2004.
T. Letter Agreement dated November 7, 2006 between Ecolab S.r.l. and Luciano Iannuzzi.
U. 2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites.
V. Non-Employee Director Compensation and Benefits Summary Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2006.
W. (i) Ecolab Inc. 2005 Stock Incentive Plan Incorporated by reference to Exhibit (10)A of our Form 8-K
dated May 6, 2005.
(ii) Sample form of Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock Incentive Plan Incorporated by reference to Exhibit (10)B of our Form 8-K dated May 6, 2005.
(iii) Sample form of Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive Plan.
27
(13) Those portions of our Annual Report to Stockholders for the year ended December 31, 2006 which are incorporated by reference into Parts I and II hereof.
(21) List of Subsidiaries as of January 31, 2007.
(23) Consent of Independent Registered Public Accounting Firm at page 32 hereof is filed as a part hereof.
(24) Powers of Attorney.
(31) Rule 13a-14(a) Certifications.
(32) Section 1350 Certifications.
28
EXECUTIVE COMPENSATION PLANS AND ARRANGEMENTS
Included in the preceding list of exhibits are the following management contracts or compensatory plans or arrangements:
Exhibit No. |
|
Description |
|
|
|
(10)C. |
|
Ecolab Inc. 1997 Stock Incentive Plan. |
|
||
(10)D. |
|
1995 Non-Employee Director Stock Option Plan. |
|
||
(10)E. |
|
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. |
|
||
(10)G. |
|
Form of Director Indemnification Agreement. |
|
||
(10)H. |
|
Ecolab Executive Death Benefits Plan. |
|
||
(10)I. |
|
Ecolab Executive Long-Term Disability Plan. |
|
||
(10)J. |
|
Ecolab Executive Financial Counseling Plan. |
|
||
(10)K. |
|
Ecolab Supplemental Executive Retirement Plan. |
|
||
(10)L. |
|
Ecolab Mirror Savings Plan. |
|
||
(10)M. |
|
Ecolab Mirror Pension Plan. |
|
||
(10)N. |
|
Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans. |
|
||
(10)O. |
|
Ecolab Inc. Management Performance Incentive Plan. |
|
||
(10)P. |
|
Ecolab Inc. Change in Control Severance Compensation Policy. |
|
||
(10)R. |
|
Ecolab Inc. 2002 Stock Incentive Plan. |
|
||
(10)S. |
|
Transition Agreement and related arrangements of Allan L. Schuman. |
|
||
(10)T. |
|
Letter Agreement between Ecolab S.r.l. and Luciano Iannuzzi. |
|
||
(10)U. |
|
2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites. |
|
||
(10)V. |
|
Non-Employee Director Compensation and Benefits Summary. |
|
||
(10)W. |
|
Ecolab Inc. 2005 Stock Incentive Plan. |
|
29
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Ecolab Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 28 th day of February, 2007.
|
ECOLAB INC. |
|
|
(Registrant) |
|
|
|
|
|
|
|
|
By: |
/s/Douglas M. Baker, Jr. |
|
|
Douglas M. Baker, Jr. |
|
|
Chairman of the Board, President |
|
|
and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Ecolab Inc. and in the capacities indicated, on the 28 th day of February 2007.
/s/Douglas M. Baker, Jr. |
|
Chairman of the Board, President |
Douglas M. Baker, Jr. |
|
and Chief Executive Officer |
|
|
(Principal Executive Officer and Director) |
|
|
|
/s/Steven L. Fritze |
|
Executive Vice President and |
Steven L. Fritze |
|
Chief Financial Officer |
|
|
(Principal Financial Officer) |
|
|
|
/s/Daniel J. Schmechel |
|
Senior Vice President and Controller |
Daniel J. Schmechel |
|
(Principal Accounting Officer) |
|
|
|
/s/Lawrence T. Bell |
|
Directors |
Lawrence T. Bell |
|
|
|
|
|
as attorney-in-fact for: |
|
|
Les S. Biller, Richard U. De Schutter, Stefan
|
|
|
|
|
|
Director not signing: Hans Van Bylen |
|
|
30
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON FINANCIAL STATEMENT SCHEDULE
To the Shareholders and Directors of Ecolab Inc.:
Our audits of the consolidated financial statements, of managements assessment of the effectiveness of internal control over financial reporting and of the effectiveness of internal control over financial reporting referred to in our report, dated February 23, 2007, which contains an explanatory paragraph indicating that Ecolab Inc. changed the manner in which it accounts for defined benefit and other post retirement plans effective December 31, 2006, appearing in the 2006 Annual Report to Shareholders of Ecolab Inc. (which report and consolidated financial statements are incorporated by reference in this Annual Report on Form 10-K) also included an audit of the financial statement schedule listed in Item 15.I(2).(i) of this Form 10-K. In our opinion, this financial statement schedule presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.
|
|
/s/ PricewaterhouseCoopers LLP |
|
|
PricewaterhouseCoopers LLP |
Minneapolis, Minnesota
February 23, 2007
31
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Registration Nos. 2-60010; 2-74944; 33-1664; 33-41828; 2-90702; 33-18202; 33-55986; 33-56101; 333-95043; 333-109890; 33-26241; 33-34000; 33-56151; 333-18627; 333-109891; 33-39228; 33-56125; 333-70835; 33-60266; 333-95041; 33-65364; 333-18617; 333-40239; 333-95037; 333-50969; 333-58360; 333-97927; 333-115567; 333-115568; 333-129427; 333-129428; 333-115568; and 333-132139) of Ecolab Inc. of our report dated February 23, 2007 relating to the consolidated financial statements, managements assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K. We also consent to the inclusion in this Annual Report on Form 10-K of our report dated February 23, 2007 relating to the financial statement schedule, which appears in this Form 10-K.
|
|
/s/ PricewaterhouseCoopers LLP |
|
|
PricewaterhouseCoopers LLP |
Minneapolis, Minnesota
February 28, 2007
32
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
ECOLAB
INC.
(In Thousands)
COL. A |
|
COL. B |
|
COL. C |
|
COL. D |
|
COL. E |
|
|||||||
|
|
|
|
Additions |
|
|
|
|
|
|||||||
|
|
Balance at |
|
Charged to |
|
Charged |
|
|
|
Balance |
|
|||||
|
|
Beginning |
|
Costs and |
|
to Other |
|
|
|
at End |
|
|||||
Description |
|
of Period |
|
Expenses |
|
Accounts (A) |
|
Deductions (B) |
|
of Period (C) |
|
|||||
Allowance for Doubtful Accounts: |
|
|
|
|
|
|
|
|
|
|
|
|||||
Year Ended December 31, 2006 |
|
$ |
38,851 |
|
$ |
12,947 |
|
$ |
3,304 |
|
$ |
(17,483 |
) |
$ |
37,619 |
|
Year Ended December 31, 2005 |
|
$ |
44,199 |
|
$ |
11,589 |
|
$ |
(2,194 |
) |
$ |
(14,743 |
) |
$ |
38,851 |
|
Year Ended December 31, 2004 |
|
$ |
44,011 |
|
$ |
14,278 |
|
$ |
2,414 |
|
$ |
(16,504 |
) |
$ |
44,199 |
|
(A) Includes the effects of changes in currency translation and business acquisitions.
(B) Uncollectible accounts charged off, net of recovery of accounts previously written off.
(C) Includes an allowance of approximately $6,500,000 million as of December 31, 2006 for the expected return of products shipped, credits related to pricing or quantities shipped. All of the returns and credit activity is recorded directly to accounts receivable or sales.
33
The following documents are filed as exhibits to this Report.
Exhibit No. |
|
Document |
|
Method of Filing |
||||
(3) |
|
A. |
|
|
|
Restated Certificate of Incorporation of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006. |
|
Incorporated by reference to Exhibit (3)A of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
B. |
|
|
|
Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective as of March 13, 2006. |
|
Incorporated by reference to Exhibit (3)C of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
C. |
|
|
|
By-Laws, as amended through February 18, 1999. |
|
Incorporated by reference to Exhibit (3)B of our Form 10-K Annual Report for the year ended December 31, 1998. |
(4) |
|
A. |
|
|
|
Common Stock. |
|
See Exhibits (3)A and (3)C. |
|
|
B. |
|
|
|
Form of Common Stock Certificate effective February 28, 2007. |
|
Filed herewith electronically. |
|
|
C. |
|
|
|
Rights Agreement, dated as of February 24, 2006, between Ecolab Inc. and Computershare Investor Services, LLC, as Rights Agent, which includes the following exhibits thereto: (i) Exhibit A Form of Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock and (ii) Exhibit B Form of Rights Certificate. |
|
Incorporated by reference to Exhibit (4)C of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
D. |
|
|
|
Second Amended and Restated Stockholders Agreement between Henkel KGaA and Ecolab Inc., dated November 30, 2001. |
|
Incorporated by reference to Exhibit (4) of our Form 8-K dated November 30, 2001. |
|
|
E. |
|
|
|
Amended and Restated Indenture dated as of January 9, 2001 between Ecolab Inc. and Bank One, N.A. (formerly known as The First National Bank of Chicago) as Trustee. |
|
Incorporated by reference to Exhibit (4)(A) of our Current Report on Form 8-K dated January 23, 2001. |
|
|
F. |
|
|
|
Officers Certificate establishing terms and conditions of 6.875% Notes due February 1, 2011. |
|
Incorporated by reference to Exhibit 4(B) of our Form 8-K dated January 23, 2001. |
|
|
G. |
|
|
|
Form of 6.875% Note due February 2, 2011. |
|
Incorporated by reference to Exhibit 4(c) of our Form 8-K dated January 23, 2001. |
Exhibit No. |
|
Document |
|
Method of Filing |
||||||
(10) |
|
A. |
|
|
|
Multicurrency Credit Agreement, dated as of September 29, 1993, as amended and restated as of June 1, 2006, among Ecolab Inc., the financial institutions party thereto as Banks from time to time, the financial institutions party thereto as Issuing Banks from time to time, Citibank, N.A., as administrative agent for the Banks and Issuing Banks thereunder, Citibank International PLC, as agent for the Banks in connection with certain of the Eurocurrency Advances, and JPMorgan Chase Bank, N.A., as syndication agent. |
|
Incorporated by reference to Exhibit (10) of our Form 8-K dated June 1, 2006. |
||
|
|
B. |
|
|
|
Documents comprising global Commercial Paper Programs. |
|
|
||
|
|
|
|
|
|
(i) |
U.S. $200,000,000 Euro-Commercial Paper Programme. |
|
|
|
|
|
|
|
|
|
|
(a) |
Amended and Restated Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers), Ecolab Inc., Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank International plc and Credit Suisse First Boston (Europe) Limited (as Dealers). |
|
Incorporated by reference to Exhibit (10)B(i)(a) of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
|
|
|
|
|
(b) |
Amended and Restated Note Agency Agreement dated as of 2 December 2005 between Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank, N.A. as Issue and Paying Agent. |
|
Incorporated by reference to Exhibit (10)B(i)(b) of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
|
|
|
|
|
(c) |
Deed of Covenant made on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH. |
|
Incorporated by reference to Exhibit (10)B(i)(c) of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
|
|
|
|
|
(d) |
Deed of Guarantee made on 2 December 2005. |
|
Incorporated by reference to Exhibit (10)B(i)(d) of our Form 10-K Annual Report for the year ended December 31, 2005. |
|
|
|
|
|
|
(ii) |
U.S. $450,000,000 U.S. Commercial Paper Program. |
|
|
|
|
|
|
|
|
|
|
(a) |
Form of Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon Smith Barney, Inc. and Banc One Capital Markets, Inc. |
|
Incorporated by reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the quarter ended June 30, 2003. |
Exhibit No. |
|
Document |
|
Method of Filing |
||||||
|
|
|
|
|
|
|
(b) |
Issuing and Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank One, National Association as Issuing and Paying Agent. |
|
Incorporated by reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended June 30, 2003. |
|
|
C. |
|
(i) |
|
Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18, 2000. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2000. |
||
|
|
|
|
(ii) |
|
Non-Statutory Stock Option Agreement as in effect for grants through May 12, 2000. |
|
Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended June 30, 2004. |
||
|
|
|
|
(iii) |
|
Non-Statutory Stock Option Agreement as in effect for grants beginning May 13, 2000 through May 10, 2002. |
|
Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended June 30, 2004. |
||
|
|
D. |
|
(i) |
|
1995 Non-Employee Director Stock Option Plan. |
|
Filed herewith electronically. |
||
|
|
|
|
(ii) |
|
Amendment No. 1 to 1995 Non-Employee Director Stock Option Plan effective February 25, 2000. |
|
Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K Annual Report for the year ended December 31, 2000. |
||
|
|
|
|
(iii) |
|
Amendment No. 2 to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001. |
|
Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K Annual Report for the year ended December 31, 2003. |
||
|
|
E. |
|
(i) |
|
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan as amended effective May 1, 2004. |
|
Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 2003. |
||
|
|
|
|
(ii) |
|
Amendment No. 1 adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, as amended and restated effective May 1, 2004, with respect to the American Jobs Creation Act of 2004. |
|
Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
||
|
|
|
|
(iii) |
|
Master Agreement Relating to Options (as in effect through May 7, 2004). |
|
Incorporated by reference to Exhibit (10)D(i) of our Form 10-Q for the quarter ended June 30, 2004. |
||
|
|
|
|
(iv) |
|
Master Agreement Relating to Periodic Options, as amended effective as of May 1, 2004. |
|
Incorporated by reference to Exhibit (10)D(ii) of our Form 10-Q for the quarter ended June 30, 2004. |
||
Exhibit No. |
|
Document |
|
Method of Filing |
||||
|
|
F. |
|
|
|
Note Purchase Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the Purchasers party thereto. |
|
Incorporated by reference to Exhibit (10) of our Form 8-K dated July 26, 2006. |
|
|
G. |
|
|
|
Form of Director Indemnification Agreement. Substantially identical agreements are in effect as to each of our directors |
|
Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2003. |
|
|
H. |
|
(i) |
|
Ecolab Executive Death Benefits Plan, as amended and restated effective March 1, 1994. See also Exhibit (10)N hereof. |
|
Filed herewith electronically. |
|
|
|
|
(ii) |
|
Amendment No. 1 to Ecolab Executive Death Benefits Plan. |
|
Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K Annual Report for the year ended December 31, 1998. |
|
|
|
|
(iii) |
|
Second Declaration of Amendment to Ecolab Executive Death Benefits Plan, effective March 1, 1998. |
|
Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K Annual Report for the year ended December 31, 1998. |
|
|
|
|
(iv) |
|
Amendment No. 3 to the Ecolab Executive Death Benefits Plan, effective August 12, 2005. |
|
Incorporated by reference to Exhibit (10)B of our Form 8-K dated December 13, 2005. |
|
|
I. |
|
|
|
Ecolab Executive Long-Term Disability Plan, as amended and restated effective January 1, 1994. See also Exhibit (10)N hereof. |
|
Incorporated by reference to Exhibit (10)I of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
J. |
|
|
|
Ecolab Executive Financial Counseling Plan. |
|
Incorporated by reference to Exhibit (10)J of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
K. |
|
(i) |
|
Ecolab Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2003. |
|
Incorporated by reference to Exhibit (10)M of our Form 10-K Annual Report for the year ended December 31, 2003. |
|
|
|
|
(ii) |
|
Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Supplemental Executive Retirement Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004. |
|
Incorporated by reference to Exhibit (10)K(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
L. |
|
(i) |
|
Ecolab Mirror Savings Plan, as amended and restated effective as of March 1, 2002. |
|
Incorporated by reference to Exhibit (10)N of our Form 10-K Annual Report for the year ended December 31, 2002. |
Exhibit No. |
|
Document |
|
Method of Filing |
||||
|
|
|
|
(ii) |
|
Amendment No. 1 adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended and Restated Effective as of March 1, 2002) With Respect to the American Jobs Creation Act of 2004. |
|
Incorporated by reference to Exhibit (10)L(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
|
|
(iii) |
|
Amendment No. 2 to the Ecolab Mirror Savings Plan, effective January 1, 2005. |
|
Incorporated by reference to Exhibit (10)A of our Form 8-K dated December 13, 2005. |
|
|
M. |
|
(i) |
|
Ecolab Mirror Pension Plan, as amended and restated effective as of January 1, 2003. |
|
Incorporated by reference to Exhibit (10)B of our Form 10-Q for the quarter ended June 30, 2003. See also Exhibit (10)N hereof. |
|
|
|
|
(ii) |
|
Amendment No. 1 and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab Mirror Pension Plan (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004. |
|
Incorporated by reference to Exhibit (10)M(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
N. |
|
(i) |
|
Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans, as amended and restated effective as of January 1, 2003. |
|
Incorporated by reference to Exhibit (10)P of our Form 10-K Annual Report for the year ended December 31, 2003. |
|
|
|
|
(ii) |
|
Amendment No. 1 adopted December 16, 2004 to the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (As Amended and Restated effective January 1, 2003) With Respect to the American Jobs Creation Act of 2004. |
|
Incorporated by reference to Exhibit (10)N(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
O. |
|
(i) |
|
Ecolab Inc. Management Performance Incentive Plan, as amended and restated on February 28, 2004. |
|
Incorporated by reference to Exhibit (10)A of our Form 10-Q for the quarter ended March 31, 2004. |
|
|
|
|
(ii) |
|
Amendment No. 1 adopted February 26, 2005 to the Ecolab Inc. Management Performance Incentive Plan. |
|
Incorporated by reference to Exhibit (10)O(ii) of our Form 10-K Annual Report for the year ended December 31, 2004. |
|
|
P. |
|
|
|
Ecolab Inc. Change in Control Severance Compensation Policy, effective February 22, 2002. |
|
Incorporated by reference to Exhibit (10)R of our Form 10-K Annual Report for the year ended December 31, 2001. |
Exhibit No. |
|
Document |
|
Method of Filing |
||||
|
|
Q. |
|
(i) |
|
Master Agreement, dated as of December 7, 2000, between Ecolab Inc. and Henkel KGaA. |
|
Incorporated by reference to Exhibit 18 of HC Investments, Inc.s and Henkel KGaAs Amendment No. 5 to Schedule 13D dated December 14, 2000. |
|
|
|
|
(ii) |
|
Amendment No. 1 to the Master Agreement, dated December 7, 2000, between Ecolab Inc. and Henkel KGaA. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended September 30, 2001. |
|
|
|
|
(iii) |
|
Intellectual Property Agreement dated November 30, 2001, between Ecolab and Henkel KGaA. |
|
Incorporated by reference to Exhibit (10) of our Form 8-K dated November 30, 2001. |
|
|
R. |
|
(i) |
|
Ecolab Inc. 2002 Stock Incentive Plan. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended June 30, 2002. |
|
|
|
|
(ii) |
|
Non-statutory Stock Option Agreement as in effect for grants beginning May 11, 2002 through August 12, 2003. |
|
Incorporated by reference to Exhibit (10)A(i) of our Form 10-Q for the quarter ended June 30, 2004. |
|
|
|
|
(iii) |
|
Non-statutory Stock Option Agreement as in effect for grants beginning August 13, 2003. |
|
Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q for the quarter ended June 30, 2004. |
|
|
S. |
|
(i) |
|
Transition Agreement effective February 28, 2004 by and between Ecolab Inc. and Allan L. Schuman including related arrangements. |
|
Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q for the quarter ended March 31, 2004. |
|
|
|
|
(ii) |
|
Amendment No. 1 to Transition Agreement by and between Ecolab Inc. and Allan L. Schuman. |
|
Incorporated by reference to Exhibit (10) of our Form 8-K dated January 1, 2006. |
|
|
|
|
(iii) |
|
Non-statutory Stock Option Agreement. |
|
Incorporated by reference to Exhibit (10)B(ii) of our Form 10-Q for the quarter ended March 31, 2004. |
|
|
|
|
(iv) |
|
Mutual Release by Allan L. Schuman and Ecolab Inc. |
|
Incorporated by reference to Exhibit (10)B(iii) of our Form 10-Q for the quarter ended March 31, 2004. |
Exhibit No. |
|
Document |
|
Method of Filing |
||||
|
|
|
|
(v) |
|
Employment Agreement (Management) dated December 19, 1994. |
|
Incorporated by reference to Exhibit (10)B(iv) of our Form 10-Q for the quarter ended March 31, 2004. |
|
|
T. |
|
|
|
Letter Agreement dated November 7, 2006 between Ecolab S.r.l. and Luciano Iannuzzi. |
|
Filed herewith electronically. |
|
|
U. |
|
|
|
2007 Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites. |
|
Filed herewith electronically. |
|
|
V. |
|
|
|
Non-Employee Director Compensation and Benefits Summary. |
|
Incorporated by reference to Exhibit (10) of our Form 10-Q for the quarter ended March 31, 2006. |
|
|
W. |
|
(i) |
|
Ecolab Inc. 2005 Stock Incentive Plan. |
|
Incorporated by reference to Exhibit (10)A of our Form 8-K dated May 6, 2005. |
|
|
|
|
(ii) |
|
Sample form of Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock Incentive Plan. |
|
Incorporated by reference to Exhibit (10)B of our Form 8-K dated May 6, 2005. |
|
|
|
|
(iii) |
|
Sample form of Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive Plan |
|
Filed herewith electronically. |
(13) |
|
|
|
|
|
Those portions of our Annual Report to Stockholders for the year ended December 31, 2006 which are incorporated by reference into Parts I and II hereof. |
|
Filed herewith electronically. |
(21) |
|
|
|
|
|
List of Subsidiaries as of January 31, 2007. |
|
Filed herewith electronically. |
(23) |
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm at page 32 hereof is filed as a part hereof. |
|
See page 32 hereof. |
(24) |
|
|
|
|
|
Powers of Attorney. |
|
Filed herewith electronically. |
(31) |
|
|
|
|
|
Rule 13a-14(a) Certifications. |
|
Filed herewith electronically. |
(32) |
|
|
|
|
|
Section 1350 Certifications. |
|
Filed herewith electronically. |
Exhibit (4)B
|
|
COMMON STOCK |
|
COMMON STOCK |
|
|
|
|
|
|
|
PAR VALUE $1.00 |
|
THIS CERTIFICATE
IS TRANSFERABLE IN
|
Certificate
|
|
|
|
Shares |
|
|
|
|
|
|
|
ECOLAB
INC.
|
|
|
|
THIS CERTIFIES THAT |
CUSIP 278865 10 0 |
||||
|
|
|
||||
|
is the owner of |
|
||||
|
|
|
||||
|
FULLY-PAID AND NON-ASSESSABLE SHARES OF THE COMMON STOCK OF |
|||||
|
|
|
||||
|
Ecolab Inc. transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar. |
|||||
|
|
|||||
|
Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers. |
|||||
|
|
|
|
|||
|
|
|
|
|||
|
|
|
|
|||
|
|
DATED |
|
|||
|
/s/ D.M. Baker |
COUNTERSIGNED AND REGISTERED: |
||||
|
Chairman of the Board |
COMPUTERSHARE INVESTOR |
||||
|
|
SERVICES, LLC. |
||||
|
|
(CHICAGO) |
||||
|
|
TRANSFER AGENT AND REGISTRAR, |
||||
|
|
|
||||
|
/s/ L. T. Bell |
By: |
|
|||
|
Secretary |
AUTHORIZED SIGNATURE |
||||
SECURITY INSTRUCTIONS ON REVERSE
ECOLAB INC.
The Corporation will furnish, without charge, to each stockholder who so requests, a printed statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof which the corporation is authorized to issue and the qualifications, limitations or restrictions of such preferences and/or rights. requests may be directed to the secretary of ecolab inc. at its principal office, or the transfer agent named on the face of this certificate.
This certificate also evidences and entitles the holder hereof to certain Rights as set forth in the Rights Agreement between Ecolab Inc. (the Company) and Computershare Investor Services, LLC (the Rights Agent), dated as of February 24, 2006, as amended from time to time (the Rights Agreement), the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal offices of the Company. Under certain circumstances, as set forth in the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by this certificate. The Company will mail to the holder of this certificate a copy of the Rights Agreement, as in effect on the date of mailing, without charge promptly after receipt of a written request therefor. Under certain circumstances set forth in the Rights Agreement, Rights issued to, or held by, any Person who is, was or becomes an Acquiring Person or an Adverse Person or any Affiliate or Associate thereof (as such terms are defined in the Rights Agreement), whether currently held by or on behalf of such Person or by any subsequent holder, may become null and void.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:
For value received, hereby sell, assign and transfer unto
PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE
(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE)
Shares |
of the capital stock represented by the within Certificate, and do hereby irrevocably constitute and appoint |
Attorney |
to transfer the said stock on the books of the within-named Corporation with full power of substitution in the premises. |
Dated: |
|
20 |
|
|
|
Signature: |
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
Signature: |
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
NOTICE: |
|
THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE, IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATEVER. |
|
Signature(s) Guaranteed: |
|
|
|
|
|
|
|
BY: |
|
|
|
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan
Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO
S.E.C. RULE 17Ad-15.
SECURITY INSTRUCTIONS
THIS IS WATERMARKED PAPER, DO NOT ACCEPT WITHOUT NOTING WATERMARK. HOLD TO LIGHT TO VERIFY WATERMARK.
Exhibit (10)D(i)
ECOLAB INC.
1995 NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN
1. Purpose . The purpose of this 1995 Non-Employee Director Stock Option Plan (the Plan) is to advance the interests of Ecolab Inc. (the Company) and its stockholders by enabling the Company to attract and retain the services of experienced and knowledgeable non-employee directors and to provide an incentive for such directors to increase their proprietary interest in the Companys long-term success and progress.
2. Administration . The Plan shall be administered by a committee consisting solely of three or more members of the Board of Directors (the Committee). Grants of stock options under the Plan (Options) and the amount and nature of the Options to be granted shall be automatic, as described in paragraph 5(b)(i) of the Plan. All questions of interpretation of the Plan or of any Options issued under it shall be determined by the Committee and such determination shall be final and binding upon all persons having an interest in the Plan. Any or all powers and discretion vested in the Committee under this Plan may be exercised by any subcommittee of three or more persons so authorized by the Committee.
3. Participation in the Plan . Directors of the Company who are not employees of the Company or any subsidiary of the Company (Eligible Directors) shall be eligible to participate in the Plan.
4. Stock Subject to the Plan .
(a) Number of Shares. The maximum number of shares of Common Stock that shall be reserved for issuance under the Plan shall be two hundred thousand (200,000) shares of the Companys common stock, $1.00 par value (the Common Stock), subject to adjustment upon changes in capitalization of the Company as provided in subparagraph (b) below. The maximum number of shares authorized may be increased from time to time by approval of the Board of Directors and the stockholders of the Company. Shares of Common Stock that may be issued upon exercise of Options granted under the Plan shall be applied to reduce the maximum number of shares of Common Stock remaining available for use under the Plan. The shares to be issued pursuant to the Plan may be, at the election of the Company, either treasury shares or shares authorized but unissued. Any shares of Common Stock that are subject to an Option granted under the Plan (or any portion thereof) that lapses, expires or for any reason is terminated unexercised shall automatically again become available for use under the Plan.
(b) Adjustments to Shares and Options . In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other change in the corporate structure or shares of the
Company, the Committee (or, if the Company is not the surviving Company in any such transaction, the board of directors of the surviving corporation) will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities available for issuance under the Plan (including, without limitation, the number of securities as to which Options are to be granted and as to which Options become exercisable pursuant to paragraphs 5(b)(i) and 5(b)(iii) below after the effective date of such change) and, in order to prevent dilution or enlargement of the rights of Optionees, the number, kind and exercise price of securities subject to outstanding Options.
5. Terms of Options .
(a) Non-Statutory Stock Options . All Options granted under the Plan shall be non-statutory stock options not entitled to special tax treatment under Section 422 of the Internal Revenue Code of 1986, as amended to date and as may be amended from time to time (the Code).
(b) Terms, Conditions and Form of Options . Each Option granted under the Plan shall be evidenced by a written agreement in such form as the Committee shall from time to time approve, which agreements shall comply with and be subject to the following terms and conditions:
(i) Grant of Options . An Option to purchase shares of Common Stock shall be granted automatically on the date the Plan is adopted by the stockholders of the Company to each Eligible Director as of such date (including directors who are elected or re-elected on such date), in the following amounts: Class I Directors, one thousand two hundred (1,200) shares; Class II Directors, two thousand four hundred (2,400) shares; Class III Directors, six thousand (6,000) shares. An Option to purchase six thousand (6,000) shares of Common Stock shall thereafter be granted automatically to each Eligible Director upon the election (or re-election) of such director to the Board of Directors for a full term by the stockholders of the Company at an annual meeting of stockholders, beginning with the annual meeting of stockholders to be held in 1996. An Eligible Director chosen pursuant to the provisions of Article IV of the Companys Restated Certificate of Incorporation to fill a newly created directorship or a vacancy in the Board of Directors shall be automatically granted, as of the date of the next subsequent annual meeting of stockholders (unless the director is chose on the date of an annual meeting of stockholders, in which case as of such date) an Option to purchase a number of shares of Common Stock equal to the product of (i) two thousand (2,000), and (ii) the number of years remaining in such directors term of office as of the date of automatic option grant. No eligible Director shall be granted more than one Option at any annual meeting of stockholders. The written agreement evidencing each Option granted under the Plan shall be
2
dated as of the applicable date of grant (the Date of Grant). An Eligible Director accepting such a grant of an Option (an Optionee) shall execute and return a copy of such option agreement to the Secretary of the Company. Whenever there is a reference in the Plan to the years remaining in the term of office of a director, the word year shall refer to the interval between the annual meeting of stockholders in one year and such meeting in the next subsequent year.
(ii) Option Exercise Price . The per share price to be paid by the Optionee at the time an Option is exercised shall be 100% of the Fair Market Value of one share of Common Stock on the Date of Grant. For purposes of the Plan, Fair Market Value shall mean, as of any date (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote), the mean between the reported high and low sale prices of the Common stock as reported on the New York Stock Exchange Composite Tape.
(iii) Exercisability of Options . Except for an Option which becomes exercisable pursuant to paragraph 5(b)(iv)(A) below, an Option may not be exercised before the next subsequent annual meeting of stockholders after its Date of Grant. The Option of an Optionee whose remaining term as a director is three years as of the Date of Grant may be exercised on a cumulative basis to the extent of two thousand (2,000) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the Date of Grant, an additional two thousand (2,000) of the total shares beginning on the date of the second subsequent annual meeting of stockholders after the Date of Grant and the remaining two thousand (2,000) shares on the date of the third subsequent annual meeting of stockholders after the Date of Grant. The Option of an Optionee whose remaining term as a director is two years as of the Date of Grant may be exercised on a cumulative basis to the extent of two thousand (2,000) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the date of Grant and the remaining two thousand (2,000) shares on the date of the second subsequent annual meeting of stockholders after the Date of Grant. The Option of an Optionee whose remaining term as a director is one year as of the Date of Grant may be exercised in full on the date of the next subsequent annual meeting. Notwithstanding the foregoing, an Option granted on the date the Plan is adopted by the stockholders of the Company to (A) a Class I Director may be exercised in full on the date of the next subsequent annual meeting of stockholders after the Date of Grant and (B) a Class II Director may be exercised on a cumulative basis to the extent of one thousand two hundred (1,200) of the total shares covered by the Option beginning on the date of the next subsequent annual meeting of stockholders after the Date of Grant and the remaining one thousand two hundred (1,200)
3
shares on the date of the second subsequent annual meeting of stockholders after the Date of Grant.
(iv) Duration of Options . Each Option shall terminate ten years after its Date of Grant. Each Option shall terminate and may no longer be exercised if and when the Optionee ceases to serve as a director of the Company, except (A) if the Optionee ceases to serve as a director of the Company by reason of death or the occurrence of an event which constitutes permanent and total disability (within the meaning of Section 22(e)(3) of the Code), then the Option shall become immediately exercisable in full and shall remain exercisable until the earlier of the expiration of five years or the remaining term of the Option, and (B) if the Optionee ceases to serve as a director of the Company for any other reason, then the Option shall remain exercisable to the extent that the Option was exercisable on the date the Optionee ceased to serve as a director of the Company until the earlier of the expiration of five years after the date the Optionee ceased to serve as a director of the Company or the remaining term of the Option.
(v) Manner of Option Exercise . An Option may be exercised by an Optionee in whole or in part from time to time, subject to the conditions contained in the Plan and in the agreement evidencing such Option, by giving written notice of exercise to the Company at its principal executive office (Attn: Secretary), such notice shall specify the particular Option that is being exercised and the number of shares with respect to which the Option is being exercised and shall be accompanied by payment of the total purchase price of the shares to be purchased under the Option. The Company shall not be required to sell or issue any shares under any outstanding Option if, in the sole opinion of the Committee, the issuance of such shares would constitute a violation by the Optionee or the Company of any applicable law or regulation of any governmental authority, including without limitation federal and state securities laws.
(vi) Payment of Exercise Price . The total purchase price of the shares to be purchased may be paid entirely in cash (including check, bank draft or money order) or by tendering shares of the Companys Common Stock already owned by the Optionee (Previously Acquired Shares), or by an combination thereof; provided, however, that any such Previously Acquired Shares tendered by an Optionee must be mature shares, as such term may be defined from time-to-time by the Financial Accounting Standards Board or any successor body.
(vii) Restrictions on Transfer . Except pursuant to testamentary will or the laws of descent and distribution or as otherwise expressly permitted by the Plan, no right or interest of any Optionee in an Option prior to the exercise
4
or vesting of such Option will be assignable or transferable, or subjected to any lien, during the lifetime of the Optionee, either voluntarily or involuntarily, directly or indirectly, by operation of law or otherwise. An Optionee will, however, be entitled to designate a beneficiary to receive an Option upon such Optionees death, and in the event of an Optionees death, payment of any amounts due under the Plan will be made to, and exercise of any Options (to the extent permitted pursuant to paragraph 5(b)(iii)(A) above may be made by, the Optionee's legal representatives, heirs and legatees.
(viii) Successive Options . Successive Options may be granted to the same Optionee, whether or not the Options previously granted to such Optionee remain unexercised. An Optionee may exercise an Option if then exercisable, notwithstanding that Options previously granted to such Optionee remain unexercised.
(ix) Withholding . The Company may require an Optionee to promptly pay the Company the amount of any federal, state or local withholding or other employment-related tax attributable to the Optionee's exercise of an Option before acting on the Optionee's notice of exercise of the Option. An Optionee may satisfy any such withholding or employment-related tax obligation by electing to tender Previously Acquired Shares or withhold shares of Common Stock that are to be issued upon exercise of an Option, or by a combination of such methods.
6. Limitation of Rights .
(a) No Right to Continue as a Director . Neither the plan, nor the granting of an Option nor any other action taken pursuant to the Plan, shall constitute or be evidence of any agreement or understanding, express or implied that the Company will retain a director for any period of time, or at any particular rate of compensation.
(b) Rights as Stockholder. No Optionee shall have any rights as a stockholder with respect to any shares of Common Stock covered by an Option granted pursuant to the Plan until the Optionee shall have become the holder of record of such shares, and no adjustments shall be made for dividends or other distributions or other rights as to which there is a record date preceding the date the Optionee becomes the holder of record of such shares.
7. Plan Amendment, Modification and Termination . The Board of Directors may suspend or terminate the Plan or any portion thereof at any time, and may amend the Plan from time to time in such respects as the Board of Directors may deem advisable in order that Options under the Plan will conform to any change in applicable laws or regulations or in any other respect the Board of Directors may deem to be in the best interest of the Company; provided, however, that no amendments to the Plan will be effective without approval of the
5
stockholders of the Company if stockholder approval of the amendment is then required pursuant to Rule 16b-3 under the Exchange Act, the Code or the rules of the New York Stock Exchange. No termination, suspension or amendment of the Plan may adversely affect any outstanding Option without the consent of the affected Optionee; provided, however, that this sentence will not impair the right of the Committee to take whatever action it deems appropriate under paragraph 4(b) above.
8. Effective Date and Duration of the Plan . The Plan shall be effective on the date of adoption by the stockholders of the Company. The Plan shall terminate at midnight on June 30, 2000, and may be terminated prior thereto by action of the Board of Directors, and no Option shall be granted after such termination. Options outstanding upon termination of the Plan may continue to be exercised in accordance with their terms.
9. Governing Laws . The Plan and all rights and obligations under the Plan shall be construed in accordance with and governed by the laws of the State of Minnesota.
6
Exhibit (10)H(i)
ECOLAB
EXECUTIVE DEATH BENEFITS PLAN
(As Amended and Restated Effective March 1, 1994)
Pursuant to Section 8.1 of the Ecolab Executive Death Benefits Plan (1991 Restatement) (the Plan), and the resolutions of the Board of Directors of Ecolab Inc. (the Company) dated February 26, 1994, the Company hereby amends and restates the Plan in its entirety to read as follows, effective March 1, 1994.
ARTICLE I
PREFACE
SECTION 1.1 . Effective Date . The effective date of this amendment and restatement of the Plan is March 1, 1994. The benefit, if any, payable with respect to a former Executive who Retired or died prior to the Effective Date (and who is not rehired by a member of the Controlled Group thereafter) shall be determined by, and paid in accordance with, the terms and provisions of the Plan as in effect prior to the Effective Date.
SECTION 1.2 . Purpose of the Plan . The purpose of this Plan is to provide further means whereby the Company may afford financial security for certain management and highly compensated employees who perform management and professional functions for the Company and certain related entities, by providing their beneficiaries with a level of protection from the financial losses that may be suffered on account of the death of such an employee.
SECTION 1.3 . Administrative Document . This Plan includes the Ecolab Inc. Administrative Document for Non-Qualified Benefit Plans (the Administrative Document), which is incorporated herein by reference.
ARTICLE II
DEFINITIONS
Words and phrases used in this Plan with initial capital letters which are defined in the Administrative Document are used herein as so defined, unless specifically defined herein or the context clearly indicates otherwise. The following words and phrases when used in this Plan with initial capital letters shall have the following respective meanings, unless the context clearly indicates otherwise:
SECTION 2.1 . Death Beneficiary . An Executives Death Beneficiary shall be the person or persons (natural or otherwise) designated by the Executive as his primary or
contingent Death Beneficiary under this Plan. Such a designation may be made, revoked or changed at any time (without the consent of any previously designated Death Beneficiary) only by a written instrument in a form prescribed by the Administrator, signed by the Executive and delivered to the Administrator during the Executives lifetime.
SECTION 2.2 . Disability or Disabled . An Executive shall be deemed to have a Disability or be Disabled if the Executives active employment with an Employer ceases due to a disability that entitles the Executive to benefits under any long-term disability plan sponsored by the Company. An Executives Disability shall continue until the earliest to occur of (1) the date on which the Executives employment with the Controlled Group as an Executive terminates, (2) the date the Executive recovers from the Disability, or (3) the date of termination of payments under the Companys long-term disability plan for any reason.
SECTION 2.3 . Executive shall mean an Employee who is selected by the Administrator to participate in this Plan and who is in a pay grade of 24 or above.
SECTION 2.4 . Executive Death Benefits shall mean the benefits described in Article III.
SECTION 2.5 . Final Average Compensation shall mean the average of an Executives Annual Compensation for the five (5) consecutive Plan Years of employment with the Employers preceding the Executives Retirement (including the Plan Year of Retirement) which yields the highest average compensation. If the Executive has been employed by the Employers for a period of less than five (5) Plan Years preceding his Retirement, Final Average Compensation shall be calculated using the Executives total period of employment with the Employers.
SECTION 2.6 . Plan shall mean the Ecolab Executive Death Benefits Plan, as described herein and as it may be amended from time to time.
SECTION 2.7 . Retirement or Retired . The Retirement of an Executive shall occur upon his termination of employment with the Controlled Group for any reason other than death or Disability on or after (1) his attainment of age 55 and the completion of at least 10 Years of Eligibility Service, or (2) his attainment of age 65. For purposes of determining Retirement under this Plan, the employment of a Disabled Executive shall be deemed to have terminated for reasons other than Disability at such time as he ceases to meet the definition of Disability, provided he does not resume active employment with the Controlled Group.
2
SECTION 2.8 . Year of Eligibility Service .
(1) An Executive shall be credited with one Year of Eligibility Service for each year of Continuous Service (or such other defined term which is used to determine vesting service) as defined by and credited to the Executive under the Pension Plan.
(2) A Disabled Executive shall continue to accrue Years of Eligibility Service during the period of his Disability for purposes of determining his eligibility for Retirement hereunder.
ARTICLE III
EXECUTIVE DEATH BENEFITS
SECTION 3.1 . Coverage . An Employee shall become covered under the Plan as of the first date on or after the Effective Date on which he is an Executive.
SECTION 3.2 . Executive Death Benefit for Actively Employed Executives .
(1) Eligibility . An Executives entitlement to the Executive Death Benefit coverage described in this Section 3.2 shall cease on the earliest to occur of (a) thirty-one (31) days after the date the Executives employment as an Executive ceases for any reason other than death or Disability, (b) the date the Executive Retires, or (c) with respect to a Disabled Executive, the date the Executive is no longer Disabled, provided he does not resume active employment as an Executive.
(2) Amount of Executive Death Benefit .
(a) The Death Beneficiary of a deceased Executive who is covered by the provisions of this Section 3.2 shall be entitled to receive a lump sum Executive Death Benefit in an amount equal to the lesser of (i) three million dollars ($3,000,000) or (ii) three hundred percent (300%) of the Executives Annual Compensation (A) for the last full Plan Year that ended prior to the Executives death in which the Executive actively performed services as an Employee, or (B) if the Executive did not actively perform services as an Employee in any full prior Plan Year, for the last Plan Year in which the Executive actively performed services as an Employee, in which case his Annual Compensation shall be annualized based on the number of days employed by the Controlled Group out of a Plan Year of 365 days.
(b) The Executive Death Benefit described in paragraph (a) shall be reduced (but not below zero) by any amount payable under any life insurance or other death benefit covering the Executive which is provided by, or payable by or on behalf of a member of the Controlled Group.
3
(c) If the Executive Death Benefit described in paragraph (a), after any reduction described in (b), is subject to United States federal income tax when paid to the Executives Death Beneficiary, the amount of such Executive Death Benefit shall be grossed-up for federal income taxes, using a thirty-four percent (34%) tax rate, so that the total Executive Death Benefit under this Section 3.2 shall be equal to the amount calculated under paragraph (a), after any reduction described in (b), divided by sixty-six percent (66%).
SECTION 3.3 . Executive Death Benefit for Retired Executives .
(1) Eligibility . The Death Beneficiary of an Executive who dies while he is Retired shall be entitled to receive the Executive Death Benefit described in this Section 3.3.
(2) Amount of Executive Death Benefit .
(a) The Death Beneficiary of a deceased Executive who is covered by the provisions of this Section 3.3 shall be entitled to receive a lump sum Executive Death Benefit in an amount equal to the lesser of (i) seven hundred and fifty thousand dollars ($750,000) or (ii) two hundred percent (200%) of the Executives Final Average Compensation.
(b) The Executive Death Benefit described in paragraph (a) of this Subsection shall be reduced (but not below zero) by any amount payable under any life insurance or other death benefit covering the Executive which is provided by, or payable by or on behalf of a member of the Controlled Group.
SECTION 3.4 . Disabled Executives . An Executive who is Disabled shall be entitled to the Executive Death Benefit described in Section 3.2, until coverage terminates in accordance with the provisions of Section 3.2(1). In the event an Executive dies while he is Disabled, no Executive Death Benefit shall be payable under the provisions of Section 3.3.
SECTION 3.5 . Protective Provisions . Notwithstanding the preceding Sections of the Article, if an Executive commits suicide during the two-year period beginning on the date of his commencement of participation in the Plan or makes any material misstatement of information or nondisclosure of medical history, then, in the Administrators sole and absolute discretion, no Executive Death Benefits shall be payable hereunder or such Executive Death Benefits may be paid in a reduced amount (as determined by the Administrator).
4
ARTICLE IV
PAYMENT OF EXECUTIVE DEATH BENEFITS
SECTION 4.1 . Commencement of Executive Death Benefits . Executive Death Benefits hereunder shall be paid to the Executives Death Beneficiary after the amount of the Executive Death Benefit and the identity of the Death Beneficiary have been identified and, in any event, within ninety (90) days after the date of the Executives death. Notwithstanding the foregoing, if payment during such 90-day period is prevented due to reasons outside of the Administrators control, payment of the Executive Death Benefits shall be made as soon as practicable following the date of the Executives death.
ARTICLE V
AMENDMENT AND TERMINATION
SECTION 5.1 . Effect of Amendment and Termination . No amendment or termination shall operate to deprive any Executive or, in the event of the Executives death, any Death Beneficiary of any Executive Death Benefit otherwise payable with respect to an Executive who has Retired or died prior to the date such amendment or termination is adopted.
IN WITNESS WHEREOF, Ecolab Inc. has executed this Executive Death Benefits Plan and has caused its corporate seal to be affixed this 29 th day of August, 1994.
|
|
ECOLAB INC. |
|
|
|
|
|
|
|
By: |
/s/Michael E. Shannon |
|
|
Michael E. Shannon |
|
|
Vice Chairman, Chief Financial |
|
|
and Administrative Officer |
(Seal)
/s/Kenneth A. Iverson |
|
Kenneth A. Iverson |
|
Secretary |
|
5
EXHIBIT (10)T
November 7, 2006
Luciano Iannuzzi
Executive VP EMEA
Ecolab GmbH & Co. OHG
Reisholzer Werftstrasse 38-42
D-40589 Düsseldorf
GERMANY
Dear Luciano:
Further to our understandings, we hereby confirm our agreement to terminate the existing employment relationship with Ecolab S.r.l. (the Company) under the following terms and conditions:
1. Your current assignment as EVP EMEA will continue until November 30, 2006. Thereafter, you will revert to your Italian contract until May 31, 2007, or any prior date if you voluntarily decide to resign earlier with reciprocal waiver to any notice. Hereinafter Termination Date shall mean May 31, 2007 or such a prior date in case of earlier voluntary resignation. Through January 1, 2007, you will assist the Company with transition and, thereafter, assist the Company CEO with special projects.
2. Your employment shall continue until the Termination Date on your current terms and conditions, except that effective January 1, 2007, you will be relocated to Milan, Italy. Costs of relocation will be paid by the Company, as per the agreement dated February 25, 2002, and you will remain entitled to the benefits of this agreement which are based upon your assignment in Germany and relocation to Italy.
3. At any time after January 1, 2007, the Company may offer you another position within the group (in the EMEA region), to begin on or before June 1, 2007. If for any reason whatsoever you do not accept such a position or such a position is not offered within the Termination Date, the employment relationship shall be considered automatically terminated by mutual consent effective from the
Termination Date with reciprocal waiver to the notice period or the correspondent indemnity in-lieu-of notice and without possibility of interruption of suspension due to illness, accident or other events. If instead you accept the offer of the Company, all following terms and conditions will cease to apply and shall be replaced by the new terms and conditions in the offer governing the continuation of employment.
4. You will be provided with tax advice (through the tax consultants of Deloitte), at the Companys expense, regarding your foreign assignment in Germany and the relocation and your tax return for the fiscal year 2006. We will also continue to be responsible for the tax equalization (i.e., for any tax paid in excess by you in Germany with respect to Italy in years during the assignment). All of this consistent with the TAXES term of your February 25, 2002 agreement.
5. You will resign as director of the Ecolab GmbH & Co. OHG and any other company of the group effective from the Termination Date.
6. Your compensation and benefits until the Termination Date will continue at their present level.
7. In addition to your salary up to the Termination Date, the severance indemnity (TFR), the pro-rata amounts of additional monthly wages, the indemnity in-lieu-of holidays (if accrued), the 2006 bonus and the pro-rata 2007 bonus (based upon a 100% bonus plan payout for 2007), we will pay you an indemnity una tantum of 504,000 as an incentive to execute this agreement and to leave the Company (in Italian incentivazione allesodo ).
8. By virtue of your continuing employment, you will vest in stock options in December 2006 consistent with the terms of the Companys 2002 and 2005 Stock Incentive Plans.
9. The bonus 2006 shall be paid consistent with the terms of the plan within March 2007; the payment of the severance indemnity (TFR), of the other pro-rata amounts of additional monthly wages including the indemnity in-lieu-of holidays (if accrued) shall be made within the last day of the month following the Termination Date, whereas the payment of the una tantum indemnity provided in article 7 shall be made within June 2007, provided that in the meantime the parties have executed a conciliation agreement, consistent with the terms of this private agreement, before the appropriate committee of the Ministry of Labor Office or before the Unions.
2
10. It is understood and agreed that the indemnity una tantum , also in consideration of its amount, is hereby accepted by you as full, final and general satisfaction of all of your possible claims connected with or arising from the employment relationship and its termination by consent, even if not expressly asserted and/or waived, including, inter alia, those concerning past salaries, alleged downgrading, biological damages or other damages, indemnities or compensation connected or related to the employment relationship (including the assignment) and with your service as director with Ecolab GmbH & Co. OHG and any other company of the group.
11. At or before the Employment Termination Date you are requested to return to the Company any Company property still in your possession.
12. It is understood and agreed that, even after the Termination Date, you will not reveal to any third parties any confidential information relating to the employment or termination from the Company, its operations, or any confidential matters entrusted to you as an employee of the Company.
13. For a period of two years after the Termination Date, you shall not engage, directly or indirectly, as a proprietor, director, officer, employee, or in any other capacity or manner whatsoever, in competition with Ecolab throughout Europe, Africa and the Middle East. You, therefore, agree:
(a) If your new employer could be construed as a Conflicting Organization, you will inform your new employer, prior to accepting employment, of the existence of this non-compete convenant and provide such employer with a copy.
(b) You will not render services, directly or indirectly, to any Conflicting Organization, except that you may accept employment with a Conflicting Organization whose business is diversified and which, as to that part of its business in which you will be employed, is not a Conflicting Organization, provided that the Company, prior to your beginning such employment, receives separate written assurances satisfactory to the Company from such Conflicting Organization and from you stating that you will not render services, directly or indirectly in connection with any Conflicting Product or Service for the two (2) year non-compete period.
3
(c) You will not hire or induce directly or indirectly any employee or agent of the Company to terminate such employees or agents relationship with the Company.
(d) You will not service, sell, solicit the sale of, or accept orders for any Conflicting Product or Service to any customer of the Company.
For the purposes of this Agreement, a Conflicting Product or Service means any product or process of, or service by, any person or organization other than the Company, in existence or under development, which is the same as or similar to or improves upon or competes with a product or process of, or service rendered by, the Company. A Conflicting Organization means any person or organization (including one owned in whole or in part by you) which is engaged in or is about to become engaged in the research on, or the development, production, marketing or sale of, or consulting pertaining to, a Conflicting Product or Service.
14. As consideration for the non-compete undertaking, you shall be paid, starting at the end of the working relationship, a compensation of 120,000 gross in 12 bi-monthly installments of 10,000 each, the first of which to be paid within July 31, 2007.
You agree that any breach of the above obligation would immediately and throughout the duration of the non-compete provision cause irreparable damages to us and therefore you agree that our Company will, under those circumstances, be entitled to obtain (i) a Courts order for specific performance, as well as adequate injunctive relief (provvedimento cautelare); or (ii) the termination of the non-compete obligation. In the first case, you will be bound to pay a penalty amounting to 120,000; in the second case, in addition to the penalty as above indicated, you will be bound to return to our Company the whole amount received until that time in connection with your non-compete obligation, with interest, paid by our Company. In both cases our Company will be entitled to ask for all other damages, if actually incurred.
4
Please return a copy of this letter, signed for acceptance.
Thanking you for your cooperation, we remain
Yours faithfully,
ECOLAB S.r.l. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/Doug Baker |
|
|
|
/s/Luciano Iannuzzi |
|
|
Doug Baker |
|
|
|
Luciano Iannuzzi |
|
|
5
EXHIBIT (10)U
2007 NAMED EXECUTIVE OFFICER
SUMMARY OF BASE SALARY, BONUS AWARD OPPORTUNITIES,
AND EXECUTIVE BENEFITS AND PERQUISITES
Base Salary
The table below sets forth the base salaries established for the 2007 fiscal year for the Companys Principal Executive Officer and Principal Financial Officer and the next three most-highly compensated executive officers who were serving in those capacities at December 31, 2006 (the NEOs).
Name and Principal Position |
|
Amount |
|
|
Douglas M. Baker, Jr. Chairman of the Board, President and Chief Executive Officer |
|
$ |
900,000 |
|
|
|
|
|
|
Steven L. Fritze Executive Vice President and Chief Financial Officer |
|
$ |
450,000 |
|
|
|
|
|
|
James A. Miller Executive Vice President Institutional Sector |
|
$ |
400,000 |
|
|
|
|
|
|
Lawrence T. Bell Senior Vice President, General Counsel and Secretary |
|
$ |
355,000 |
|
|
|
|
|
|
C. William Snedeker Executive Vice President Global Services Sector |
|
$ |
330,000 |
|
Bonus Award Opportunities
The Company maintains annual cash incentive programs for executives referred to as the Management Incentive Plan or MIP and Management Performance Incentive Plan or MPIP. The Companys stockholders approved the current version of the MPIP in 2004, an annual incentive plan under which awards should qualify as performance based under Internal Revenue Code Section 162(m). On February 22, 2007, as required under the terms of the MPIP, the Compensation Committee of the Board (Committee) selected Messrs. Baker, Fritze and Miller to participate in the MPIP for 2007, established the 2007 performance goal based upon the performance criteria of diluted earnings per share (EPS), set an EPS performance target of a designated earnings per share, and designated a cash award of 300% of the base salary of each such officer for 2007 to the extent the goal is achieved. The award is subject to and interpreted in accordance with the terms and conditions of the MPIP and no amount will be paid under the MPIP unless and until the Committee has determined the extent to which the performance goal has been met and the corresponding amount of the award earned by the participant. The MPIP permits the Committee to exercise downward discretion so as to pay an amount which is less than the amount of the award earned by the participant. In applying this downward discretion, the Committee considers
underlying operable metrics communicated to the participant, which are noted in the table below. Messrs. Bell and Snedeker will participate in the MIP in 2007 and the operating metrics with respect to their participation are similarly noted in the table below.
|
|
Target
|
|
Potential Award Payouts at Different Levels
|
|
Performance Measure Mix |
|
||||||||
|
|
(% of base |
|
|
|
|
|
|
|
|
|
Business |
|
|
|
Name |
|
salary) |
|
Threshold |
|
Target |
|
Max |
|
EPS |
|
Unit |
|
Individual |
|
Douglas M. Baker |
|
110 |
% |
40 |
% |
100 |
% |
200 |
% |
100 |
% |
0 |
% |
0 |
% |
Steven L. Fritze |
|
60 |
% |
40 |
% |
100 |
% |
200 |
% |
70 |
% |
0 |
% |
30 |
% |
James A. Miller |
|
60 |
% |
40 |
% |
100 |
% |
200 |
% |
30 |
% |
70 |
% |
0 |
% |
Lawrence T. Bell |
|
55 |
% |
40 |
% |
100 |
% |
200 |
% |
70 |
% |
0 |
% |
30 |
% |
C. William Snedeker |
|
55 |
% |
40 |
% |
100 |
% |
200 |
% |
30 |
% |
70 |
% |
0 |
% |
Executive Benefits and Perquisites
The following table sets forth the executive benefits and perquisites made available by the Company to the NEOs for the 2007 fiscal year.
Executive Benefit |
|
Description |
Physical Examination |
|
· Annual reimbursement |
Mirror Savings and Pension Plan |
|
· Nonqualified ERISA excess benefit plans intended to restore benefits limited by law under the tax-qualified savings and pension plans · Executives may also elect to defer up to 25% of base salary and annual bonus, subject to the same investment alternatives and returns as under the tax-qualified savings plan |
Supplemental Executive Retirement Plan |
|
· Maximum annual benefit of 60% of highest five consecutive years of base salary and annual bonus (offset by other qualified and nonqualified pension benefits) · Provides past service credit |
Post-Retirement Death Benefit |
|
· Two times final average pay |
Executive Life, Accidental Death and Dismemberment and Business Travel Accident Insurance |
|
· Each are three times annual compensation for the preceding year |
Long-Term Disability Insurance |
|
· 60% of compensation, less the amount of the qualified benefit |
Company Automobile |
|
· Full reimbursement to principal executive officer · $39,800 purchase price or $790 monthly lease rate for other named executive officers |
Financial Counseling |
|
· Five percent of base salary for principal executive officer · Three percent of base salary for other named executive officers |
Club Memberships |
|
· Limited to principal executive officer |
Private Aircraft Usage |
|
· Limited to principal executive officer (Not used in 2006) |
Spousal Travel |
|
· Only when related to a business purpose |
Relocation Expense |
|
· Includes home sale assistance, transportation of household goods, temporary living costs, travel to new location, home finding costs, closing costs on home purchase and expense allowance. |
Exhibit (10)W(iii)
RESTRICTED STOCK AWARD AGREEMENT
THIS AGREE MENT is entered into and effective as of this day of , 20 , (the Date of Grant), by and between Ecolab Inc. (the Company) and (the Grantee).
A. The Company has adopted the Ecolab Inc. 2005 Stock Incentive Plan, (the Plan), authorizing the Board of Directors of the Company, or a committee as provided for in the Plan (the Board or such a committee to be referred to as the Committee), to grant restricted stock awards to certain employees of the Company and its Subsidiaries.
B. The Company desires to give the Grantee a proprietary interest in the Company and an added incentive to advance the interests of the Company by granting to the Grantee a restricted award of shares of common stock of the Company pursuant to the Plan.
Accordingly, the parties agree as follows:
ARTICLE 1. GRANT OF AWARD .
The Company hereby grants to the Grantee a restricted stock award (the Award) consisting of ( ) shares (the Award Shares) of the Companys common stock, par value $1.00 per share (the Common Stock), according to the terms and subject to the restrictions and conditions hereinafter set forth and as set forth in the Plan. Reference to the Award Shares in this Agreement will be deemed to include the Non-Quarterly Dividend Proceeds (as defined in Section 3.2 of this Agreement) with respect to such Award Shares that are retained and held by the Committee as provided in Section 3.2 of this Agreement.
ARTICLE 2. GRANT RESTRICTION .
2.1 Restriction and Forfeiture . The Grantees right to retain the Award Shares will be subject to the Grantee remaining in the continuous employ or service of the Company or any Subsidiary for a period of ( ) years (the Restriction Period) following the Date of Grant; provided, however, that such employment period restrictions (the Restrictions) will lapse and terminate prior to end of the Restriction Period with respect to % of the Award Shares (excluding any fractional portion less than one share) on the anniversary of the Date of Grant and with respect to the remaining Award Shares on the anniversary of the Date of Grant.
2.2 Termination of Employment or Other Service .
(a) In the event that the Grantees employment or other service with the Company and all Subsidiaries is terminated by reason of the Grantees death or Disability, all Restrictions applicable to the Award Shares will immediately lapse and terminate.
(b) In the event that the Grantees employment or other service with the Company and all Subsidiaries is terminated by reason of the Grantees Retirement or for any reason other than death or Disability, all rights of the Grantee under the Plan and this Agreement will immediately
terminate without notice of any kind, and this Award will be terminated and all Award Shares with respect to which Restrictions have not lapsed will be forfeited and returned to the Company.
2.3 Change in Control . In the event of a Change in Control, all Restrictions applicable to Award Shares will immediately lapse and terminate.
2.4 Effects of Actions Constituting Cause . Notwithstanding anything in this Agreement to the contrary, in the event that the Grantee is determined by the Committee, acting in its sole discretion, to have committed any action which would constitute Cause, irrespective of whether such action or the Committees determination occurs before or after termination of the Grantees employment with the Company or any Subsidiary, all rights of the Grantee under the Plan and this Agreement shall terminate and be forfeited without notice of any kind. The Company may defer the vesting of the Award Shares for up to forty-five (45) days in order for the Committee to make any determination as to the existence of Cause.
ARTICLE 3. ISSUANCE OF AWARD SHARES .
3.1 Privileges of a Stockholder; Transferability . As soon as practicable after this Agreement is executed and delivered, the Award Shares will be transferred on the books of the Company into the name of, or into an account for the benefit of, the Grantee. Except as provided in Section 3.2 of this Agreement, the Grantee will have all voting, dividend, liquidation and other rights with respect to the Award Shares in accordance with their terms upon becoming the holder of record of such shares; provided, however, that prior to the lapse or other termination of the Restrictions applicable to Award Shares, such shares will not be assignable or transferable by the Grantee, either voluntarily or involuntarily, and may not be subjected to any lien, directly or indirectly, by operation of law or otherwise. Any attempt to transfer, assign or encumber the Award Shares other than in accordance with this Agreement and the Plan will be null and void and will void the Award, and all Award Shares for which the Restrictions have not lapsed will be forfeited and immediately returned to the Company.
3.2 Dividends and Other Distributions . The Grantee will have no right to receive dividends or distributions with respect to Award Shares, including stock dividends or dividends in kind, the proceeds of any stock split or the proceeds resulting from any changes or exchanges described in Article 4 of this Agreement (all of which will collectively be referred to as Non-Quarterly Dividend Proceeds). The Committee may, in its sole discretion, distribute such Non-Quarterly Dividend Proceeds to the Grantee or it may direct the retention and holding of such proceeds subject to the Restrictions and the other terms and conditions of this Agreement. In addition, the Committee may, in its sole discretion, cause such Non-Quarterly Dividend Proceeds to be paid to the Company pursuant to Article 7 of this Agreement in order to satisfy any federal, state or local withholding or other employment-related tax requirements attributable to such dividends or to the Grantees receipt of the Award or the lapse or termination of the Restrictions applicable to Award Shares.
ARTICLE 4. ADJUSTMENTS .
In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering or divestiture (including a spin-off) or any other change in the corporate structure or shares of the Company, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation), in order to prevent dilution or enlargement of the rights of the
2
Grantee, will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities subject to this Award.
ARTICLE 5. RIGHTS AS A STOCKHOLDER .
The Grantee will have no rights as a stockholder with respect to any of the Award Shares until the Grantee becomes the holder of record of such Award Shares, and no adjustments will be made for dividends or other distributions or other rights as to which there is a record date preceding the date the Grantee becomes the holder of record of such Award Shares.
ARTICLE 6. EMPLOYMENT OR SERVICE .
Nothing in this Agreement will be construed to (a) limit in any way the right of the Company to terminate the employment or service of the Grantee at any time, or (b) be evidence of any agreement or understanding, express or implied, that the Company will retain the Grantee in any particular position at any particular rate of compensation or for any particular period of time.
ARTICLE 7. WITHHOLDING TAXES .
7.1 General Rules . The Company is entitled to (a) withhold and deduct from future wages of the Grantee, or cause to be paid to the Company out of Non-Quarterly Dividend Proceeds, all legally required amounts necessary to satisfy any federal, state or local withholding tax requirements attributable to the receipt of the Award, the receipt of dividends or distributions on Award Shares, or the lapse or termination of the Restrictions applicable to Award Shares, (b) withhold cash paid or payable or Award Shares issued or issuable to the Grantee, or (c) require the Grantee to promptly remit the amount of such withholding to the Company. In the event that the Company is unable to withhold such amounts, for whatever reason, the Grantee must promptly pay to the Company an amount equal to the amount the Company would otherwise be required to withhold under federal, state or local law.
7.2 Special Rules . The Committee may, in its sole discretion and upon terms and conditions established by the Committee, permit or require the Grantee to satisfy, in whole or in part, any withholding or tax obligation as described in Section 7.1 above by electing to tender, or by attestation as to ownership of, Previously Acquired Shares that have been held for the period of time necessary to avoid a charge to the Companys earnings for financial reporting purposes and that are otherwise acceptable to the Committee. For purposes of satisfying the Grantees withholding or employment-related tax obligation, Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value.
ARTICLE 8. SUBJECT TO PLAN .
8.1 Terms of Plan Prevail . The Award and the Award Shares granted pursuant to this Agreement have been granted under, and are subject to the terms of, the Plan. The terms of the Plan are incorporated by reference in this Agreement in their entirety, and the Grantee, by execution of this Agreement, acknowledges having received a copy of the Plan. The provisions of this Agreement will be interpreted as to be consistent with the Plan, and any ambiguities in this Agreement will be interpreted by reference to the Plan. In the event that any provision in this Agreement is inconsistent with the terms of the Plan, the terms of the Plan will prevail.
3
8.2 Definitions . Unless otherwise defined in this Agreement, the terms capitalized in this Agreement have the same meanings as given to such terms in the Plan.
ARTICLE 9. MISCELLANEOUS .
9.1 Binding Effect . This Agreement will be binding upon the heirs, executors, administrators and successors of the parties hereto.
9.2 Governing Law . This Agreement and all rights and obligations under this Agreement will be construed in accordance with the Plan and governed by the laws of the State of Minnesota without regard to conflicts of law provisions. Any legal proceeding related to this Agreement will be brought in an appropriate Minnesota court, and the parties to this Agreement consent to the exclusive jurisdiction of the court for this purpose.
9.3 Entire Agreement . This Agreement and the Plan set forth the entire agreement and understanding of the parties hereto with respect to the grant and exercise of this Award and the administration of the Plan and supersede all prior agreements, arrangements, plans and understandings relating to the grant and vesting of this Award and the administration of the Plan.
9.4 Amendment and Waiver . Other than as provided in the Plan, this Agreement may be amended, waived, modified or canceled only by a written instrument executed by the parties hereto or, in the case of a waiver, by the party waiving compliance.
9.5 Captions . The Article, Section and paragraph captions in this Agreement are for convenience of reference only, do not constitute part of this Agreement and are not to be deemed to limit or otherwise affect any of the provisions of this Agreement.
9.6 Counterparts . For convenience of the parties hereto, this Agreement may be executed in any number of counterparts, each such counterpart to be deemed an original instrument, and all such counterparts together to constitute the same agreement.
The parties hereto have executed this Agreement effective the day and year first above written.
|
|
|
|
By execution hereof, the Grantee acknowledges having received a copy of the Plan. |
|
|
|
|
|
|
|
|
ECOLAB INC. |
|
|
GRANTEE |
|
|
|
|
|
|
|
By: |
|
|
By: |
|
|
|
|
|
|
(Signature) |
|
Its |
|
|
|
|
|
|
|
|
|
(Print Name) |
|
|
|
|
|
|
|
|
|
|
|
(Address) |
|
|
|
|
|
|
|
|
|
|
|
(City, State, Zip) |
|
|
|
|
|
|
|
|
|
|
|
SSN |
|
4
Exhibit 13
Financial Discussion
EXECUTIVE SUMMARY
This Financial Discussion should be read in conjunction with the information on Forward-Looking Statements and Risk Factors found at the end of the Financial Discussion.
2006 was an outstanding year for Ecolab. We achieved a strong financial performance including record net sales of $4.9 billion and improved operating income margins which drove 16 percent diluted earnings per share growth. We realized major competitive gains, made significant investments in our people and business, and further improved our long-term growth potential.
We exceeded all three of our long-term financial objectives:
|
|
2006 RESULTS |
|
LONG-TERM OBJECTIVE |
EPS Growth |
|
16.3% |
|
15% |
ROBE |
|
22.4% |
|
20% |
Balance Sheet |
|
A |
|
Investment Grade |
OPERATING HIGHLIGHTS
· We made important competitive gains in our market during 2006, creating enhanced global opportunities to pursue our Circle the Customer Circle the Globe growth strategy as we believe Ecolab alone can offer consistent service around the globe.
· We enjoyed double-digit sales and profit growth in the United States and improved sales and profit growth from our International operations.
· In 2006 we continued our tradition of new product innovation building on our core product platforms. We introduced a product in our antimicrobial platform that reduces microbial contamination in ready-to-eat meat and poultry products, making them safer and contributing to a longer shelf life. To help reduce the risk of foodborne illness, we introduced the first EPA-registered antimicrobial product that reduces pathogens in fruit and vegetable process water at food processing plants. We also continued our efforts to customize solutions to meet specific customer needs through new programs.
· We continued to make business acquisitions in order to broaden our product and service offerings in line with our Circle the Customer Circle the Globe strategy. Details of these acquisitions are shown below.
· We grew our industry-leading sales and service force by more than 500 people, to more than 13,400 strong, and made key investments in tools, training and technology to improve their sales productivity and effectiveness.
· We made significant investments in our business systems that will drive competitive advantage in the future.
· We continue to work to simplify and streamline our business processes, bolstering our ability to deliver growth more efficiently in the future.
FINANCIAL PERFORMANCE
· Consolidated net sales reached a record of $4.9 billion for 2006, an increase of 8 percent over net sales of $4.5 billion in 2005.
· Our operating income for 2006 increased 13 percent to a record $612 million.
· Diluted net income per share increased 16 percent to $1.43 per share for 2006, compared to $1.23 per share in 2005.
· Cash flow from operating activities reached a record $628 million in 2006 and allowed us to fund investments in our business operations, make business acquisitions, reacquire $283 million of our common stock and make a voluntary contribution of $45 million to our U.S. pension plan.
· We increased our quarterly dividend rate for the fifteenth consecutive year. The dividend was increased 15 percent in December 2006 to an indicated annual rate of $0.46 per common share.
· Our return on beginning shareholders equity (net income divided by beginning shareholders equity) rose to 22.4 percent in 2006, the fifteenth consecutive year in which we achieved our long-term financial objective of a 20 percent return on beginning shareholders equity.
· Our balance sheet remained strong, maintaining our debt rating within the A categories of the major rating agencies during 2006. We also strengthened and solidified our capital structure, successfully refinancing a maturing debt instrument and lowering our future financing cost.
· We adopted the provisions of Statement of Financial Accounting Standard No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans (SFAS 158) effective as of our 2006 year end. The impact of adopting SFAS 158 is reflected as a reduction in net assets on our balance sheet of $168 million, with no impact to the statements of income and cash flows. See Note 15 for more information on this adoption.
ACQUISITIONS
· In June, we acquired Shield Medicare Ltd., based in the UK. With annual sales of $19 million, Shield is a leading provider of contamination control products for pharmaceutical, medical device and hospital clean rooms.
· In September, we acquired DuChem Industries, Inc., a U.S. manufacturer and marketer of cleaning and sanitizing products for the food and beverage market. DuChems core focus is the protein (meat & poultry) market segment, and has annual sales of $10 million.
· In September, we acquired Powles Hunt & Sons International Ltds UK commercial laundry business. With annual sales of $5 million, this acquisition will add scale to our textile care business in the UK.
2007 EXPECTATIONS
· We look for continued momentum from our existing business, investments in our key growth drivers and from competitive gains achieved in 2006 to drive growth and market share opportunities in 2007.
17
· We will continue to leverage our Circle the Customer Circle the Globe growth strategy through cross-selling and enhanced marketing of our many product and service solutions under the Ecolab brand.
· We will continue to invest in new product, system and service development in order to deliver improved value to our customers and thereby earn more of their business.
· We plan to seek strategic business acquisitions which complement our growth strategy.
· We will continue to work on streamlining our business processes in order to reduce costs and improve sustainability.
· We intend to make significant investments in our business systems to drive growth in the future.
· We will continue to work to deliver superior results to our customers, returns to shareholders and opportunity to our valued associates.
CRITICAL ACCOUNTING ESTIMATES
Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). We have adopted various accounting policies to prepare the consolidated financial statements in accordance with U.S. GAAP. Our most significant accounting policies are disclosed in Note 2 of the notes to the consolidated financial statements.
Preparation of our consolidated financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates are considered to be critical if they meet both of the following criteria: (1) the estimate requires assumptions to be made about matters that are highly uncertain at the time the accounting estimate is made, and (2) different estimates that the company reasonably could have used for the accounting estimate in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, have a material impact on the presentation of the companys results of operations.
Besides estimates that meet the critical estimate criteria, we make many other accounting estimates in preparing our financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses as well as disclosures of contingent assets and liabilities. Estimates are based on experience and other information available prior to the issuance of the financial statements. Materially different results can occur as circumstances change and additional information becomes known, even from estimates not deemed critical. Our critical accounting estimates include the following:
REVENUE RECOGNITION
We recognize revenue on product sales at the time title to the product and risk of loss transfers to the customer. We recognize revenue on services as they are performed. Our sales policies do not provide for general rights of return and do not contain customer acceptance clauses. We record estimated reductions to revenue for customer programs and incentive offerings including pricing arrangements, promotions and other volume-based incentives at the time the sale is recorded. Depending on market conditions, we may increase customer incentive offerings, which could reduce gross profit margins at the time the incentive is offered.
VALUATION ALLOWANCES AND ACCRUED LIABILITIES
We estimate sales returns and allowances by analyzing historical returns and credits, and apply these trend rates to the most recent 12 months future credits. We estimate the allowance for doubtful accounts by analyzing accounts receivable balances by age, applying historical write-off trend rates to the most recent 12 months sales, less actual write-offs to date. In addition, our estimates also include separately providing for 100 percent of specific customer balances when it is deemed probable that the balance is uncollectible. Actual results could differ from these estimates under different assumptions.
Estimates used to record liabilities related to pending litigation and environmental claims are based on our best estimate of probable future costs. Estimated future legal costs are expensed as incurred. We record the amounts that represent the points in the range of estimates that we believe are most probable or the minimum amounts when no amount within the range is a better estimate than any other amount. Potential insurance reimbursements are not anticipated in our accruals for environmental liabilities. While the final resolution of litigation and environmental contingencies could result in amounts different than current accruals, and therefore have an impact on our consolidated financial results in a future reporting period, we believe the ultimate outcome will not have a significant effect on our consolidated results of operations, financial position or cash flows.
ACTUARIALLY DETERMINED LIABILITIES
The measurement of our pension and postretirement benefit obligations are dependent on a variety of assumptions determined by management and used by our actuaries. These assumptions affect the amount and timing of future contributions and expenses.
The assumptions used in developing the required estimates include, among others, discount rate, projected salary and health financial care cost increases and expected return or earnings on assets. Beginning in 2005, the discount rate assumption for the U.S. Plans is calculated using a bond yield curve constructed from a large population of high-quality, non-callable, corporate bond issues with maturity dates of six months to thirty years. Bond issues in the population are rated no less than Aa by Moodys Investor Services or AA by Standard & Poors. The discount rate is calculated by matching of the plan liability cash flows to the yield curve. Prior to 2005, the discount rate assumption was based on the investment yields available at year-end on corporate long-term bonds rated AA. Projected salary and health care cost increases are based on our long-term actual experience, the near-term outlook and assumed inflation. The expected return on plan assets reflects asset allocations, investment strategies and the views of investment advisors. The effects of actual results differing from our assumptions, as well as changes in assumptions, are reflected in the unrecognized actuarial loss and amortized over future periods and, therefore, generally affect our recognized expense in future periods. Our unrecognized actuarial loss on our U.S. qualified and nonqualified pension plans decreased to $189 million (before tax) due primarily to a better than expected return on plan assets and an increase in the discount rate at the end of 2006. As of December 31, 2006, this unrecognized loss is included on our balance sheet as a component of Accumulated Other Comprehensive Income due to the adoption of SFAS 158. Significant differences in actual experience or significant changes in assumptions may materially affect pension and other post-retirement obligations.
18
In determining our U.S. pension and postretirement obligations for 2006, our discount rate increased to 5.79 percent from 5.57 percent at year-end 2005. Our projected salary increase was unchanged at 4.32 percent and our expected return on plan assets used for determining 2006 expense remained unchanged at 8.75 percent.
The effect on 2007 expense of a decrease in the discount rate or expected return on assets assumption as of December 31, 2006 is shown below assuming no changes in benefit levels and no amortization of gains or losses for our major plans:
|
|
Effect on U.S. Pension Plan |
|
||||||
|
|
|
|
Increase in |
|
Higher |
|
||
millions |
|
Assumption |
|
Recorded |
|
2007 |
|
||
Assumption |
|
Change |
|
Obligation |
|
Expense |
|
||
|
|
|
|
|
|
|
|
||
Discount rate |
|
-0.25 pts |
|
$ |
30.8 |
|
$ |
4.2 |
|
Expected return on assets |
|
-0.25 pts |
|
N/A |
|
$ |
1.9 |
|
|
|
|
Effect on U.S. Postretirement |
|
||||||
|
|
Health Care Benefits Plan |
|
||||||
|
|
|
|
Increase in |
|
Higher |
|
||
millions |
|
Assumption |
|
Recorded |
|
2007 |
|
||
Assumption |
|
Change |
|
obligation |
|
Expense |
|
||
|
|
|
|
|
|
|
|
||
Discount rate |
|
-0.25 pts |
|
$ |
4.8 |
|
$ |
0.7 |
|
Expected return on assets |
|
-0.25 pts |
|
N/A |
|
$ |
0.1 |
|
|
See Note 15 for further discussion concerning our accounting policies, estimates, funded status, planned contributions and overall financial positions of our pension and post-retirement plan obligations.
We are self-insured in North America for most workers compensation, general liability and automotive liability losses, subject to per occurrence and aggregate annual liability limitations. We are insured for losses in excess of these limitations. We have recorded both a liability and an offsetting receivable for amounts in excess of these limitations. We are also self-insured for health care claims for eligible participating employees, subject to certain deductibles and limitations. We determine our liabilities for claims incurred but not reported on an actuarial basis. A change in these assumptions would cause reported results to differ.
SHARE-BASED COMPENSATION
Effective October 1, 2005 we adopted Statement of Financial Accounting Standards No. 123 (Revised 2004), Share-Based Payment (SFAS 123R) under the modified retrospective application method. All prior period financial statements were restated to recognize share-based compensation historically reported in the notes to the consolidated financial statements. As required by SFAS 123R, we measure compensation expense for share-based awards at fair value at the date of grant and recognize compensation expense over the service period for awards expected to vest. Upon adoption of SFAS 123R in the fourth quarter of 2005 we began using a lattice-based binomial model for valuing new stock option grants. We believe this model considers appropriate probabilities of option exercise and post-vesting termination which are more consistent with actual and projected experience, and therefore support more accurate valuation of a stock option. We also started using a forfeiture estimate for all share-based awards in the amount of compensation expense being recognized. This change from our historical practice of recognizing forfeitures as they occur did not result in the recognition of any cumulative adjustment to income.
Determining the fair value of share-based awards at the grant date requires judgment, including estimating expected volatility, exercise and post-vesting termination behavior, expected dividends and risk-free rates of return. Additionally, the expense that is recorded is dependent on the amount of share-based awards that is expected to be forfeited. If actual forfeiture results differ significantly from these estimates, share-based compensation expense and our results of operations could be impacted. For additional information on our stock incentive and option plans, including significant assumptions used in determining fair value, see Note 10.
INCOME TAXES
Judgment is required to determine the annual effective income tax rate, deferred tax assets and liabilities and any valuation allowances recorded against net deferred tax assets. Our effective income tax rate is based on annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which we operate. We establish liabilities or reserves when we believe that certain positions are likely to be challenged by authorities and we may not succeed, despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances. Our annual effective income tax rate includes the impact of reserve provisions and changes to reserves that we consider appropriate. During interim periods, this annual rate is then applied to our year-to-date operating results. In the event that there is a significant one-time item recognized in our interim operating results, the tax attributable to that item would be separately calculated and recorded in the same period as the one-time item.
Tax regulations require items to be included in our tax returns at different times than the items are reflected in our financial statements. As a result, the effective income tax rate reflected in our financial statements differs from that reported in our tax returns. Some of these differences are permanent, such as expenses that are not deductible on our tax return, and some are temporary differences, such as depreciation expense. Temporary differences create deferred tax assets and liabilities. Deferred tax assets generally represent items that can be used as a tax deduction or credit in our tax return in future years for which we have already recorded the tax benefit in our income statement. We establish valuation allowances for our deferred tax assets when the amount of expected future taxable income is not likely to support the utilization of the deduction or credit. Deferred tax liabilities generally represent items for which we have already taken a deduction in our tax return, but have not yet recognized that tax benefit in our financial statements. Undistributed earnings of foreign subsidiaries are considered to have been reinvested indefinitely or available for distribution with foreign tax credits available to offset the amount of applicable income tax and foreign withholding taxes that might be payable on earnings. It is impractical to determine the amount of incremental taxes that might arise if all undistributed earnings were distributed.
A number of years may elapse before a particular tax matter, for which we have established a reserve, is audited and finally resolved. The number of tax years with open tax audits varies depending on the tax jurisdiction. In the United States, during 2004, the Internal Revenue Service completed their field work examination of our tax returns for 1999 through 2001. We expect the final resolution for these returns by 2008. We also expect the Internal Revenue Service to complete their field work examination of our tax returns for 2002 through 2004 in 2007.
19
While it is often difficult to predict the final outcome or the timing of resolution of any tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. Unfavorable settlement of any particular issue could result in additional tax expense and would require the use of cash. Favorable resolution could result in reduced income tax expense reported in the financial statements in the future. Our tax reserves are presented in the balance sheet within other non-current liabilities.
LONG-LIVED AND INTANGIBLE ASSETS
We periodically review our long-lived and intangible assets for impairment and assess whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. This could occur when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated as the excess of the assets carrying value over its estimated fair value. We also periodically reassess the estimated remaining useful lives of our long-lived assets. Changes to estimated useful lives would impact the amount of depreciation and amortization expense recorded in earnings. We have experienced no significant changes in the carrying value or estimated remaining useful lives of our long-lived assets.
We review our goodwill for impairment on an annual basis for all reporting units. If circumstances change significantly within a reporting unit, we would test for impairment prior to the annual test.
Goodwill and certain intangible assets are assessed for impairment using fair value measurement techniques. Specifically, goodwill impairment is determined using a two-step process. Both the first step of determining the fair value of a reporting unit and the second step of determining the fair value of individual assets and liabilities of a reporting unit (including unrecognized intangible assets) are judgmental in nature and often involve the use of significant estimates and assumptions. Estimates of fair value are primarily determined using discounted cash flows, market comparisons and recent transactions. These valuation methodologies use significant estimates and assumptions, which include projected future cash flows (including timing), discount rate reflecting the risk inherent in future cash flows, perpetual growth rate, and determination of appropriate market comparables. No impairments were recorded in 2006, 2005 or 2004 as a result of the tests performed. Of the total goodwill included in our consolidated balance sheet, 19 percent is recorded in our United States Cleaning & Sanitizing reportable segment, 5 percent in our United States Other Services segment and 76 percent in our International segment.
FUNCTIONAL CURRENCIES
In preparing the consolidated financial statements, we are required to translate the financial statements of our foreign subsidiaries from the currency in which they keep their accounting records, generally the local currency, into United States dollars. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income in shareholders equity. Income statement accounts are translated at average rates of exchange prevailing during the year. We evaluate our International operations based on fixed rates of exchange; however, the different exchange rates from period to period impact the amount of reported income from our consolidated operations.
RESULTS OF OPERATIONS
CONSOLIDATED
millions, except per share |
|
2006 |
|
2005 |
|
2004 |
|
|||
|
|
|
|
|
|
|
|
|||
Net sales |
|
$ |
4,896 |
|
$ |
4,535 |
|
$ |
4,185 |
|
Operating income |
|
612 |
|
542 |
|
490 |
|
|||
Net income |
|
369 |
|
319 |
|
283 |
|
|||
Diluted net income per common share |
|
$ |
1.43 |
|
$ |
1.23 |
|
$ |
1.09 |
|
Our consolidated net sales for 2006 increased 8 percent over 2005. The components include 6 percent volume growth and 2 percent favorable effect from price changes. Acquisitions and divestitures and changes in currency translation did not have a significant impact on the consolidated sales growth rate.
|
|
2006 |
|
2005 |
|
2004 |
|
|
|
|
|
|
|
|
|
Gross profit as a percent of net sales |
|
50.7 |
% |
50.4 |
% |
51.4 |
% |
Selling, general & administrative expenses as a percent of net sales |
|
38.2 |
% |
38.4 |
% |
39.6 |
% |
Our consolidated gross profit margin (defined as gross profit divided by net sales) for 2006 increased from 2005, primarily driven by pricing and cost savings initiatives which more than offset higher delivered product costs during the year.
Selling, general and administrative expenses as a percentage of sales continued to improve in 2006. The improvement in the 2006 expense ratio is primarily due to increased sales leverage and cost saving programs which more than offset investments in the business.
|
|
2006 |
|
2005 |
|
2004 |
|
|
|
|
|
|
|
|
|
Operating income as a percent of net sales |
|
12.5 |
% |
12.0 |
% |
11.7 |
% |
Operating income increased 13 percent in 2006 over 2005. As a percent of sales, operating income also increased from 2005. The increase in operating income in 2006 is due to pricing, sales volume and cost reduction initiatives partially offset by higher delivered product costs as well as investments in the business.
Our net income was $369 million in 2006, an increase of 15 percent compared to $319 million in 2005. Net income in both years included items of a non-recurring nature that are not necessarily indicative of future operating results. Net income in 2006 included the benefit of a $1.8 million tax settlement for stewardship costs which was offset by a $2.8 million charge ($1.8 million net of tax benefit) in selling, general and administrative expense to recognize minimum royalties under a licensing agreement with no future benefit. Net income in 2005 included a tax charge of $3.1 million related to the repatriation of foreign earnings under the American Jobs Creation Act (AJCA). Excluding these items, net income increased 14 percent for 2006. This increase in net income reflects improved sales, gross margin and operating income growth. Currency translation positively impacted net income in 2006 by approximately $2 million. Our 2006 net income also benefited when compared to 2005 due to a lower overall effective income tax rate which was the result of international mix, lower international statutory rates and tax planning efforts.
20
2005 COMPARED WITH 2004
Our consolidated net sales for 2005 increased 8 percent to $4.5 billion compared to $4.2 billion in 2004. Acquisitions and divestitures increased consolidated net sales by 1 percent. Changes in currency translation also positively impacted the sales growth rate by 1 percent. Sales benefited from pricing, new account gains, new product and service offerings and investments in the sales-and-service-force.
Our consolidated gross profit margin for 2005 decreased from 2004. The decrease was primarily driven by higher delivered product costs, partially offset by pricing and cost savings programs.
Selling, general and administrative expenses as a percentage of sales improved for 2005 compared to 2004. The improvement in the 2005 expense ratio is primarily due to pricing, sales leverage and cost savings programs partially offset by investments in the sales-and-service force, research and development and technology.
Operating income for 2005 increased 11 percent over 2004. As a percent of sales, operating income also increased from 2004. The increase in operating income in 2005 is due to sales volume, pricing, cost reduction initiatives and lower share-based compensation expense, partially offset by higher delivered product costs as well as investments in the sales-and-service force, research and development and technology. Operating income also benefited from significant operating improvement at GCS Service in 2005.
Our net income was $319 million in 2005, an increase of 13 percent as compared to $283 million in 2004. Net income in both years included items of a non-recurring nature that are not necessarily indicative of future operating results. Net income in 2005 included a tax charge of $3.1 million related to the repatriation of foreign earnings under the AJCA. Net income in 2004 included benefits from a reduction in previously recorded restructuring expenses of $0.6 million (after tax) and a gain on the sale of a small international business of $0.2 million (after tax). Income tax expense and net income in 2004 also included a tax benefit of $1.9 million related to prior years. These benefits were more than offset by a charge of $1.6 million for in-process research and development as part of the acquisition of Alcide Corporation and a charge of $2.4 million (after tax) related to the disposal of a grease management product line. Excluding these items from both years, net income increased 14 percent for 2005. This increase in net income reflects improved operating income growth by most of our business units in the face of a challenging raw material cost environment. Currency translation positively impacted net income growth in 2005 by approximately $5 million. Our 2005 net income also benefited when compared to 2004 due to a lower overall effective income tax rate which was the result of a lower international rate, international mix and tax planning efforts. Excluding the items of a non-recurring nature previously mentioned, net income was 7 percent of net sales for both 2005 and 2004.
SEGMENT PERFORMANCE
Our operating segments have been aggregated into three reportable segments: United States Cleaning & Sanitizing, United States Other Services and International. We evaluate the performance of our International operations based on fixed management rates of currency exchange. Therefore, International sales and operating income totals, as well as the International financial information included in this financial discussion, are based on translation into U.S. dollars at the fixed currency exchange rates used by management for 2006. The difference between actual currency exchange rates and the fixed currency exchange rates used by management is included in Effect of Foreign Currency Translation within our operating segment results. All other accounting policies of the reportable segments are consistent with U.S. GAAP and the accounting policies of the company described in Note 2 of the notes to consolidated financial statements. Additional information about our reportable segments is included in Note 16 of the notes to consolidated financial statements.
SALES BY REPORTABLE SEGMENT
millions |
|
2006 |
|
2005 |
|
2004 |
|
|||
Net sales |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
$ |
2,152 |
|
$ |
1,952 |
|
$ |
1,797 |
|
Other Services |
|
411 |
|
375 |
|
339 |
|
|||
Total United States |
|
2,563 |
|
2,327 |
|
2,136 |
|
|||
International |
|
2,261 |
|
2,137 |
|
2,038 |
|
|||
Total |
|
4,824 |
|
4,464 |
|
4,174 |
|
|||
Effect of foreign currency translation |
|
72 |
|
71 |
|
11 |
|
|||
Consolidated |
|
$ |
4,896 |
|
$ |
4,535 |
|
$ |
4,185 |
|
Percent Change From Prior Year |
|
2006 |
|
2005 |
|
Net sales |
|
|
|
|
|
United States |
|
|
|
|
|
Cleaning & Sanitizing |
|
10 |
% |
9 |
% |
Other Services |
|
9 |
|
11 |
|
Total United States |
|
10 |
|
9 |
|
International (management rates) |
|
6 |
|
5 |
|
Consolidated (management rates) |
|
8 |
|
8 |
|
Consolidated (public rates) |
|
8 |
% |
7 |
% |
Sales of our United States Cleaning & Sanitizing operations increased 10 percent to $2.2 billion in 2006. Sales were driven by double-digit sales growth in our Institutional and Kay divisions, along with good growth from our Food & Beverage division. Institutional sales increased 11 percent in 2006, benefiting from significant new account gains during the year. Institutional results reflect sales growth into all end market segments, including double-digit growth in travel, casual dining and health care markets. Food & Beverage division sales increased 8 percent for 2006. The acquisition of DuChem added 1 percent and the remaining increase was due to double-digit gains in the meat & poultry market as well as good gains in the dairy, food
21
and soft drink markets. Kay recorded an 11 percent sales increase in 2006 led by gains in its core quickservice and food retail markets. Kay benefited from good ongoing demand from existing customers as well as new account gains.
Sales of our United States Other Services operations increased 9 percent in 2006. Pest Elimination continued its double-digit sales growth as sales rose 13 percent. Sales were driven by growth in both core pest elimination contract and non-contract services. Sales also benefited from new accounts and strong customer retention. GCS Service sales grew modestly as service and installed parts sales increased over last year. GCS Service continued to focus on infrastructure and process development that will improve competitive advantage and business scalability in the future.
Management rate sales of our International operations were $2.3 billion in 2006, an increase of 6 percent over 2005. Acquisitions and divestitures added 1 percent to the year over year sales growth in 2006. Sales in Europe increased 4 percent from 2005. Good sales growth in the United Kingdom was partially offset by slower sales growth in Germany, France and Italy. Europe also achieved geographic growth in 2006 through further expansion in eastern Europe. Asia Pacific sales grew 6 percent primarily driven by growth in China, Australia, Thailand and Hong Kong partially offset by weakness in Japan. Asia Pacific sales benefited from new corporate accounts and good results in the beverage and brewery segment. Latin America recorded strong 14 percent sales growth in 2006. The growth over last year was driven by results in Mexico, the Caribbean and Venezuela. Results were due to new account gains, growth of existing accounts and success with new programs. Sales in Canada increased 8 percent in 2006, reflecting good results from all divisions. Sales benefited from pricing, account retention and new business.
OPERATING INCOME BY REPORTABLE SEGMENT
millions |
|
2006 |
|
2005 |
|
2004 |
|
|||
Operating income |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
$ |
329 |
|
$ |
280 |
|
$ |
266 |
|
Other Services |
|
39 |
|
36 |
|
21 |
|
|||
Total United States |
|
368 |
|
316 |
|
287 |
|
|||
International |
|
234 |
|
219 |
|
209 |
|
|||
Total |
|
602 |
|
535 |
|
496 |
|
|||
Corporate |
|
|
|
|
|
(4 |
) |
|||
Effect of foreign currency translation |
|
10 |
|
7 |
|
(2 |
) |
|||
Consolidated |
|
$ |
612 |
|
$ |
542 |
|
$ |
490 |
|
Operating income as a percent of net sales |
|
|
|
|
|
|
|
|||
United States |
|
|
|
|
|
|
|
|||
Cleaning & Sanitizing |
|
15.3 |
% |
14.3 |
% |
14.8 |
% |
|||
Other Services |
|
9.5 |
|
9.6 |
|
6.0 |
|
|||
Total United States |
|
14.4 |
|
13.6 |
|
13.4 |
|
|||
International |
|
10.3 |
|
10.3 |
|
10.2 |
|
|||
Consolidated |
|
12.5 |
% |
12.0 |
% |
11.7 |
% |
Operating income of our United States Cleaning & Sanitizing operations increased 18 percent to $329 million in 2006. As a percentage of net sales, operating income increased to 15.3 percent in 2006 from 14.3 percent in 2005. Acquisitions and divestitures had no effect on the overall percentage increase in operating income. Operating income increased due to pricing, higher sales volume and improved cost efficiencies, which more than offset higher delivered product costs and investments in the business.
Operating income of our United States Other Services operations increased 8 percent to $39 million in 2006. As a percentage of net sales, operating income decreased slightly to 9.5 percent in 2006 from 9.6 percent in 2005. Double-digit operating income growth at Pest Elimination was offset by slow sales growth as well as investments in the GCS business. Operating income growth and operating income margin comparisons were also impacted by a $0.5 million regulatory expense in the second quarter of 2006 and a $0.5 million patent settlement benefit in the first quarter of 2005.
Management-rate based operating income of International operations rose 7 percent to $234 million in 2006. The International operating income margin was 10.3 percent in both 2006 and 2005. Acquisitions and divestitures occurring in 2006 and 2005 increased operating income growth by 1 percent over 2005. Operating income growth benefited from pricing, sales volume growth and cost efficiencies which more than offset higher delivered product costs and investments in the business.
Operating income margins of our International operations are generally less than those realized for our U.S. operations. The lower International margins are due to (i) the additional costs caused by the difference in scale of International operations where many operating locations are smaller in size, (ii) the additional cost of operating in numerous and diverse foreign jurisdictions and (iii) higher costs of importing raw materials and finished goods. Proportionately larger investments in sales, technical support and administrative personnel are also necessary in order to facilitate the growth of our International operations.
22
2005 COMPARED WITH 2004
Sales of our United States Cleaning & Sanitizing operations reached nearly $2.0 billion in 2005 and increased 9 percent over net sales of $1.8 billion in 2004. Acquisitions and divestitures increased sales by 1 percent for 2005. Sales benefited from double-digit organic growth in our Kay division, along with good growth in our Institutional and Food & Beverage divisions. This sales performance reflects increased account retention and penetration through enhanced service, new product and program initiatives and aggressive new account sales efforts. Institutional sales grew 7 percent in 2005 reflecting sales growth in all end market segments, including travel, casual dining, healthcare, and government markets. Food & Beverage sales increased 9 percent compared to 2004. Excluding the benefits of the 2004 Alcide acquisition, Food & Beverage sales increased 5 percent for 2005 primarily due to gains in the dairy, food and soft drink markets reflecting increasing penetration of existing corporate accounts as well as new business. Kays sales increased 11 percent, led by strong gains in sales to its core quickservice customers and in its food retail services business.
Sales of our United States Other Services operations increased 11 percent to $375 million in 2005. Pest Elimination had 12 percent sales growth including double-digit sales growth in both core pest elimination contract and non-contract services, such as bird and termite work, fumigation, one-shot services and its food safety audit business. GCS Service sales grew 8 percent in 2005 as service and installed parts sales increased over 2004. GCS continued to increase technician productivity and improve customer service satisfaction.
Management rate sales of our International operations were $2.1 billion in 2005, an increase of 5 percent over sales of $2.0 billion in 2004. Acquisitions and divestitures increased sales 1 percent in 2005. Sales in Europe, excluding acquisitions and divestitures, were up 2 percent from 2004. Sales were affected by an overall weak European economy, particularly in the major central countries. Sales in Asia Pacific, excluding acquisitions and divestitures, increased 7 percent. The growth was primarily driven by East Asia, including continued growth in China. Asia Pacific growth was driven by new corporate accounts and good results in the beverage and brewery segment. Latin America continued its double-digit sales growth as sales grew 15 percent over 2004, reflecting growth in all countries with Mexico, Chile and Argentina showing the strongest growth. Results were due to new account gains, growth of existing accounts and strong equipment sales. Sales in Canada increased 8 percent in 2005, reflecting good results from all divisions.
Operating income of our United States Cleaning & Sanitizing operations was $280 million in 2005, an increase of 5 percent from operating income of $266 million in 2004. As a percentage of net sales, operating income decreased from 14.8 percent in 2004 to 14.3 percent in 2005. Acquisitions and divestitures had no effect on the overall percentage increase in operating income. The increase in operating income in 2005 reflects the benefits of higher sales, pricing and lower share-based compensation expense being partially offset by higher delivered product costs. Operating income margins declined because the negative impact of higher delivered product costs more than offset the benefits of pricing, cost savings and sales leverage.
Operating income of United States Other Services operations increased 76 percent to $36 million in 2005. The operating income margin for United States Other Services increased to 9.6 percent in 2005 from 6.0 percent in 2004. Pest Elimination had double-digit operating income growth and GCS Service results reflect sharp profitability improvement in 2005. The increase in operating income for Pest Elimination was driven by strong sales and leverage of sales and administrative teams, with pricing and productivity improvements offsetting cost increases. GCS Service narrowed its operating loss substantially in 2005 due to good sales growth and operational improvements. GCS Service operating income growth also benefited from a favorable comparison to 2004 which included a sales decline, increased marketing expenses and higher than expected costs resulting from centralizing the parts and administration activities.
Management-rate based operating income of International operations rose 5 percent to $219 million in 2005 from operating income of $209 million in 2004. The International operating income margin was 10.3 percent in 2005 and 10.2 percent 2004. Excluding the impact of acquisitions and divestitures occurring in 2005 and 2004, operating income increased 3 percent over 2004. Sales growth, pricing, lower share-based compensation expense and cost efficiencies were partially offset by higher delivered product costs, unfavorable business mix and investments.
CORPORATE
We had no operating expenses in our corporate segment in 2006 or 2005 and $4.5 million in 2004. In 2004, corporate operating expense included a charge of $1.6 million for in-process research and development as part of the acquisition of Alcide Corporation and a charge of $4.0 million related to the disposal of a grease management product line, which were partially offset by $0.8 million of income for reductions in restructuring accruals and a $0.3 million gain on the sale of a small international business.
INTEREST AND INCOME TAXES
Net interest expense was $44 million for both 2006 and 2005. An increase in interest expense during 2006 was offset by higher interest income.
Net interest expense in 2005 decreased to $44 million compared to $45 million in 2004. The decrease was caused by higher interest income during the year due to increased levels of cash and cash equivalents and short-term investments offset partially by a small increase in interest expense.
Our effective income tax rate was 35.0 percent for 2006, compared with an effective income tax rate of 35.9 percent for 2005 and 36.4 percent in 2004. Reductions in our effective income tax rates over the last three years have primarily been due to favorable international mix, lower international statutory rates and the impact of tax planning efforts. Excluding the benefit of the $1.8 million tax settlement for stewardship costs and a $0.5 million benefit related to prior years, the estimated effective income tax rate was 35.4 percent for 2006. Excluding the effects of the $3.1 million tax charge related to the repatriation of foreign earnings under the AJCA and other onetime benefits, the estimated annual effective income tax rate for 2005 was 35.6 percent. Excluding the effects of special charges mentioned above in the corporate section and a $1.9 million tax benefit related to prior years, the estimated annual effective income tax rate was 36.7 percent for 2004.
23
FINANCIAL POSITION & LIQUIDITY
FINANCIAL POSITION
Our debt continued to be rated within the A categories by the major rating agencies during 2006. Significant changes in our financial position during 2006 included the following:
Total assets increased 16 percent to $4.4 billion as of December 31, 2006 from $3.8 billion at year-end 2005. Total assets increased primarily due to an increase in cash and cash equivalents resulting from $396 million of proceeds received from a new debt offering in December. Foreign currency translation added approximately $175 million to the value of non-U.S. assets on the balance sheet as the U.S. dollar weakened against foreign currencies, primarily the euro. Additionally, acquisitions added $83 million of assets.
Total liabilities increased $592 million in 2006. This included an increase in total debt discussed below and an increase of $81 million in post retirement healthcare and pension benefits due to the adoption of SFAS 158 as discussed in Note 15. Total liabilities also reflected an increase resulting from the effects of currency translation.
Total debt was $1.1 billion at December 31, 2006 and increased from total debt of $746 million at year-end 2005. This increase in total debt during 2006 was primarily due to the issuance of euro 300 million senior notes ($396 million as of December 31, 2006) to refinance our euronotes which became due in February 2007. The ratio of total debt to capitalization (total debt divided by the sum of shareholders equity plus total debt) was 39 percent at year-end 2006 and 31 percent at year-end 2005. The debt to capitalization ratio increased significantly in 2006, due to the new senior notes issued as well as a decrease in our equity of $168 million for a change in accounting due to the adoption of SFAS 158. Normalizing for these items, the total debt to capitalization would have been 27 percent for 2006. We view our debt to capitalization ratio as an important indicator of our creditworthiness.
CASH FLOWS
Cash provided by operating activities was $628 million for 2006, an increase over $590 million in 2005 and $571 million in 2004. The increase in operating cash flow for 2006 over 2005 reflects our higher net income offset partially by an increase in income tax payments and accounts receivable in 2006. The increase in operating cash flow for 2005 over 2004 is due to higher net income and improved collection of accounts receivable as well as better inventory management. Historically, we have had strong operating cash flows and we anticipate this will continue. We expect to continue to use this cash flow to acquire new businesses, repurchase our common stock, pay down debt and meet our ongoing obligations and commitments.
Cash used for investing activities decreased from 2005 due primarily to the timing of purchases and sales of short-term investments offset by higher acquisition activity, capital expenditures and capitalized software expenditures. Capital software expenditures increased due to investments in business systems. We expect capital software expenditures to increase significantly in 2007 as we continue to invest in our business systems.
Financing cash flow activity included cash proceeds from new senior note borrowings of $396 million, debt repayment and dividend payments. Share repurchases were $283 million in 2006, $213 million in 2005 and $165 million in 2004. These repurchases were funded with operating cash flows and cash from the exercise of employee stock options. In December 2004, we announced an authorization to repurchase up to 10 million shares of Ecolab common stock. In October 2006, we announced an authorization to repurchase up to 10 million additional shares of Ecolab common stock. As of December 31, 2006, approximately 12.9 million shares remained to be purchased under these authorizations. Shares are repurchased for the purpose of offsetting the dilutive effect of stock options and incentives and for general corporate purposes. During 2007, we expect to repurchase at least enough shares to offset the dilutive effect of stock options. Cash proceeds from the exercises as well as the tax benefits will provide a portion of the funding for this repurchase activity.
In 2006, we increased our indicated annual dividend rate for the fifteenth consecutive year. We have paid dividends on our common stock for 70 consecutive years. Cash dividends declared per share of common stock, by quarter, for each of the last three years were as follows:
|
|
FIRST |
|
SECOND |
|
THIRD |
|
FOURTH |
|
|
|
|||||
|
|
QUARTER |
|
QUARTER |
|
QUARTER |
|
QUARTER |
|
YEAR |
|
|||||
2006 |
|
$ |
0.1000 |
|
$ |
0.1000 |
|
$ |
0.1000 |
|
$ |
0.1150 |
|
$ |
0.4150 |
|
2005 |
|
0.0875 |
|
0.0875 |
|
0.0875 |
|
0.1000 |
|
0.3625 |
|
|||||
2004 |
|
0.0800 |
|
0.0800 |
|
0.0800 |
|
0.0875 |
|
0.3275 |
|
|||||
LIQUIDITY AND CAPITAL RESOURCES
We currently expect to fund all of the requirements which are reasonably foreseeable for 2007, including scheduled debt repayments, new investments in the business, share repurchases, dividend payments, possible business acquisitions and pension contributions from operating cash flow, cash reserves and short-term borrowings.
In December 2006, we issued and sold in a private placement euro 300 million ($396 million as of December 31, 2006) aggregate principal amount of senior notes in two series: 4.355% Series A Senior Notes due 2013 in the aggregate principal amount of euro 125 million and 4.585% Series B Senior Notes due 2016 in the aggregate principal amount of euro 175 million (the Notes), pursuant to a Note Purchase Agreement dated July 26, 2006, between the company and the purchasers. The Notes are not subject to prepayment except where, in certain specified instances, we consolidate or merge all or substantially all of our assets with any other Person (as defined in the Note Purchase Agreement). Upon such consolidation or merger, we will offer to prepay all of the Notes at 100 percent of
24
the principal amount outstanding plus accrued interest. In the event of a default by the company under the Note Purchase Agreement, the Notes may become immediately due and payable for the unpaid principal amount, accrued interest and a make-whole amount determined as of the time of the default. The proceeds were used to repay our euro 300 million 5.375 percent euronotes which became due in February 2007.
While cash flows could be negatively affected by a decrease in revenues, we do not believe that our revenues are highly susceptible, in the short term, to rapid changes in technology within our industry. We have a $450 million U.S. commercial paper program and a $200 million European commercial paper program. Both programs are rated A-1 by Standard & Poors and P-1 by Moodys. To support our commercial paper programs andother general business funding needs, we maintain a $450 million multi-year committed credit agreement which expires in June 2011 and under certain circumstances can be increased by $150 million for a total of $600 million. We can draw directly on the credit facility on a revolving credit basis. As of December 31, 2006, $30 million of this credit facility was committed to support outstanding U.S. commercial paper, leaving $420 million available for other uses. In addition, we have other committed and uncommitted credit lines of approximately $190 million with major international banks and financial institutions to support our general global funding needs. Additional details on our credit facilities are included in Note 6 of the notes to consolidated financial statements.
During 2006, we voluntarily contributed $45 million to our U.S. pension plan. In making this contribution, we considered the normal growth in accrued plan benefits, the impact of lower year-end discount rates on the plan liability and the tax deductibility of the contribution. We expect our combined U.S. qualified and nonqualified pension plan expense to decrease slightly to approximately $40 million in 2007 from $41 million in 2006, primarily due to expected returns on a higher level of plan assets and an increase in the discount rate from 5.57 percent to 5.79 percent for the 2007 expense calculation. The expected return on plan assets of 8.75 percent is consistent with 2006.
A schedule of our obligations under various notes payable, long-term debt agreements, operating leases with noncancelable terms in excess of one year, interest obligations and benefit payments are summarized in the following table:
|
|
PAYMENTS DUE BY PERIOD |
|
|||||||||||||
THOUSANDS |
|
|
|
LESS |
|
|
|
|
|
MORE |
|
|||||
|
|
|
|
THAN |
|
1-3 |
|
3-5 |
|
THAN |
|
|||||
Contractual Obligations |
|
TOTAL |
|
1 YEAR |
|
YEARS |
|
YEARS |
|
5 YEARS |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Note payable |
|
$ |
109,100 |
|
$ |
109,100 |
|
$ |
|
|
$ |
|
|
$ |
|
|
Long-term debt |
|
956,936 |
|
399,878 |
|
4,475 |
|
151,988 |
|
400,595 |
|
|||||
Operating leases |
|
142,000 |
|
44,000 |
|
57,000 |
|
28,000 |
|
13,000 |
|
|||||
Interest* |
|
223,347 |
|
34,172 |
|
64,250 |
|
54,290 |
|
70,635 |
|
|||||
Benefit payments** |
|
760,000 |
|
52,000 |
|
123,000 |
|
138,000 |
|
447,000 |
|
|||||
Total contractual cash obligations |
|
$ |
2,191,383 |
|
$ |
639,150 |
|
$ |
248,725 |
|
$ |
372,278 |
|
$ |
931,230 |
|
* Interest on variable rate debt was calculated using the interest rate at year-end 2006.
** Benefit payments are paid out of the companys pension and postretirement health care benefit plans.
We are not required to make any contributions to our U.S. pension and postretirement health care benefit plans in 2007, based on plan asset values as of December 31, 2006. Certain international pension benefit plans are required to be funded in accordance with local government requirements. We estimate contributions to be made to our international plans will approximate $20 million in 2007. These amounts have been excluded from the schedule of contractual obligations.
We lease sales and administrative office facilities, distribution center facilities, computers and other equipment under longer-term operating leases. Vehicle leases are generally shorter in duration. Vehicle leases have guaranteed residual value requirements that have historically been satisfied by the proceeds on the sale of the vehicles. No amounts have been recorded for these guarantees in the table preceding as we believe that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.
Except for approximately $56 million of letters of credit supporting domestic and international commercial relationships and transactions, we do not have significant unconditional purchase obligations, or significant other commercial commitments, such as commitments under lines of credit, standby letters of credit, guarantees, standby repurchase obligations or other commercial commitments.
As of year-end 2006, we are in compliance with all covenants and other requirements of our credit agreements and indentures. Our $450 million multicurrency credit agreement, as amended and restated effective June 1, 2006, no longer includes a covenant regarding the ratio of total debt to capitalization. Our new euro 300 million senior notes include covenants regarding the amount of indebtedness secured by liens and subsidiary indebtedness allowed. Additionally, we do not have any rating triggers that would accelerate the maturity dates of our debt.
A downgrade in our credit rating could limit or preclude our ability to issue commercial paper under our current programs. A credit rating downgrade could also adversely affect our ability to renew existing, or negotiate new credit facilities in the future and could increase the cost of these facilities. Should this occur, we could seek additional sources of funding, including issuing term notes or bonds. In addition, we have the ability at our option to draw upon our $450 million committed credit facilities prior to their termination and, under certain conditions, can increase this amount to $600 million.
OFF-BALANCE SHEET ARRANGEMENTS
Other than operating leases, we do not have any off-balance sheet financing arrangements. See Note 12 for information on our operating leases. We do not have relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purposes entities, which are sometimes established for the purpose of facilitating off-balance sheet financial arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.
NEW ACCOUNTING PRONOUNCEMENTS
We adopted the provisions of SFAS 158 effective as of our 2006 year end. The impact of adopting SFAS 158 is reflected as a reduction in net assets on our balance sheet of $168 million, with no impact to the statements of income and cash flows. See Note 15 for more information on this adoption.
FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (FIN 48) is effective beginning January 1, 2007 with the cumulative effect of initially applying FIN 48 recognized as a
25
change in accounting principle recorded as an adjustment to opening retained earnings. We do not expect the impact of adoption to be material to our consolidated financial statements.
See Note 2 for additional information on these and other new accounting pronouncements.
MARKET RISK
We enter into contractual arrangements (derivatives) in the ordinary course of business to manage foreign currency exposure and interest rate risks. We do not enter into derivatives for trading purposes. Our use of derivatives is subject to internal policies that provide guidelines for control, counterparty risk and ongoing monitoring and reporting and is designed to reduce the volatility associated with movements in foreign exchange and interest rates on our income statement and cash flows.
We enter into forward contracts, swaps and foreign currency options to hedge certain intercompany financial arrangements, and to hedge against the effect of exchange rate fluctuations on transactions related to cash flows and net investments denominated in currencies other than U.S. dollars. At December 31, 2006, we had approximately $375 million notional amount of foreign currency forward exchange contracts with face amounts denominated primarily in euros.
We manage interest expense using a mix of fixed and floating rate debt. To help manage borrowing costs, we may enter into interest rate swap agreements. Under these arrangements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. At year-end 2006, we had an interest rate swap that converts approximately euro 78 million (approximately $103 million U.S. dollars) of our Euronote debt from a fixed interest rate to a floating or variable interest rate. This swap agreement expired in February 2007.
Based on a sensitivity analysis (assuming a 10 percent adverse change in market rates) of our foreign exchange and interest rate derivatives and other financial instruments, changes in exchange rates or interest rates would not materially affect our financial position and liquidity. The effect on our results of operations would be substantially offset by the impact of the hedged items.
FORWARD-LOOKING STATEMENTS AND RISK FACTORS
This financial discussion and other portions of this Annual Report to Shareholders contain various Forward-Looking Statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning:
· business progress and expansion,
· business acquisitions,
· currency translation,
· cash flows,
· debt repayments,
· share repurchases,
· global economic conditions,
· pension expenses and potential contributions,
· income taxes
· and liquidity requirements.
Without limiting the foregoing, words or phrases such as will likely result, are expected to, will continue, is anticipated, we believe, we expect, estimate, project (including the negative or variations thereof) or similar terminology, general identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statements are set forth under Item 1A of our Form 10-K for the year ended December 31, 2006, entitled Risk Factors.
In addition, we note that our stock price can be affected by fluctuations in quarterly earnings. There can be no assurances that our earnings levels will meet investors expectations. We undertake no duty to update our Forward-Looking Statements.
26
Consolidated Statement of Income
Year ended December 31 (thousands, except per share) |
|
2006 |
|
2005 |
|
2004 |
|
|||
|
|
|
|
|
|
|
|
|||
Net sales |
|
$ |
4,895,814 |
|
$ |
4,534,832 |
|
$ |
4,184,933 |
|
|
|
|
|
|
|
|
|
|||
Operating expenses |
|
|
|
|
|
|
|
|||
Cost of sales (including special charges (income) of ($106) in 2004) |
|
2,416,058 |
|
2,248,831 |
|
2,033,492 |
|
|||
Selling, general and administrative expenses |
|
1,868,114 |
|
1,743,581 |
|
1,657,084 |
|
|||
Special charges |
|
|
|
|
|
4,467 |
|
|||
Operating income |
|
611,642 |
|
542,420 |
|
489,890 |
|
|||
Interest expense, net |
|
44,418 |
|
44,238 |
|
45,344 |
|
|||
Income before income taxes |
|
567,224 |
|
498,182 |
|
444,546 |
|
|||
Provision for income taxes |
|
198,609 |
|
178,701 |
|
161,853 |
|
|||
Net income |
|
$ |
368,615 |
|
$ |
319,481 |
|
$ |
282,693 |
|
|
|
|
|
|
|
|
|
|||
Net income per common share |
|
|
|
|
|
|
|
|||
Basic |
|
$ |
1.46 |
|
$ |
1.25 |
|
$ |
1.10 |
|
Diluted |
|
$ |
1.43 |
|
$ |
1.23 |
|
$ |
1.09 |
|
|
|
|
|
|
|
|
|
|||
Dividends declared per common share |
|
$ |
0.4150 |
|
$ |
0.3625 |
|
$ |
0.3275 |
|
|
|
|
|
|
|
|
|
|||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|||
Basic |
|
252,132 |
|
255,741 |
|
257,575 |
|
|||
Diluted |
|
257,144 |
|
260,098 |
|
260,407 |
|
The accompanying notes are an integral part of the consolidated financial statements.
27
Consolidated Balance Sheet
DECEMBER 31 (THOUSANDS, EXCEPT PER SHARE) |
|
2006 |
|
2005 |
|
||
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
||
Current assets |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
484,029 |
|
$ |
104,378 |
|
Short-term investments |
|
|
|
125,063 |
|
||
Accounts receivable, net |
|
867,541 |
|
743,520 |
|
||
Inventories |
|
364,886 |
|
325,574 |
|
||
Deferred income taxes |
|
86,870 |
|
65,880 |
|
||
Other current assets |
|
50,231 |
|
57,251 |
|
||
Total current assets |
|
1,853,557 |
|
1,421,666 |
|
||
Property, plant and equipment, net |
|
951,569 |
|
868,053 |
|
||
Goodwill |
|
1,035,929 |
|
937,019 |
|
||
Other intangible assets, net |
|
223,787 |
|
202,936 |
|
||
Other assets, net |
|
354,523 |
|
366,954 |
|
||
Total assets |
|
$ |
4,419,365 |
|
$ |
3,796,628 |
|
|
|
|
|
|
|
||
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
||
Current liabilities |
|
|
|
|
|
||
Short-term debt |
|
$ |
508,978 |
|
$ |
226,927 |
|
Accounts payable |
|
330,858 |
|
277,635 |
|
||
Compensation and benefits |
|
252,686 |
|
214,131 |
|
||
Income taxes |
|
17,698 |
|
39,583 |
|
||
Other current liabilities |
|
392,510 |
|
361,081 |
|
||
Total current liabilities |
|
1,502,730 |
|
1,119,357 |
|
||
Long-term debt |
|
557,058 |
|
519,374 |
|
||
Postretirement health care and pension benefits |
|
420,245 |
|
302,048 |
|
||
Other liabilities |
|
259,102 |
|
206,639 |
|
||
Shareholders equity (a) |
|
1,680,230 |
|
1,649,210 |
|
||
Total liabilities and shareholders equity |
|
$ |
4,419,365 |
|
$ |
3,796,628 |
|
(a) Common stock, 400,000 shares authorized, $1.00 par value, 251,337 shares issued and outstanding at December 31, 2006, 254,143 shares issued and outstanding at December 31, 2005.
The accompanying notes are an integral part of the consolidated financial statements.
28
Consolidated Statement of Cash Flows
YEAR ENDED DECEMBER 31 (THOUSANDS) |
|
2006 |
|
2005 |
|
2004 |
|
|||
|
|
|
|
|
|
|
|
|||
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|||
Net income |
|
$ |
368,615 |
|
$ |
319,481 |
|
$ |
282,693 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
|
|
|
|||
Depreciation and amortization |
|
268,569 |
|
256,935 |
|
246,954 |
|
|||
Deferred income taxes |
|
(18,806 |
) |
(13,021 |
) |
14,342 |
|
|||
Share-based compensation expense |
|
36,326 |
|
39,087 |
|
44,660 |
|
|||
Excess tax benefits from share-based payment arrangements |
|
(19,763 |
) |
(11,682 |
) |
(11,556 |
) |
|||
Disposal loss, net |
|
387 |
|
|
|
3,691 |
|
|||
Charge for in-process research and development |
|
|
|
|
|
1,600 |
|
|||
Other, net |
|
1,282 |
|
(882 |
) |
(2,507 |
) |
|||
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|||
Accounts receivable |
|
(66,774 |
) |
(44,839 |
) |
(47,217 |
) |
|||
Inventories |
|
(17,987 |
) |
2,553 |
|
(5,481 |
) |
|||
Other assets |
|
(27,138 |
) |
(21,853 |
) |
(31,723 |
) |
|||
Accounts payable |
|
44,519 |
|
18,987 |
|
34,841 |
|
|||
Other liabilities |
|
58,334 |
|
45,370 |
|
40,611 |
|
|||
Cash provided by operating activities |
|
627,564 |
|
590,136 |
|
570,908 |
|
|||
|
|
|
|
|
|
|
|
|||
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|||
Capital expenditures |
|
(287,885 |
) |
(268,783 |
) |
(275,871 |
) |
|||
Property disposals |
|
25,622 |
|
21,209 |
|
18,373 |
|
|||
Capitalized software expenditures |
|
(33,054 |
) |
(10,949 |
) |
(9,688 |
) |
|||
Businesses acquired and investments in affiliates, net of cash acquired |
|
(65,532 |
) |
(26,967 |
) |
(129,822 |
) |
|||
Sale of businesses and assets |
|
1,802 |
|
1,441 |
|
3,417 |
|
|||
Proceeds from sales and maturities of short-term investments |
|
125,063 |
|
60,625 |
|
|
|
|||
Purchases of short-term investments |
|
|
|
(185,688 |
) |
|
|
|||
Cash used for investing activities |
|
(233,984 |
) |
(409,112 |
) |
(393,591 |
) |
|||
|
|
|
|
|
|
|
|
|||
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|||
Net borrowings (repayments) of notes payable |
|
(47,712 |
) |
96,683 |
|
(17,474 |
) |
|||
Long-term debt borrowings |
|
396,150 |
|
4,664 |
|
7,325 |
|
|||
Long-term debt repayments |
|
(86,287 |
) |
(5,710 |
) |
(6,632 |
) |
|||
Reacquired shares |
|
(282,764 |
) |
(213,266 |
) |
(165,414 |
) |
|||
Cash dividends on common stock |
|
(101,174 |
) |
(89,807 |
) |
(82,419 |
) |
|||
Exercise of employee stock options |
|
87,946 |
|
49,726 |
|
59,989 |
|
|||
Excess tax benefits from share-based payment arrangements |
|
19,763 |
|
11,682 |
|
11,556 |
|
|||
Other, net |
|
(2,283 |
) |
|
|
(800 |
) |
|||
Cash used for financing activities |
|
(16,361 |
) |
(146,028 |
) |
(193,869 |
) |
|||
|
|
|
|
|
|
|
|
|||
Effect of exchange rate changes on cash |
|
2,432 |
|
(1,849 |
) |
2,157 |
|
|||
|
|
|
|
|
|
|
|
|||
Increase (decrease) in cash and cash equivalents |
|
379,651 |
|
33,147 |
|
(14,395 |
) |
|||
Cash and cash equivalents, beginning of year |
|
104,378 |
|
71,231 |
|
85,626 |
|
|||
Cash and cash equivalents, end of year |
|
$ |
484,029 |
|
$ |
104,378 |
|
$ |
71,231 |
|
The accompanying notes are an integral part of the consolidated financial statements.
29
Consolidated Statement of Comprehensive Income and Shareholders' Equity
|
|
|
|
|
|
|
|
ACCUMULATED |
|
|
|
|
|
||||||
|
|
|
|
ADDITIONAL |
|
|
|
OTHER |
|
|
|
|
|
||||||
|
|
COMMON |
|
PAID-IN |
|
RETAINED |
|
COMPREHENSIVE |
|
TREASURY |
|
|
|
||||||
(THOUSANDS) |
|
STOCK |
|
CAPITAL |
|
EARNINGS |
|
INCOME (LOSS) |
|
STOCK |
|
TOTAL |
|
||||||
Balance December 31, 2003 |
|
$ |
310,284 |
|
$ |
459,974 |
|
$ |
1,294,165 |
|
$ |
4,098 |
|
$ |
(747,440 |
) |
$ |
1,321,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net income |
|
|
|
|
|
282,693 |
|
|
|
|
|
282,693 |
|
||||||
Foreign currency translation |
|
|
|
|
|
|
|
71,029 |
|
|
|
71,029 |
|
||||||
Other comprehensive loss |
|
|
|
|
|
|
|
(2,674 |
) |
|
|
(2,674 |
) |
||||||
Minimum pension liability |
|
|
|
|
|
|
|
(293 |
) |
|
|
(293 |
) |
||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
350,755 |
|
||||||
Cash dividends declared |
|
|
|
|
|
(84,410 |
) |
|
|
|
|
(84,410 |
) |
||||||
Stock options and awards |
|
3,624 |
|
115,238 |
|
|
|
|
|
118 |
|
118,980 |
|
||||||
Business acquisitions |
|
1,835 |
|
55,314 |
|
|
|
|
|
|
|
57,149 |
|
||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
(165,414 |
) |
(165,414 |
) |
||||||
Balance December 31, 2004 |
|
315,743 |
|
630,526 |
|
1,492,448 |
|
72,160 |
|
(912,736 |
) |
1,598,141 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net income |
|
|
|
|
|
319,481 |
|
|
|
|
|
319,481 |
|
||||||
Foreign currency translation |
|
|
|
|
|
|
|
(50,516 |
) |
|
|
(50,516 |
) |
||||||
Other comprehensive income |
|
|
|
|
|
|
|
4,365 |
|
|
|
4,365 |
|
||||||
Minimum pension liability |
|
|
|
|
|
|
|
(16,245 |
) |
|
|
(16,245 |
) |
||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
257,085 |
|
||||||
Cash dividends declared |
|
|
|
|
|
(92,728 |
) |
|
|
|
|
(92,728 |
) |
||||||
Stock options and awards |
|
2,860 |
|
96,902 |
|
|
|
|
|
216 |
|
99,978 |
|
||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
(213,266 |
) |
(213,266 |
) |
||||||
Balance December 31, 2005 |
|
318,603 |
|
727,428 |
|
1,719,201 |
|
9,764 |
|
(1,125,786 |
) |
1,649,210 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net income |
|
|
|
|
|
368,615 |
|
|
|
|
|
368,615 |
|
||||||
Foreign currency translation |
|
|
|
|
|
|
|
65,776 |
|
|
|
65,776 |
|
||||||
Other comprehensive income |
|
|
|
|
|
|
|
(3,352 |
) |
|
|
(3,352 |
) |
||||||
Minimum pension liability |
|
|
|
|
|
|
|
(617 |
) |
|
|
(617 |
) |
||||||
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
430,422 |
|
||||||
Cumulative effect adjustment for adoption of SFAS 158 |
|
|
|
|
|
|
|
(168,083 |
) |
|
|
(168,083 |
) |
||||||
Cash dividends declared |
|
|
|
|
|
(104,544 |
) |
|
|
|
|
(104,544 |
) |
||||||
Stock options and awards |
|
3,975 |
|
140,745 |
|
|
|
|
|
960 |
|
145,680 |
|
||||||
Reacquired shares |
|
|
|
|
|
|
|
|
|
(272,455 |
) |
(272,455 |
) |
||||||
Balance December 31, 2006 |
|
$ |
322,578 |
|
$ |
868,173 |
|
$ |
1,983,272 |
|
$ |
(96,512 |
) |
$ |
(1,397,281 |
) |
$ |
1,680,230 |
|
COMMON STOCK ACTIVITY
|
|
2006 |
|
2005 |
|
2004 |
|
||||||
|
|
COMMON |
|
TREASURY |
|
COMMON |
|
TREASURY |
|
COMMON |
|
TREASURY |
|
YEAR ENDED DECEMBER 31 (SHARES) |
|
STOCK |
|
STOCK |
|
STOCK |
|
STOCK |
|
STOCK |
|
STOCK |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares, beginning of year |
|
318,602,705 |
|
(64,459,800 |
) |
315,742,759 |
|
(58,200,908 |
) |
310,284,083 |
|
(52,867,561 |
) |
Stock options |
|
3,975,722 |
|
172,665 |
|
2,859,946 |
|
18,666 |
|
3,623,917 |
|
1,200 |
|
Stock awards, net issuances |
|
|
|
49,519 |
|
|
|
34,689 |
|
|
|
24,460 |
|
Business acquisitions |
|
|
|
|
|
|
|
|
|
1,834,759 |
|
|
|
Reacquired shares |
|
|
|
(7,003,944 |
) |
|
|
(6,312,247 |
) |
|
|
(5,359,007 |
) |
Shares, end of year |
|
322,578,427 |
|
(71,241,560 |
) |
318,602,705 |
|
(64,459,800 |
) |
315,742,759 |
|
(58,200,908 |
) |
The accompanying notes are an integral part of the consolidated financial statements.
30
Notes to Consolidated Financial Statements
1. NATURE OF BUSINESS
Ecolab Inc. (the company) develops and markets premium products and services for the hospitality, foodservice, healthcare and industrial markets. The company provides cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quickservice (fast-food and convenience stores) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of the company and all majority-owned subsidiaries. International subsidiaries are included in the financial statements on the basis of their November 30 fiscal year-ends to facilitate the timely inclusion of such entities in the companys consolidated financial reporting. All intercompany transactions and profits are eliminated in consolidation.
USE OF ESTIMATES
The preparation of the companys financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates.
FOREIGN CURRENCY TRANSLATION
Financial position and results of operations of the companys international subsidiaries generally are measured using local currencies as the functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect at each fiscal year end. The translation adjustments related to assets and liabilities that arise from the use of differing exchange rates from period to period are included in accumulated other comprehensive income (loss) in shareholders equity. The cumulative translation gain as of year-end 2006, 2005 and 2004 was $57.0 million, $8.1 million and $87.1 million, respectively. Income statement accounts are translated at the average rates of exchange prevailing during the year. The different exchange rates from period to period impact the amount of reported income from the companys international operations. Foreign currency translation positively impacted net income by approximately $2 million, $5 million and $11 million for the years ended December 31, 2006, 2005 and 2004, respectively.
RECLASSIFICATION
Capitalized software has been reclassified on the companys balance sheet from Other Assets to Property, Plant and Equipment. Prior period balance sheet amounts have also been reclassified to conform to the current year presentation. Net capitalized software was $54.7 million and $32.6 million at December 31, 2006 and 2005, respectively.
CASH AND CASH EQUIVALENTS
Cash equivalents include highly-liquid investments with a maturity of three months or less when purchased.
SHORT-TERM INVESTMENTS
Short-term investments at December 31, 2005 consist solely of auction-rate debt securities classified as available-for-sale, which are stated at estimated fair value. All of these securities held by the company as of December 31, 2005 have auction reset periods of 35 days or less and the carrying value approximates market value given the short reset periods. These investments were sold in the first quarter of 2006. No unrealized or realized gains or losses were recognized related to short-term investments during the years ended December 31, 2006 and 2005.
ALLOWANCE FOR DOUBTFUL ACCOUNTS
The company estimates the balance of allowance for doubtful accounts by analyzing accounts receivable balances by age and applying historical write-off trend rates to the most recent 12 months sales, less actual write-offs to date. The company estimates include separately providing for specific customer balances when it is deemed probable that the balance is uncollectible. Account balances are charged off against the allowance when it is probable the receivable will not be recovered.
The companys allowance for doubtful accounts balance includes an allowance for the expected return of products shipped and credits related to pricing or quantities shipped of approximately $6 million and $5 million as of December 31, 2006 and 2005, respectively. This returns and credit activity is recorded directly to sales.
The following table summarizes the activity in the allowance for doubtful accounts:
THOUSANDS |
|
2006 |
|
2005 |
|
||
|
|
|
|
|
|
||
Beginning balance |
|
$ |
38,851 |
|
$ |
44,199 |
|
Bad debt expense |
|
12,947 |
|
11,589 |
|
||
Write-offs |
|
(17,483 |
) |
(14,743 |
) |
||
Other* |
|
3,304 |
|
(2,194 |
) |
||
Ending balance |
|
$ |
37,619 |
|
$ |
38,851 |
|
* Other amounts are primarily the effects of changes in currency.
INVENTORY VALUATIONS
Inventories are valued at the lower of cost or market. Domestic chemical inventory costs are determined on a last-in, first-out (lifo) basis. Lifo inventories represented 28 percent and 32 percent of consolidated inventories at year-end 2006 and 2005, respectively. All other inventory costs are determined on a first-in, first-out (fifo) basis.
PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are stated at cost. Merchandising equipment consists principally of various systems that dispense the companys cleaning and sanitizing products and dishwashing machines. The dispensing systems are accounted for on a mass asset basis, whereby equipment is capitalized and depreciated as a group and written off when fully depreciated. The company capitalizes both internal and external costs of development or purchase of computer software for internal use. Costs incurred for data conversion, training and maintenance associated with capitalized software are expensed as incurred.
Depreciation is charged to operations using the straight-line method over the assets estimated useful lives ranging from 5 to 50 years for buildings and leaseholds, 3 to 11 years for machinery and equipment and 3 to 7 years for merchandising equipment and capital software.
31
Expenditures for repairs and maintenance are charged to expense as incurred. Expenditures for major renewals and betterments, which significantly extend the useful lives of existing plant and equipment, are capitalized and depreciated.
Upon retirement or disposition of plant and equipment, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in income.
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill and other intangible assets arise principally from business acquisitions. Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired. Other intangible assets primarily include customer relationships, trademarks, patents and other technology. The fair value of identifiable intangible assets is estimated based upon discounted future cash flow projections. Other intangible assets are amortized on a straight-line basis over their estimated economic lives. The weighted-average useful life of other intangible assets was 14 years as of December 31, 2006 and 2005.
The weighted-average useful life by type of asset at December 31, 2006 is as follows:
|
|
Number of Years |
|
Customer relationships |
|
12 |
|
Intellectual property |
|
15 |
|
Trademarks |
|
20 |
|
Other |
|
7 |
|
The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the company in each reporting period. Total amortization expense related to other intangible assets during the years ended December 31, 2006, 2005 and 2004 was approximately $25.0 million, $23.5 million and $21.7 million, respectively. As of December 31, 2006, future estimated amortization expense related to amortizable other identifiable intangible assets will be:
thousands |
|
|
|
|
2007 |
|
$ |
28,000 |
|
2008 |
|
28,000 |
|
|
2009 |
|
26,000 |
|
|
2010 |
|
24,000 |
|
|
2011 |
|
23,000 |
|
|
The company tests goodwill for impairment on an annual basis for all reporting units. Generally, the companys reporting units are its operating segments. An impairment charge is recognized for the amount, if any, by which the carrying amount of goodwill exceeds its implied fair value. Fair values of reporting units are established using a discounted cash flow method. Where available and as appropriate comparative market multiples are used to corroborate the results of the discounted cash flow method. Based on the companys testing, there has been no impairment of goodwill during the three years ended December 31, 2006. The company performs its annual goodwill impairment test during the second quarter. If circumstances change significantly within a reporting unit, the company would also test a reporting unit for impairment prior to the annual test.
LONG-LIVED ASSETS
The company periodically reviews its long-lived assets for impairment and assesses whether significant events or changes in business circumstances indicate that the carrying value of the assets may not be recoverable. An impairment loss may be recognized when the carrying amount of an asset exceeds the anticipated future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. The amount of the impairment loss to be recorded, if any, is calculated by the excess of the assets carrying value over its fair value.
REVENUE RECOGNITION
The company recognizes revenue as services are performed or on product sales at the time title to the product and risk of loss transfers to the customer. The companys sales policies do not provide for general rights of return and do not contain customer acceptance clauses. Trade accounts receivable are recorded at the invoiced amount and generally do not bear interest. The company records estimated reductions to revenue for customer programs and incentive offerings, including pricing arrangements, promotions and other volume-based incentives at the time the sale is recorded. The company also records estimated reserves for anticipated uncollectible accounts and for product returns and credits at the time of sale.
INCOME PER COMMON SHARE
The computations of the basic and diluted net income per share amounts were as follows:
thousands, except per share |
|
2006 |
|
2005 |
|
2004 |
|
|||
|
|
|
|
|
|
|
|
|||
Net income |
|
$ |
368,615 |
|
$ |
319,481 |
|
$ |
282,693 |
|
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|||
Basic |
|
252,132 |
|
255,741 |
|
257,575 |
|
|||
Effect of dilutive stock options and awards |
|
5,012 |
|
4,357 |
|
2,832 |
|
|||
Diluted |
|
257,144 |
|
260,098 |
|
260,407 |
|
|||
Net income per common share |
|
|
|
|
|
|
|
|||
Basic |
|
$ |
1.46 |
|
$ |
1.25 |
|
$ |
1.10 |
|
Diluted |
|
$ |
1.43 |
|
$ |
1.23 |
|
$ |
1.09 |
|
Restricted stock awards of 24,670 shares for 2006, 22,175 shares for 2005 and 62,300 shares for 2004 were excluded from the computation of basic weighted-average shares outstanding because such shares were not yet vested at those dates.
Stock options to purchase approximately 2.6 million shares for 2006, 7.1 million shares for 2005 and 4.2 million shares for 2004 were not dilutive and, therefore, were not included in the computations of diluted common shares outstanding.
SHARE-BASED COMPENSATION
Effective October 1, 2005, the company early-adopted Statement of Financial Accounting Standard No. 123 (Revised 2004), Share-Based Payment (SFAS 123R) under the modified retrospective application method. SFAS 123R requires the company to measure compensation expense for share-based awards at fair value at the date of grant and recognize compensation expense over the service period for awards expected to vest. As part of the transition to the new standard, all prior period financial statements were restated to recognize share-based compensation expense historically reported in the notes to the consolidated financial statements.
Effective with the companys adoption of SFAS 123R, new stock option grants to retirement eligible recipients are attributed to
32
expense using the non-substantive vesting method and are fully expensed by the time recipients attain age 55 with at least 5 years of service. If the company had used the non-substantive vesting method during all periods, net income for 2006, 2005 and 2004 would have increased by approximately $2.7 million, $2.5 million and $5.2 million, respectively. In addition, the company previously accounted for forfeitures when they occurred. Commencing at the date of adoption, the company includes a forfeiture estimate in the amount of compensation expense being recognized. This change from the companys historical practice of recognizing forfeitures as they occur did not result in the recognition of any cumulative adjustments to income. The company has used the actual tax effects of stock options and the transition guidance prescribed within SFAS 123R for establishing the pool of excess tax benefits (APIC Pool).
COMPREHENSIVE INCOME
Comprehensive income includes net income, foreign currency translation adjustments, minimum pension liabilities, gains and losses on derivative instruments designated and effective as cash flow hedges and nonderivative instruments designated and effective as foreign currency net investment hedges that are charged or credited to the accumulated other comprehensive income (loss) account in shareholders equity.
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The company uses foreign currency forward contracts, interest rate swaps and foreign currency debt to manage risks generally associated with foreign exchange rates, interest rates and net investments in foreign operations. The company does not hold derivative financial instruments of a speculative nature. On the date that the company enters into a derivative contract, it designates the derivative as (1) a hedge of (a) the fair value of a recognized asset or liability or (b) an unrecognized firm commitment (a fair value hedge), (2) a hedge of (a) a forecasted transaction or (b) the variability of cash flows that are to be received or paid in connection with a recognized asset or liability (a cash flow hedge); or (3) a foreign-currency fair-value or cash flow hedge (a foreign currency hedge). The company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. The company also formally assesses (both at the hedges inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the company will discontinue hedge accounting prospectively. The company believes that on an ongoing basis its portfolio of derivative instruments will generally be highly effective as hedges.
All of the companys derivatives are recognized on the balance sheet at their fair value. The earnings impact resulting from the change in fair value of the derivative instruments is recorded in the same line item in the consolidated statement of income as the underlying exposure being hedged.
NEW ACCOUNTING PRONOUNCEMENTS
In September 2006, the FASB issued SFAS 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans an amendment of FASB statements 87, 88, 106 and 132(R) (SFAS 158). SFAS 158 requires the company to recognize on its balance sheet the funded status of the companys defined benefit pension and post-retirement plans. SFAS 158 also requires that all benefit plans use the companys fiscal year-end as its measurement date. As required, the company prospectively adopted SFAS 158 beginning with its 2006 year end. The effect of initially adopting SFAS 158 is reflected as a cumulative adjustment to Accumulated Other Comprehensive Income (Loss) net of applicable taxes in the year of adoption. The impact of adopting SFAS 158 is reflected as a reduction in net assets on the companys balance sheet of $168 million, with no impact to the statement of income and cash flows. See Note 15 for additional information.
In September 2006, the FASB issued SFAS 157, Fair Value Measurement, which defines fair value, establishes a framework for measuring fair value and expanded disclosures about fair value measurement. Companies are required to adopt the new standard for fiscal periods beginning after November 15, 2007. The company is evaluating the impact of this standard and does not expect it will have a material impact on its consolidated financial statements.
In July 2006, the FASB issued FIN 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (FIN 48). FIN 48 clarifies the accounting for uncertain tax positions in accordance with FASB Statement No. 109, Accounting for Income Taxes. For each tax position the company will be required to recognize, in its financial statements, the largest tax benefit that is more-likely-than-not to be sustained on audit based solely on the technical merits of the position as of the reporting date. FIN 48 also provides guidance on new disclosure requirements, reporting and accrual of interest and penalties, accounting in interim periods, and transition. FIN 48 is effective beginning January 1, 2007 with the cumulative effect of initially applying FIN 48 recognized as a change in accounting principle recorded as an adjustment to opening retained earnings. The company does not expect the impact of adoption to be material to the companys consolidated financial statements.
No other new accounting pronouncement issued or effective has had or is expected to have a material impact on the companys consolidated financial statements.
3. SPECIAL CHARGES
Special charges in 2004 included a charge of $1.6 million for inprocess research and development related to the Alcide acquisition and a charge of $4.0 million on the disposal of a grease management product line, which were partially offset by $0.8 million of income for reductions in restructuring accruals and a $0.3 million gain on the sale of a small international business. For segment reporting purposes, these items have been included in the companys corporate segment, which is consistent with the companys internal management reporting.
4. RELATED PARTY TRANSACTIONS
Henkel KGaA (Henkel) beneficially owned 72.7 million shares, or approximately 28.9 percent, of the companys outstanding common stock on December 31, 2006. Under a stockholders agreement between the company and Henkel, Henkel is permitted ownership in the company of up to 35 percent of the companys outstanding common stock. Henkel is also entitled to proportionate representation on the companys board of directors.
33
In 2006, 2005 and 2004, the company and its affiliates sold products and services in the aggregate amounts of $5.7 million, $3.6 million and $3.2 million, respectively, to Henkel or its affiliates, and purchased products and services in the amounts of $66.0 million, $65.3 million and $70.9 million, respectively, from Henkel or its affiliates. The transactions with Henkel and its affiliates were made in the ordinary course of business and were negotiated at arms length.
5. BUSINESS ACQUISITIONS AND DISPOSITIONS
BUSINESS ACQUISITIONS
Business acquisitions made by the company during 2006, 2005 and 2004 were as follows:
|
|
|
|
|
|
ESTIMATED |
|
|
|
|
|
|
|
|
ANNUAL SALES |
|
|
BUSINESS |
|
DATE OF |
|
|
|
PRIOR TO |
|
|
ACQUIRED |
|
ACQUISITION |
|
SEGMENT |
|
ACQUISITION |
|
|
|
|
|
|
|
|
(MILLIONS) |
|
|
|
|
|
|
|
|
(UNAUDITED) |
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
Shield Medicare Ltd. |
|
June 2006 |
|
International (Europe) |
|
$19 |
|
|
DuChem Industries, Inc. |
|
Sept. 2006 |
|
U.S.
C&S
|
|
10 |
|
|
Powles Hunt & Sons International Ltd. |
|
Sept. 2006 |
|
International (Europe) |
|
5 |
|
|
2005 |
|
|
|
|
|
|
|
|
Associated Chemicals
& Services, Inc.
|
|
Jan. 2005 |
|
U.S. C&S (Water Care) |
|
16 |
|
|
YSC Chemical Company |
|
Feb. 2005 |
|
International (Asia Pacific) |
|
3 |
|
|
Kilco Chemicals Ltd. |
|
Apr. 2005 |
|
International (Europe) |
|
5 |
|
|
2004 |
|
|
|
|
|
|
|
|
Nigiko |
|
Jan. 2004 |
|
International
|
|
55 |
|
|
Daydots International |
|
Feb. 2004 |
|
U.S.
C&S
|
|
22 |
|
|
Elimco |
|
May 2004 |
|
International
|
|
4 |
|
|
Restoration and Maintenance unit of VIC International |
|
June 2004 |
|
U.S.
C&S
|
|
5 |
|
|
Alcide Corporation |
|
July 2004 |
|
U.S. C&S
|
|
24 |
|
|
The total cash consideration paid by the company for acquisitions and investments in affiliates was approximately $66 million, $27 million and $130 million for 2006, 2005 and 2004, respectively. In addition, 1,834,759 shares of common stock were issued with a market value of $57 million in the Alcide acquisition in 2004, plus $23,000 of cash in lieu of fractional shares. Total cash paid in 2004 also includes payments of restructuring costs related to the acquisition of the remaining 50 percent interest in the former Henkel-Ecolab joint venture that were accrued in 2002. The aggregate purchase price has been reduced for any cash or cash equivalents acquired with the acquisitions.
These acquisitions have been accounted for as purchases and, accordingly, the results of their operations have been included in the financial statements of the company from the dates of acquisition. Net sales and operating income of these businesses were not significant to the companys consolidated financial statements, therefore pro forma financial information is not presented.
Based upon purchase price allocations, the components of the aggregate purchase prices of the acquisitions made were as follows:
MILLIONS |
|
2006 |
|
2005 |
|
2004 |
|
|||
Net tangible assets acquired (liabilities assumed) |
|
$ |
(6 |
) |
$ |
|
|
$ |
14 |
|
Identifiable intangible assets |
|
28 |
|
8 |
|
44 |
|
|||
In-process research and development |
|
|
|
|
|
2 |
|
|||
Goodwill |
|
44 |
|
19 |
|
127 |
|
|||
Purchase price |
|
$ |
66 |
|
$ |
27 |
|
$ |
187 |
|
The allocation of purchase price includes adjustments to preliminary allocations from prior periods, if any. During 2004, the company recorded a charge of $1.6 million for in-process research and development (IPR&D) as part of the allocation of purchase price in the Alcide acquisition. The value assigned to IPR&D is based on an independent appraisers valuation and was determined by identifying research projects in areas for which technological feasibility had not been established and no alternative uses for the technology existed. The values were determined by estimating the discounted amount of after-tax cash flows attributable to these projects. The future cash flows were discounted to present value utilizing a risk-adjusted rate of return that considered the uncertainty surrounding the successful development of the IPR&D.
34
The changes in the carrying amount of goodwill for each of the companys reportable segments for the years ended December 31, 2006, 2005 and 2004 are as follows:
THOUSANDS |
|
U.S.
|
|
U.S.
|
|
TOTAL
|
|
INTERNATIONAL |
|
CONSOLIDATED |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance December 31, 2003 |
|
$ |
122,346 |
|
$ |
48,929 |
|
$ |
171,275 |
|
$ |
625,936 |
|
$ |
797,211 |
|
Goodwill acquired during year* |
|
54,936 |
|
|
|
54,936 |
|
72,270 |
|
127,206 |
|
|||||
Goodwill allocated to business dispositions |
|
(69 |
) |
|
|
(69 |
) |
(25 |
) |
(94 |
) |
|||||
Foreign currency translation |
|
|
|
|
|
|
|
67,488 |
|
67,488 |
|
|||||
Balance December 31, 2004 |
|
177,213 |
|
48,929 |
|
226,142 |
|
765,669 |
|
991,811 |
|
|||||
Goodwill acquired during year* |
|
12,639 |
|
595 |
|
13,234 |
|
6,162 |
|
19,396 |
|
|||||
Goodwill allocated to business dispositions |
|
(130 |
) |
|
|
(130 |
) |
(376 |
) |
(506 |
) |
|||||
Foreign currency translation |
|
|
|
|
|
|
|
(73,682 |
) |
(73,682 |
) |
|||||
Balance December 31, 2005 |
|
189,722 |
|
49,524 |
|
239,246 |
|
697,773 |
|
937,019 |
|
|||||
Goodwill acquired during year* |
|
7,346 |
|
990 |
|
8,336 |
|
35,713 |
|
44,049 |
|
|||||
Goodwill allocated to business dispositions |
|
|
|
|
|
|
|
(423 |
) |
(423 |
) |
|||||
Foreign currency translation |
|
|
|
|
|
|
|
55,284 |
|
55,284 |
|
|||||
Balance December 31, 2006 |
|
$ |
197,068 |
|
$ |
50,514 |
|
$ |
247,582 |
|
$ |
788,347 |
|
$ |
1,035,929 |
|
* For 2006, 2005 and 2004, goodwill related to businesses acquired of $7.7 million, $3.5 million and $92.8 million, respectively, is expected to be tax deductible. Goodwill acquired in 2006, 2005 and 2004 also includes adjustments to prior year acquisitions.
BUSINESS DISPOSITIONS
The company had no significant business dispositions in 2006 or 2005. In April 2004, the company sold its grease management product line. This sale resulted in a loss of approximately $4.0 million ($2.4 million after tax). Sales of the grease management product line totaled approximately $20 million in 2003 and were included in the companys U.S. Cleaning & Sanitizing operations. In 2004, the company also recognized a gain of $0.3 million ($0.2 million after tax) on the sale of a small Hygiene Services business in its International operations.
6. BALANCE SHEET INFORMATION
December 31 (thousands) |
|
2006 |
|
2005 |
|
||
Accounts Receivable, Net |
|
|
|
|
|
||
Accounts receivable |
|
$ |
905,160 |
|
$ |
782,371 |
|
Allowance for doubtful accounts |
|
(37,619 |
) |
(38,851 |
) |
||
Total |
|
$ |
867,541 |
|
$ |
743,520 |
|
Inventories |
|
|
|
|
|
||
Finished goods |
|
$ |
199,516 |
|
$ |
177,574 |
|
Raw materials and parts |
|
180,619 |
|
161,488 |
|
||
Excess of fifo cost over lifo cost |
|
(15,249 |
) |
(13,488 |
) |
||
Total |
|
$ |
364,886 |
|
$ |
325,574 |
|
Property, Plant and Equipment, Net |
|
|
|
|
|
||
Land |
|
$ |
30,851 |
|
$ |
32,164 |
|
Buildings and leaseholds |
|
306,775 |
|
283,487 |
|
||
Machinery and equipment |
|
630,821 |
|
617,408 |
|
||
Merchandising equipment |
|
1,204,716 |
|
1,072,853 |
|
||
Capitalized software |
|
72,904 |
|
68,062 |
|
||
Construction in progress |
|
72,139 |
|
42,244 |
|
||
|
|
2,318,206 |
|
2,116,218 |
|
||
Accumulated depreciation |
|
(1,366,637 |
) |
(1,248,165 |
) |
||
Total |
|
$ |
951,569 |
|
$ |
868,053 |
|
Other Intangible Assets, Net |
|
|
|
|
|
||
Cost |
|
|
|
|
|
||
Customer relationships |
|
$ |
217,423 |
|
$ |
176,778 |
|
Intellectual property |
|
45,569 |
|
41,887 |
|
||
Trademarks |
|
73,216 |
|
63,933 |
|
||
Other intangibles |
|
11,624 |
|
7,459 |
|
||
|
|
347,832 |
|
290,057 |
|
||
Accumulated amortization |
|
|
|
|
|
||
Customer relationships |
|
(80,153 |
) |
(55,328 |
) |
||
Intellectual property |
|
(17,254 |
) |
(9,901 |
) |
||
Trademarks |
|
(23,542 |
) |
(16,523 |
) |
||
Other intangibles |
|
(3,096 |
) |
(5,369 |
) |
||
Total |
|
$ |
223,787 |
|
$ |
202,936 |
|
Other Assets, Net |
|
|
|
|
|
||
Deferred income taxes |
|
$ |
176,184 |
|
$ |
42,618 |
|
Pension |
|
37,591 |
|
201,078 |
|
||
Sole supply fees |
|
67,423 |
|
61,632 |
|
||
Other |
|
73,325 |
|
61,626 |
|
||
Total |
|
$ |
354,523 |
|
$ |
366,954 |
|
Short-Term Debt |
|
|
|
|
|
||
Notes payable |
|
$ |
109,100 |
|
$ |
146,725 |
|
Long-term debt, current maturities |
|
399,878 |
|
80,202 |
|
||
Total |
|
$ |
508,978 |
|
$ |
226,927 |
|
Other Current Liabilities |
|
|
|
|
|
||
Discounts and rebates |
|
$ |
190,434 |
|
$ |
152,774 |
|
Dividends payable |
|
28,930 |
|
25,526 |
|
||
Other |
|
173,146 |
|
182,781 |
|
||
Total |
|
$ |
392,510 |
|
$ |
361,081 |
|
Long-Term Debt |
|
|
|
|
|
||
4.355% series A senior notes, due 2013 |
|
$ |
165,062 |
|
$ |
|
|
4.585% series B senior notes, due 2016 |
|
231,088 |
|
|
|
||
6.875% notes, due 2011 |
|
149,356 |
|
149,356 |
|
||
5.375% euronotes, due 2007 |
|
397,415 |
|
355,246 |
|
||
7.19% senior notes, due 2006 |
|
|
|
74,673 |
|
||
Other |
|
14,015 |
|
20,301 |
|
||
|
|
956,936 |
|
599,576 |
|
||
Long-term debt, current maturities |
|
(399,878 |
) |
(80,202 |
) |
||
Total |
|
$ |
557,058 |
|
$ |
519,374 |
|
Other Liabilities |
|
|
|
|
|
||
Deferred income taxes |
|
$ |
92,478 |
|
$ |
80,760 |
|
Income taxes payable noncurrent |
|
66,202 |
|
43,695 |
|
||
Other |
|
100,422 |
|
82,184 |
|
||
Total |
|
$ |
259,102 |
|
$ |
206,639 |
|
35
The company has a $450 million multicurrency credit agreement with a consortium of banks that has a term through June 1, 2011. Under certain circumstances, this credit agreement can be increased by $150 million for a total of $600 million. The company may borrow varying amounts in different currencies from time to time on a revolving credit basis. The company has the option of borrowing based on various short-term interest rates. Effective June 1, 2006, the credit agreement was amended and restated by, among other things, deleting the financial covenant regarding total debt to capitalization, increasing the lien basket from $75 million to $100 million and extending the term of the agreement from August 2009 to June 2011. No amounts were outstanding under this agreement at year-end 2006 and 2005.
The multicurrency credit agreement supports the companys $450 million U.S. commercial paper program and its $200 million European commercial paper program. The company had $30.3 million in outstanding U.S. commercial paper at December 31, 2006, with an average annual interest rate of 5.3 percent. There was no U.S. commercial paper outstanding at December 31, 2005. The company had $88.2 million in outstanding European commercial paper at December 31, 2005, with an average annual interest rate of 2.4 percent. The company had no commercial paper outstanding under its European commercial paper program at December 31, 2006. Both programs were rated A-1 by Standard & Poors and P-1 by Moodys as of December 31, 2006.
In December 2006, the company issued and sold in a private placement 300 million euro ($396 million as of December 31, 2006) aggregate principal amount of the companys senior notes in two series: 4.355% Series A Senior Notes due 2013 in the aggregate principal amount of 125 million euro and 4.585% Series B Senior Notes due 2016 in the aggregate principal amount of 175 million euro, pursuant to a Note Purchase Agreement dated July 26, 2006, between the company and the purchasers. The company used the proceeds to repay its euro 300 million ($396 million as of December 31, 2006) 5.375 percent euronotes which became due in February 2007.
In January 2006, the company repaid the $75 million 7.19% senior notes which were due January 2006.
As of December 31, the weighted-average interest rate on notes payable was 6.0 percent in 2006, 3.9 percent in 2005 and 5.7 percent in 2004.
As of December 31, 2006, the aggregate annual maturities of long-term debt for the next five years were:
thousands |
|
|
|
2007 |
|
$399,878 |
|
2008 |
|
2,830 |
|
2009 |
|
1,645 |
|
2010 |
|
1,277 |
|
2011 |
|
150,711 |
|
7. INTEREST
Interest expense was $51.3 million in 2006, $49.8 million in 2005 and $48.5 million in 2004. Interest income was $6.9 million in 2006, $5.6 million in 2005 and $3.2 million in 2004. Total interest paid was $50.6 million in 2006, $49.4 million in 2005 and $47.0 million in 2004.
8. FINANCIAL INSTRUMENTS
FOREIGN CURRENCY FORWARD CONTRACTS
The company has entered into foreign currency forward contracts to hedge transactions related to intercompany debt, subsidiary royalties, product purchases, firm commitments and other intercompany transactions. The company uses these contracts to hedge against the effect of foreign currency exchange rate fluctuations on forecasted cash flows. These contracts generally relate to the companys European operations and are denominated in euros. The company had foreign currency forward exchange contracts that totaled approximately $375 million at December 31, 2006, $395 million at December 31, 2005 and $239 million at December 31, 2004. These contracts generally expire within one year. The gains and losses related to these contracts were included as a component of other comprehensive income until the hedged item is reflected in earnings. As of December 31, 2006, other comprehensive income includes a cumulative loss of $1.3 million related to these contracts.
INTEREST RATE SWAP AGREEMENTS
The company enters into interest rate swap agreements to manage interest rate exposures and to achieve a desired proportion of variable and fixed rate debt.
In May 2006, the company entered into two forward starting interest rate swap agreements in connection with the senior note private placement offering that convert euro 250 million (euro 125 million due December 2013 and euro 125 million due December 2016) of the private placement funding from a variable interest rate to a fixed interest rate. The interest rate swap agreements were designated as, and effective as a cash flow hedge of the private placement offering. In June 2006 the company closed the swap agreements. The decline in fair value of $2.1 million, net of tax, was recorded in other comprehensive income and will be recognized in earnings as part of interest expense as the forecasted transactions occur.
During 2002, the company entered into an interest rate swap agreement in connection with the issuance of its euronotes. This agreement converts approximately euro 78 million (approximately $103 million at year-end 2006) of the euronote debt from a fixed interest rate to a floating or variable interest rate and is effective until February 2007. This interest rate swap was designated as a fair value hedge and had a value of $1.7 million, $4.0 million and $7.0 million as of December 31, 2006, 2005 and 2004, respectively. The mark to market gain on this agreement has been recorded as part of interest expense and has been offset by the loss recorded in interest expense on the mark to market on this portion of the euronotes. There is no hedge ineffectiveness on this interest rate swap.
NET INVESTMENT HEDGES
The company designated all euro 300 million euronote debt as a hedge of existing foreign currency exposures related to net investments the company has in certain European subsidiaries. Accordingly, the transaction gains and losses that are designated and effective as hedges of the companys net investments have been included as a component of the cumulative translation account within accumulated other comprehensive income (loss). Total transaction gains and losses related to the euronotes and charged to this shareholders equity account were a loss of $44.8 million in 2006, a gain of $45.7 million for 2005 and a loss of $39.6 million for 2004.
36
CREDIT RISK
The company is exposed to credit loss in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swap agreements. The company monitors its exposure to credit risk by using credit approvals and credit limits and selecting major international banks and financial institutions as counterparties. The company does not anticipate nonperformance by any of these counterparties.
FAIR VALUE OF OTHER FINANCIAL INSTRUMENTS
The carrying amount and the estimated fair value of other financial instruments held by the company were:
December 31 (thousands) |
|
2006 |
|
2005 |
|
||
|
|
|
|
|
|
||
Carrying amount |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
484,029 |
|
$ |
104,378 |
|
Short-term investments |
|
|
|
125,063 |
|
||
Accounts receivable |
|
867,541 |
|
743,520 |
|
||
Notes payable |
|
78,850 |
|
58,525 |
|
||
Commercial paper |
|
30,250 |
|
88,200 |
|
||
Long-term debt (including current maturities) |
|
956,936 |
|
599,576 |
|
||
Fair value |
|
|
|
|
|
||
Long-term debt (including current maturities) |
|
$ |
967,020 |
|
$ |
623,040 |
|
The carrying amounts of cash equivalents, short-term investments, accounts receivable, notes payable and commercial paper approximate fair value because of their short maturities.
The fair value of long-term debt is based on quoted market prices for the same or similar debt instruments.
9. SHAREHOLDERS EQUITY
Authorized common stock, par value $1.00 per share, was 400 million shares in 2006, 2005 and 2004. Treasury stock is stated at cost. Dividends declared per share of common stock were $0.4150 for 2006, $0.3625 for 2005 and $0.3275 for 2004.
The company has 15 million shares, without par value, of authorized but unissued preferred stock. Of these 15 million shares, 0.4 million shares were designated as Series A Junior Participating Preferred Stock and 14.6 million shares were undesignated.
In February 2006, the companys Board of Directors authorized the renewal of the companys shareholder rights plan. Under the companys renewed shareholder rights plan, one preferred stock purchase right is issued for each outstanding share of the companys common stock. A right entitles the holder, upon occurrence of certain events, to buy one one-thousandth of a share of Series A Junior Participating Preferred Stock at a purchase price of $135, subject to adjustment. The rights, however, do not become exercisable unless and until, among other things, any person or group acquires 15 percent or more of the outstanding common stock of the company, or the companys board of directors declares a holder of 10 percent or more of the outstanding common stock to be an adverse person as defined in the rights plan. Upon the occurrence of either of these events, the rights will become exercisable for common stock of the company (or in certain cases common stock of an acquiring company) having a market value of twice the exercise price of a right. The rights provide that the holdings by Henkel KGaA or its affiliates at the time of the renewal of the rights plan, subject to compliance by Henkel with certain conditions, will not cause the rights to become exercisable nor cause Henkel to be an adverse person. The rights are redeemable under certain circumstances at one cent per right and, unless redeemed earlier, will expire on March 10, 2016.
The company reacquired 6,875,400 shares of its common stock in 2006, 5,974,300 shares in 2005 and 4,581,400 shares in 2004 through open and private market purchases. The company also reacquired 128,544 shares, 337,947 shares and 777,607 shares of its common stock in 2006, 2005 and 2004, respectively, related to the exercise of stock options and the vesting of stock awards. In December 2004, the companys Board of Directors authorized the repurchase of up to 10 million shares of the companys common stock, including shares to be repurchased under Rule 10b5-1. In October 2006, the companys Board of Directors authorized the repurchase of up to 10 million additional shares of common stock, including shares to be repurchased under Rule 10b5-1. Shares are repurchased to offset the dilutive effect of stock options and incentives and for general corporate purposes. As of December 31, 2006, 12,926,000 shares remained to be purchased under the companys repurchase authority. The company intends to repurchase all shares under this authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions. The company expects to repurchase at least enough shares during 2007 to offset the dilutive effect of stock options, based on estimates of stock option exercises for 2007. Cash proceeds from the exercises as well as the tax benefits will provide a portion of the funding for this repurchase activity.
10. STOCK INCENTIVE AND OPTION PLANS
The companys stock incentive and option plans provide for grants of stock options, stock awards and other incentives. Common shares available for grant as of December 31 were 11,689,435 for 2006, 12,748,989 for 2005 and 4,216,012 for 2004. Common shares available for grant reflect 12 million shares approved by shareholders in 2005 for issuance under the plans.
Almost all of the awards granted are non-qualified stock options granted to employees that vest annually in equal amounts over a three year service period. Options are granted to purchase shares of the companys stock at the average daily share price on the date of grant. These options generally expire within ten years from the grant date. The company recognizes compensation expense for these awards on a straight-line basis over the three year vesting period, in accordance with SFAS 123R. Upon adoption of SFAS 123R, new stock option grants to retirement eligible recipients are attributed to expense using the non-substantive vesting method.
37
A summary of stock option activity and average exercise prices is as follows:
SHARES |
|
2006 |
|
2005 |
|
2004 |
|
Granted |
|
2,669,223 |
|
3,862,966 |
|
4,876,408 |
|
Exercised |
|
(4,215,387 |
) |
(2,878,612 |
) |
(3,625,117 |
) |
Canceled |
|
(368,984 |
) |
(148,568 |
) |
(386,512 |
) |
December 31: |
|
|
|
|
|
|
|
Outstanding |
|
21,653,143 |
|
23,568,291 |
|
22,732,505 |
|
Exercisable |
|
15,804,403 |
|
16,461,958 |
|
15,332,623 |
|
AVERAGE
|
|
2006 |
|
2005 |
|
2004 |
|
|||
Granted |
|
$ |
44.93 |
|
$ |
33.93 |
|
$ |
33.49 |
|
Exercised |
|
21.57 |
|
17.27 |
|
16.55 |
|
|||
Canceled |
|
33.36 |
|
29.03 |
|
24.81 |
|
|||
December 31: |
|
|
|
|
|
|
|
|||
Outstanding |
|
29.74 |
|
26.61 |
|
24.20 |
|
|||
Exercisable |
|
26.36 |
|
23.87 |
|
21.31 |
|
|||
The total intrinsic value of options (the amount by which the stock price exceeded the exercise price of the option on the date of exercise) that were exercised during 2006, 2005 and 2004 was $80.2 million, $45.3 million and $53.8 million, respectively.
Information related to stock options outstanding and stock options exercisable as of December 31, 2006, is as follows:
OPTIONS OUTSTANDING |
|
|||||||
RANGE OF |
|
|
|
WEIGHTED-
|
|
WEIGHTED-
|
|
|
EXERCISE |
|
OPTIONS |
|
REMAINING |
|
EXERCISE |
|
|
PRICES |
|
OUTSTANDING |
|
CONTRACTURAL LIFE |
|
PRICE |
|
|
$10.95-19.27 |
|
3,542,308 |
|
4.0 years |
|
$ |
18.62 |
|
$19.72-24.90 |
|
3,880,787 |
|
5.4 years |
|
23.67 |
|
|
$25.21-30.58 |
|
4,119,915 |
|
7.0 years |
|
27.52 |
|
|
$31.29-34.08 |
|
4,374,642 |
|
8.7 years |
|
33.86 |
|
|
$34.26-34.50 |
|
3,049,590 |
|
7.9 years |
|
34.50 |
|
|
$35.26-46.05 |
|
2,685,633 |
|
9.9 years |
|
44.92 |
|
|
$93.42* |
|
268 |
|
0.8 years |
|
93.42 |
|
|
|
|
21,653,143 |
|
|
|
|
|
|
* Includes 268 shares of Ecolabs common stock subject to stock options which Ecolab assumed in connection with the acquisition of Alcide Corporation in June 2004.
OPTIONS EXERCISABLE |
|
|||||||
RANGE OF |
|
|
|
WEIGHTED-
|
|
WEIGHTED-
|
|
|
EXERCISE |
|
OPTIONS |
|
REMAINING |
|
EXERCISE |
|
|
PRICES |
|
EXERCISABLE |
|
CONTRACTURAL LIFE |
|
PRICE |
|
|
$10.95-19.27 |
|
3,542,308 |
|
4.0 years |
|
$ |
18.62 |
|
$19.72-24.90 |
|
3,880,787 |
|
5.4 years |
|
23.67 |
|
|
$25.21-30.58 |
|
4,054,239 |
|
7.0 years |
|
27.49 |
|
|
$31.29-34.08 |
|
2,145,597 |
|
8.5 years |
|
33.68 |
|
|
$34.26-34.50 |
|
2,031,021 |
|
7.9 years |
|
34.50 |
|
|
$35.26-46.05 |
|
150,183 |
|
9.4 years |
|
41.08 |
|
|
$93.42* |
|
268 |
|
0.8 years |
|
93.42 |
|
|
|
|
15,804,403 |
|
|
|
|
|
|
* Includes 268 shares of Ecolabs common stock subject to stock options which Ecolab assumed in connection with the acquisition of Alcide Corporation in June 2004.
The total aggregate intrinsic value of options outstanding and options exercisable as of December 31, 2006 was $336.7 million and $299.1 million, respectively.
The lattice (binomial) option-pricing model was used to estimate the fair value of options at grant date beginning in the fourth quarter of 2005. The companys primary employee option grant occurs during the fourth quarter. Prior to adoption of SFAS 123R, the Black-Scholes option-pricing model was used. The weighted-average grant-date fair value of options granted in 2006, 2005 and 2004, and the significant assumptions used in determining the underlying fair value of each option grant, on the date of grant were as follows:
|
|
2006 |
|
2005 |
|
2004 |
|
|
|
|
|
|
|
|
|
Weighted-average grant-date fair value of options granted at market prices |
|
$12.92 |
|
$9.35 |
|
$9.45 |
|
|
|
|
|
|
|
|
|
Assumptions |
|
|
|
|
|
|
|
Risk-free rate of return |
|
4.5 |
% |
4.4 |
% |
3.8 |
% |
Expected life |
|
6 years |
|
6 years |
|
6 years* |
|
Expected volatility |
|
24.4 |
% |
24.3 |
% |
25.5 |
% |
Expected dividend yield |
|
1.0 |
% |
1.2 |
% |
1.0 |
% |
* During 2004 significant reload options were also granted with a weighted-average expected life of 3.5 years.
The risk-free rate of return is determined based on a yield curve of U.S. treasury rates from one month to ten years and a period commensurate with the expected life of the options granted. Expected volatility is established based on historical volatility of the companys stock price. The expected dividend yield is determined based on the companys annual dividend amount as a percentage of the average stock price at the time of the grant.
The expense associated with shares of restricted stock issued under the companys stock incentive plans is based on the market price of the companys stock at the date of grant and is amortized on a straight-line basis over the periods during which the restrictions lapse. The company currently has restricted stock outstanding that vests over periods between 12 and 36 months. Stock awards are not performance based and vest with continued employment. Stock awards are subject to forfeiture in the event of termination of employment. The company granted 14,845 shares in 2006, 11,479 shares in 2005 and 13,550 shares in 2004 under its restricted stock award program.
38
A summary of non-vested stock option and stock award activity is as follows:
NON-VESTED STOCK OPTIONS AND STOCK AWARDS |
|
||||||||||
|
|
|
|
WEIGHTED- |
|
|
|
WEIGHTED- |
|
||
|
|
|
|
AVERAGE |
|
|
|
AVERAGE |
|
||
|
|
|
|
FAIR VALUE |
|
|
|
FAIR VALUE |
|
||
|
|
STOCK |
|
AT GRANT |
|
STOCK |
|
AT GRANT |
|
||
|
|
OPTIONS |
|
DATE |
|
AWARDS |
|
DATE |
|
||
December 31, 2005 |
|
7,106,333 |
|
$ |
9.37 |
|
22,175 |
|
$ |
32.53 |
|
Granted |
|
2,669,223 |
|
12.92 |
|
14,845 |
|
44.46 |
|
||
Vested/Earned |
|
(3,537,235 |
) |
9.16 |
|
(10,350 |
) |
32.85 |
|
||
Cancelled |
|
(389,581 |
) |
9.27 |
|
(2,000 |
) |
36.57 |
|
||
December 31, 2006 |
|
5,848,740 |
|
$ |
11.13 |
|
24,670 |
|
$ |
39.25 |
|
Total compensation expense related to share-based compensation plans was $36.3 million, ($23.1 million net of tax benefit), $39.1 million, ($24.7 million net of tax benefit) and $44.7 million, ($28.1 million net of tax benefit) during 2006, 2005 and 2004, respectively.
As of December 31, 2006, there was $54.0 million of total measured but unrecognized compensation expense related to non-vested share-based compensation arrangements granted under our plans. That cost is expected to be recognized over a weighted-average period of 1.9 years.
Total cash received from the exercise of share-based instruments in 2006 was $87.9 million.
The company generally issues authorized but previously unissued shares to satisfy stock option exercises. The company has a policy of repurchasing shares on the open market to offset the dilutive effect of stock options, as discussed in Note 9.
11. INCOME TAXES
Income before income taxes consisted of:
THOUSANDS |
|
2006 |
|
2005 |
|
2004 |
|
|||
Domestic |
|
$ |
321,117 |
|
$ |
278,795 |
|
$ |
238,307 |
|
Foreign |
|
246,107 |
|
219,387 |
|
206,239 |
|
|||
Total |
|
$ |
567,224 |
|
$ |
498,182 |
|
$ |
444,546 |
|
The provision for income taxes consisted of:
THOUSANDS |
|
2006 |
|
2005 |
|
2004 |
|
|||
Federal and state |
|
$ |
143,647 |
|
$ |
121,409 |
|
$ |
79,830 |
|
Foreign |
|
73,768 |
|
70,313 |
|
67,681 |
|
|||
Currently payable |
|
217,415 |
|
191,722 |
|
147,511 |
|
|||
|
|
|
|
|
|
|
|
|||
Federal and state |
|
(15,847 |
) |
(8,901 |
) |
13,470 |
|
|||
Foreign |
|
(2,959 |
) |
(4,120 |
) |
872 |
|
|||
Deferred |
|
(18,806 |
) |
(13,021 |
) |
14,342 |
|
|||
|
|
|
|
|
|
|
|
|||
Provision for income taxes |
|
$ |
198,609 |
|
$ |
178,701 |
|
$ |
161,853 |
|
The companys overall net deferred tax assets and deferred tax liabilities were comprised of the following:
DECEMBER 31 (THOUSANDS) |
|
2006 |
|
2005 |
|
||
Deferred tax assets |
|
|
|
|
|
||
Other accrued liabilities |
|
$ |
56,979 |
|
$ |
49,257 |
|
Loss carryforwards |
|
6,256 |
|
6,538 |
|
||
Share-based compensation |
|
47,253 |
|
45,718 |
|
||
Other comprehensive income |
|
163,092 |
|
42,028 |
|
||
Other, net |
|
36,457 |
|
24,739 |
|
||
Valuation allowance |
|
(376 |
) |
(2,711 |
) |
||
Total |
|
309,661 |
|
165,569 |
|
||
Deferred tax liabilities |
|
|
|
|
|
||
Postretirement health care and pension benefits |
|
7,787 |
|
3,217 |
|
||
Property, plant and equipment basis differences |
|
37,785 |
|
61,489 |
|
||
Intangible assets |
|
95,516 |
|
73,853 |
|
||
Other, net |
|
3,484 |
|
2,631 |
|
||
Total |
|
144,572 |
|
141,190 |
|
||
Net deferred tax assets |
|
$ |
165,089 |
|
$ |
24,379 |
|
A reconciliation of the statutory U.S. federal income tax rate to the companys effective income tax rate was:
|
|
2006 |
|
2005 |
|
2004 |
|
Statutory U.S. rate |
|
35.0 |
% |
35.0 |
% |
35.0 |
% |
State income taxes, net of federal benefit |
|
2.3 |
|
2.3 |
|
2.4 |
|
Foreign operations |
|
(1.8 |
) |
(2.0 |
) |
(0.9 |
) |
Reinvested earnings in U.S. under the American Jobs Creation Act |
|
|
|
0.6 |
|
|
|
Other, net |
|
(0.5 |
) |
|
|
(0.1 |
) |
Effective income tax rate |
|
35.0 |
% |
35.9 |
% |
36.4 |
% |
Cash paid for income taxes was approximately $182 million in 2006, $165 million in 2005 and $163 million in 2004.
As of December 31, 2006, the company had undistributed earnings of international affiliates of approximately $607 million. These earnings are considered to be reinvested indefinitely or available for distribution with foreign tax credits available to offset the amount of applicable income tax and foreign withholding taxes that might be payable on earnings. It is impractical to determine the amount of incremental taxes that might arise if all undistributed earnings were distributed.
On October 22, 2004, the President signed the American Jobs Creation Act of 2004 (the Act). The Act provides a deduction for income from qualified domestic production activities, which will be phased in from 2005 through 2010. In return, the Act also provides for a two-year phase-out of the existing extra-territorial income exclusion (ETI) for foreign sales that was viewed to be inconsistent with international trade protocols by the European Union.
Under the guidance in FASB Staff Position No. 109-1, Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004, the deduction will be treated as a special deduction as described in SFAS No. 109. As such, the special deduction has no effect on deferred tax assets
39
and liabilities existing at the enactment date. Rather, the impact of this deduction is reported in the period in which the deduction is claimed on the companys tax return. The company recorded a modest benefit in both 2006 and 2005 from this deduction.
The Act also creates a temporary incentive for U.S. corporations to repatriate accumulated income earned abroad by providing an 85 percent dividends received deduction for certain dividends from controlled foreign corporations. In the fourth quarter of 2005 the company approved a plan for the reinvestment of foreign earnings in the U.S. pursuant to the provisions of the Act. The company repatriated $223 million of foreign earnings into the U.S. As a result of completing the repatriation, the company recorded tax expense of approximately $3.1 million, net of available foreign tax credits, in the fourth quarter of 2005.
12. RENTALS AND LEASES
The company leases sales and administrative office facilities, distribution center facilities, automobiles, computers and other equipment under operating leases. Rental expense under all operating leases was $104.3 million in 2006, $97.3 million in 2005 and $86.6 million in 2004. As of December 31, 2006, future minimum payments under operating leases with noncancelable terms in excess of one year were:
thousands |
|
|
|
2007 |
|
$44,000 |
|
2008 |
|
33,000 |
|
2009 |
|
24,000 |
|
2010 |
|
17,000 |
|
2011 |
|
11,000 |
|
Thereafter |
|
13,000 |
|
Total |
|
$142,000 |
|
The company enters into operating leases for vehicles whose noncancelable terms are one year or less in duration with month-to-month renewal options. These leases have been excluded from the table above. The company estimates payments under such leases will approximate $51 million in 2007. These automobile leases have guaranteed residual values that have historically been satisfied primarily by the proceeds on the sale of the vehicles. No estimated losses have been recorded for these guarantees as the company believes, based upon the results of previous leasing arrangements, that the potential recovery of value from the vehicles when sold will be greater than the residual value guarantee.
13. RESEARCH EXPENDITURES
Research expenditures that related to the development of new products and processes, including significant improvements and refinements to existing products are expensed as incurred. Such costs were $73.3 million in 2006, $68.4 million in 2005 and $61.5 million in 2004.
14. COMMITMENTS AND CONTINGENCIES
The company and certain subsidiaries are party to various lawsuits, claims and environmental actions that have arisen in the ordinary course of business. These include possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain chemical substances at various sites, such as Superfund sites and other operating or closed facilities. The effect of all actions on the companys financial position, results of operations and cash flows to date has not been material. The company is currently participating in environmental assessments and remediation at a number of locations and environmental liabilities have been accrued reflecting managements best estimate of future costs. The accrual for environmental remediation costs was $4.9 million and $4.3 million at December 31, 2006 and 2005, respectively. Potential insurance reimbursements are not anticipated in the companys accruals for environmental liabilities.
The company is self-insured in North America for most workers compensation, general liability and automotive liability losses subject to per occurrence and aggregate annual liability limitations. The company is insured for losses in excess of these limitations. The company has recorded both a liability and an offsetting receivable for amounts in excess of these limitations. The company is self-insured for health care claims for eligible participating employees subject to certain deductibles and limitations. The company determines its liability for claims incurred but not reported on an actuarial basis. While the final resolution of these contingencies could result in expenses different than current accruals, and therefore have an impact on the companys consolidated financial results in a future reporting period, management believes the ultimate outcome will not have a significant effect on the companys consolidated results of operations, financial position or cash flows.
15. RETIREMENT PLANS
PENSION AND POSTRETIREMENT HEALTH CARE BENEFITS PLANS
The company has a noncontributory defined benefit pension plan covering most of its U.S. employees. Effective January 1, 2003, the U.S. pension plan was amended to provide a cash balance type pension benefit to employees hired on or after the effective date. For employees hired prior to January 1, 2003, plan benefits are based on years of service and highest average compensation for five consecutive years of employment. For employees hired after December 31, 2002, plan benefits are based on contribution credits equal to a fixed percentage of their current salary and interest credits. The company also has U.S. noncontributory non-qualified defined benefit plans, which provide for benefits to employees in excess of limits permitted under its U.S. pension plan. The measurement date used for determining the U.S. pension plan assets and obligations is December 31. Various international subsidiaries also have defined benefit pension plans. The measurement date used for determining the international pension plan assets and obligations is November 30, the fiscal year-end of the companys international affiliates. The information following includes all of the companys international defined benefit pension plans.
The company provides postretirement health care benefits to certain U.S. employees. The plan is contributory based on years of service and family status, with retiree contributions adjusted annually. The measurement date used to determine the U.S. postretirement healthcare plan assets and obligations is December 31. Certain employees outside the U.S. are covered under government-sponsored programs, which are not required to be fully funded. The expense and obligation for providing international postretirement healthcare benefits is not significant.
40
Effective December 31, 2006, the company prospectively adopted Statement of Financial Accounting Standards No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans An Amendment of FASB Statements No. 87, 88, 106 and 132(R) (SFAS 158). As a result of the adoption of SFAS 158, the company has recorded a cumulative effect adjustment as a component of other comprehensive income within shareholders equity. The companys disclosures for the fiscal year ended 2006 also reflect the revised accounting and disclosure requirements of SFAS 158. Reported items for fiscal years 2005 and 2004 were not affected.
The adoption of SFAS 158 on December 31, 2006 resulted in incremental adjustments to the following individual line items in the consolidated balance sheet:
|
|
Before |
|
|
|
After |
|
|||
|
|
Application of |
|
|
|
Application of |
|
|||
thousands |
|
SFAS 158 |
|
Adjustments |
|
SFAS 158 |
|
|||
Deferred income taxes |
|
$ |
86,084 |
|
$ |
786 |
|
$ |
86,870 |
|
Other assets, net* |
|
456,833 |
|
(102,310 |
) |
354,523 |
|
|||
Total assets |
|
4,520,889 |
|
(101,524 |
) |
4,419,365 |
|
|||
Compensation and benefits |
|
244,172 |
|
8,514 |
|
252,686 |
|
|||
Postretirement health care and pension benefit liabilities |
|
338,990 |
|
81,255 |
|
420,245 |
|
|||
Other liabilities** |
|
282,312 |
|
(23,210 |
) |
259,102 |
|
|||
Shareholders equity |
|
1,848,313 |
|
(168,083 |
) |
1,680,230 |
|
|||
Total liabilities and shareholders equity |
|
4,520,889 |
|
(101,524 |
) |
4,419,365 |
|
|||
* The adjustment to Other assets, net represents the net effect of an adjustment of $(179,046) to the companys net pension assets, an adjustment of $99,946 for the recognition of deferred taxes and the reclassification of deferred tax liabilities of $(23,210) from the application of SFAS 158.
** The adjustment to the Other liabilities represents the recognition and reclassification of deferred taxes from the application of SFAS 158.
A reconciliation of changes in the benefit obligations and fair value of assets of the companys plan as follows:
|
|
U.S. Pension Benefits
|
|
International
|
|
U.S. Postretirement
|
|
||||||||||||
thousands |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||
Benefit obligation, beginning of year |
|
$ |
785,664 |
|
$ |
709,676 |
|
$ |
402,317 |
|
$ |
372,045 |
|
$ |
165,358 |
|
$ |
158,030 |
|
Service cost |
|
40,635 |
|
40,646 |
|
18,899 |
|
14,970 |
|
3,113 |
|
3,085 |
|
||||||
Interest cost |
|
43,611 |
|
40,174 |
|
18,995 |
|
18,307 |
|
8,992 |
|
8,860 |
|
||||||
Participant contributions |
|
|
|
|
|
2,336 |
|
2,539 |
|
2,675 |
|
2,467 |
|
||||||
Divestitures |
|
|
|
|
|
|
|
(58 |
) |
|
|
|
|
||||||
Plan amendments, settlements and curtailments |
|
1,175 |
|
|
|
(2,159 |
) |
18 |
|
127 |
|
(3,566 |
) |
||||||
Actuarial loss (gain) |
|
(15,076 |
) |
17,482 |
|
8,375 |
|
48,342 |
|
1,276 |
|
7,535 |
|
||||||
Benefits paid |
|
(22,199 |
) |
(22,314 |
) |
(19,629 |
) |
(14,622 |
) |
(12,183 |
) |
(11,053 |
) |
||||||
Foreign currency translation |
|
|
|
|
|
48,806 |
|
(39,224 |
) |
|
|
|
|
||||||
Benefit obligation, end of year |
|
$ |
833,810 |
|
$ |
785,664 |
|
$ |
477,940 |
|
$ |
402,317 |
|
$ |
169,358 |
|
$ |
165,358 |
|
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
||||||||||||
THOUSANDS |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||
Fair value of plan assets, beginning of year |
|
$ |
679,209 |
|
$ |
618,133 |
|
$ |
220,143 |
|
$ |
201,482 |
|
$ |
25,224 |
|
$ |
21,740 |
|
Actual gains on plan assets |
|
89,974 |
|
42,171 |
|
22,245 |
|
23,126 |
|
3,610 |
|
1,499 |
|
||||||
Company contributions |
|
46,416 |
|
41,219 |
|
18,873 |
|
27,273 |
|
12,176 |
|
10,571 |
|
||||||
Participant contributions |
|
|
|
|
|
2,336 |
|
2,539 |
|
1,388 |
|
2,467 |
|
||||||
Settlements |
|
|
|
|
|
(315 |
) |
|
|
|
|
|
|
||||||
Benefits paid |
|
(22,199 |
) |
(22,314 |
) |
(19,629 |
) |
(14,622 |
) |
(12,183 |
) |
(11,053 |
) |
||||||
Foreign currency translation |
|
|
|
|
|
25,987 |
|
(19,655 |
) |
|
|
|
|
||||||
Fair value of plan assets, end of year |
|
$ |
793,400 |
|
$ |
679,209 |
|
$ |
269,640 |
|
$ |
220,143 |
|
$ |
30,215 |
|
$ |
25,224 |
|
41
A reconciliation of the funded status for the pension and postretirement plans to the net amount recognized is as follows:
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
||||||||||||
THOUSANDS |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||
Funded status |
|
$ |
(40,410 |
) |
$ |
(106,455 |
) |
$ |
(208,300 |
) |
$ |
(182,174 |
) |
$ |
(139,143 |
) |
$ |
(140,134 |
) |
Unrecognized actuarial loss |
|
|
|
248,451 |
|
|
|
82,672 |
|
|
|
58,539 |
|
||||||
Unrecognized prior service cost (benefit) |
|
|
|
6,978 |
|
|
|
1,425 |
|
|
|
(25,981 |
) |
||||||
Unrecognized net transition (asset) obligation |
|
|
|
|
|
|
|
(21 |
) |
|
|
|
|
||||||
Net amount recognized |
|
$ |
(40,410 |
) |
$ |
148,974 |
|
$ |
(208,300 |
) |
$ |
(98,098 |
) |
$ |
(139,143 |
) |
$ |
(107,576 |
) |
The total amounts recognized in the balance sheet, including accumulated other comprehensive income, and the accumulated benefit obligation are as follows:
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
||||||||||||
THOUSANDS |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
||||||
Noncurrent benefit asset |
|
$ |
13,591 |
|
$ |
174,063 |
|
$ |
24,000 |
|
$ |
27,015 |
|
|
|
|
|
||
Current benefit liability |
|
(3,400 |
) |
|
|
(6,484 |
) |
|
|
$ |
(1,130 |
) |
|
|
|||||
Noncurrent benefit liability |
|
(50,601 |
) |
(25,089 |
) |
(225,816 |
) |
(169,143 |
) |
(138,013 |
) |
$ |
(107,576 |
) |
|||||
Intangible asset |
|
|
|
|
|
|
|
1,211 |
|
|
|
|
|
||||||
Accumulated other comprehensive loss (pre-tax) |
|
195,080 |
|
|
|
86,955 |
|
42,819 |
|
30,965 |
|
|
|
||||||
Total amount recognized |
|
$ |
154,670 |
|
$ |
148,974 |
|
$ |
(121,345 |
) |
$ |
(98,098 |
) |
$ |
(108,178 |
) |
$ |
(107,576 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Accumulated benefit obligation |
|
$ |
687,708 |
|
$ |
627,917 |
|
$ |
330,751 |
|
$ |
358,837 |
|
$ |
169,358 |
|
$ |
165,358 |
|
Accumulated other comprehensive loss for pension and other postretirement benefit plan activity is as follows:
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
|||
THOUSANDS |
|
2006 |
|
2006 |
|
2006 |
|
|||
Accumulated other comprehensive loss, beginning of year |
|
$ |
|
|
$ |
27,117 |
|
$ |
|
|
Recognition of additional minimum pension liability |
|
|
|
979 |
|
|
|
|||
Cumulative effect adjustment of change in accounting adoption of SFAS 158 to recognize funded status |
|
195,080 |
|
43,157 |
|
30,965 |
|
|||
Tax benefit |
|
(75,569 |
) |
(13,917 |
) |
(11,995 |
) |
|||
Accumulated other comprehensive loss (income), end of year |
|
$ |
119,511 |
|
$ |
57,336 |
|
$ |
18,970 |
|
The components of accumulated other comprehensive loss related to pension and postretirement benefit plans are as follows:
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
|||
THOUSANDS |
|
2006 |
|
2006 |
|
2006 |
|
|||
Unrecognized net actuarial losses |
|
$ |
188,924 |
|
$ |
87,248 |
|
$ |
50,384 |
|
Unrecognized net prior service costs (benefits) |
|
6,156 |
|
(325 |
) |
(19,419 |
) |
|||
Unrecognized net transition costs |
|
|
|
32 |
|
|
|
|||
Tax benefit |
|
(75,569 |
) |
(29,619 |
) |
(11,995 |
) |
|||
Accumulated other comprehensive loss, end of year |
|
$ |
119,511 |
|
$ |
57,336 |
|
$ |
18,970 |
|
42
Estimated amounts in accumulated other comprehensive income expected to be reclassified to net period cost during 2007 are as follows:
THOUSANDS |
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
|||
Net actuarial losses |
|
$ |
13,021 |
|
$ |
3,048 |
|
$ |
7,354 |
|
Net prior service costs/(benefits) |
|
2,008 |
|
21 |
|
(6,419 |
) |
|||
Net transition costs |
|
|
|
4 |
|
|
|
|||
Total |
|
$ |
15,029 |
|
$ |
3,073 |
|
$ |
935 |
|
For certain international pension plans, the accumulated benefit obligations exceeded the fair value of plan assets. The company recognized an addition to the minimum pension liability in other comprehensive income of $1.0 million pre-tax ($0.6 million net of deferred tax asset) in 2006, $24.4 million pre-tax ($16.2 million net of deferred tax asset) during 2005 and $0.4 million pre-tax ($0.3 million net of deferred tax asset) during 2004. The additional minimum pension liability recognized prior to adoption of SFAS 158 was considered in determining the cumulative effect adjustment of adopting SFAS 158 as of December 31, 2006.
The aggregate projected benefit obligation, accumulated benefit obligation and fair value of plan assets for those U.S. nonqualified plans and international plans with accumulated benefit obligations in excess of plan assets were as follows:
|
|
DECEMBER 31 |
|
||||
THOUSANDS |
|
2006 |
|
2005 |
|
||
Aggregate projected benefit obligation |
|
$ |
414,731 |
|
$ |
385,141 |
|
Accumulated benefit obligation |
|
364,034 |
|
331,640 |
|
||
Fair value of plan assets |
|
138,479 |
|
136,937 |
|
||
These plans relate to various international subsidiaries and the U.S. nonqualified plans and are funded consistent with local practices and requirements. As of December 31, 2006, there were approximately $17 million of future postretirement benefits covered by insurance contracts.
PLAN ASSETS
UNITED STATES
The companys pension and postretirement health care benefits plans at December 31, 2006 and 2005 and target allocation for 2007 are as follows:
ASSET |
|
2007
|
|
PERCENTAGE OF PLAN ASSETS |
|
|||||
CATEGORY |
|
PERCENTAGE |
|
2006 |
|
2005 |
|
|||
Large cap equity |
|
43 |
% |
|
43 |
% |
|
43 |
% |
|
Small cap equity |
|
12 |
|
|
12 |
|
|
12 |
|
|
International equity |
|
15 |
|
|
16 |
|
|
16 |
|
|
Fixed income |
|
25 |
|
|
24 |
|
|
24 |
|
|
Real estate |
|
5 |
|
|
5 |
|
|
5 |
|
|
Total |
|
100 |
% |
|
100 |
% |
|
100 |
% |
|
The companys U.S. investment strategy and policies are designed to maximize the possibility of having sufficient funds to meet the long-term liabilities of the pension fund, while achieving a balance between the goals of asset growth of the plan and keeping risk at a reasonable level. Current income is not a key goal of the plan. The pension and health care plans demographic characteristics generally reflect a younger plan population relative to an average pension plan. Therefore, the asset allocation position reflects the ability and willingness to accept relatively more short-term variability in the performance of the pension plan portfolio in exchange for the expectation of better long-term returns, lower pension costs and better funded status in the long run.
Since diversification is widely recognized as important to reduce unnecessary risk, the pension fund is diversified across a number of asset classes and securities. Selected individual portfolios within the asset classes may be undiversified while maintaining the diversified nature of total plan assets.
The companys U.S. investment policies prohibit investing in letter stock, warrants and options, and engaging in short sales, margin transactions, private placements, or other specialized investment activities. The use of derivatives is also prohibited for the purpose of speculation or introducing leverage in the portfolio, circumventing the investment guidelines or taking risks that are inconsistent with the funds guidelines. Selected derivatives may only be used for hedging and transactional efficiency.
INTERNATIONAL
The companys plan asset allocations for its international defined benefit pension plans at December 31, 2006 and 2005 are as follows:
ASSET |
|
PERCENTAGE OF PLAN ASSETS |
|
||
CATEGORY |
|
2006 |
|
2005 |
|
Equity securities |
|
40% |
|
44% |
|
Fixed income |
|
46 |
|
45 |
|
Real estate |
|
5 |
|
2 |
|
Other |
|
9 |
|
9 |
|
Total |
|
100% |
|
100% |
|
Assets of funded retirement plans outside the U.S. are managed in each local jurisdiction and asset allocation strategy is set in accordance with local rules, regulations and practice. Therefore, no target asset allocation for 2007 is presented. The funds are invested in a variety of stocks, fixed income and real estate investments and in some cases, the assets are managed by insurance companies which may offer a guaranteed rate of return. Total international pension plan assets represent 24 percent of total Ecolab pension plan assets worldwide.
43
AMENDMENTS
During 2004, the American Jobs Creation Act of 2004 (the Act) added a new Section 409A to the Internal Revenue Code (the Code) which significantly changed the federal tax law applicable to amounts deferred after December 31, 2004 under nonqualified deferred compensation plans. In response to this, the company amended the Non-Employee Director Stock Option and Deferred Compensation Plan (Director Plan) and the Mirror Savings Plan in December 2004. The amendments (1) allow compensation that was deferred (as defined by the Act) prior to January 1, 2005 to qualify for grandfathered status and to continue to be governed by the law applicable to nonqualified deferred compensation prior to the addition of Internal Revenue Code Section 409A by the Act, and (2) cause deferred compensation that is deferred after December 31, 2004 to be in compliance with the requirements of Code Section 409A. For amounts deferred after December 31, 2004, the amendments generally (1) require that such amounts be distributed as a single lump sum payment as soon as practicable after the participant has had a separation of service, with the exception of payments to key employees (as defined by the Act) which lump sum payments are required to be held for 6 months after their separation from service, and (2) prohibit the acceleration of distribution of such amounts except for an unforeseeable emergency (as defined by the Act).
Additionally, in December 2004 the company amended the Supplemental Executive Retirement Plan (SERP) and the Mirror Pension Plan to (1) allow amounts deferred prior to January 1, 2005 to qualify for grandfathered status and to continue to be governed by the law applicable to nonqualified deferred compensation prior to the Act, and (2) temporarily freeze the accrual of benefits as of December 31, 2004 due to the uncertainty regarding the effect of the Act on such benefits. The Secretary of Treasury and the Internal Revenue Service are expected to issue regulations and/or other guidance with respect to the provisions of the new Act throughout 2007 and final amendments to comply with the Act are required by the end of 2007. The company currently intends to rescind the freeze, following issuance of regulations to ensure compliance for post-2004 benefit accruals.
CASH FLOWS
As of year-end 2006, the companys estimate of benefits expected to be paid in each of the next five fiscal years, and in the aggregate for the five fiscal years thereafter for the companys pension and postretirement health care benefit plans are as follows:
|
|
|
|
MEDICARE
|
|
||
THOUSANDS |
|
ALL PLANS |
|
RECEIPTS |
|
||
2007 |
|
$ |
52,000 |
|
$ |
1,000 |
|
2008 |
|
59,000 |
|
1,000 |
|
||
2009 |
|
64,000 |
|
1,000 |
|
||
2010 |
|
66,000 |
|
1,000 |
|
||
2011 |
|
72,000 |
|
1,000 |
|
||
2012-2016 |
|
447,000 |
|
11,000 |
|
||
The companys funding policy for the U.S. pension plan is to achieve and maintain a return on assets that meets the long-term funding requirements identified by the projections of the pension plans fiduciary responsibilities prescribed in ERISA. The company also takes into consideration the tax deductibility of contributions to the benefit plans. The company is not required to make any contributions to the U.S. pension and postretirement health care benefit plans in 2007. The company estimates contributions to be made to the international plans will approximate $20 million in 2007.
The company is not aware of any expected refunds of plan assets within the next 12 months from any of its existing U.S. or international pension or postretirement benefit plans.
NET PERIODIC BENEFIT COSTS
Pension and postretirement health care benefits expense for the companys operations was:
|
|
U.S. PENSION BENEFITS
|
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
|||||||||||||||||||||
THOUSANDS |
|
2006 |
|
2005 |
|
2004 |
|
2006 |
|
2005 |
|
2004 |
|
2006 |
|
2005 |
|
2004 |
|
|||||||||
Service cost employee benefits earned during the year |
|
$ |
40,635 |
|
$ |
40,646 |
|
$ |
32,806 |
|
$ |
18,899 |
|
$ |
14,970 |
|
$ |
13,409 |
|
$ |
3,113 |
|
$ |
3,085 |
|
$ |
3,188 |
|
Interest cost on benefit obligation |
|
43,611 |
|
40,174 |
|
36,401 |
|
18,995 |
|
18,307 |
|
17,830 |
|
8,992 |
|
8,860 |
|
9,041 |
|
|||||||||
Expected return on plan assets |
|
(62,109 |
) |
(53,114 |
) |
(50,161 |
) |
(13,192 |
) |
(11,751 |
) |
(11,403 |
) |
(2,457 |
) |
(1,770 |
) |
(1,843 |
) |
|||||||||
Recognition of net actuarial loss |
|
16,586 |
|
11,183 |
|
6,547 |
|
3,059 |
|
1,597 |
|
1,458 |
|
8,278 |
|
5,734 |
|
5,706 |
|
|||||||||
Amortization of prior service cost (benefit) |
|
1,997 |
|
1,906 |
|
2,026 |
|
45 |
|
162 |
|
426 |
|
(6,435 |
) |
(5,660 |
) |
(5,696 |
) |
|||||||||
Amortization of net transition (asset) obligation |
|
|
|
(702 |
) |
(1,403 |
) |
24 |
|
329 |
|
333 |
|
|
|
|
|
|
|
|||||||||
Curtailment (gain) loss |
|
|
|
|
|
|
|
(170 |
) |
(40 |
) |
(51 |
) |
|
|
|
|
|
|
|||||||||
Total expense |
|
$ |
40,720 |
|
$ |
40,093 |
|
$ |
26,216 |
|
$ |
27,660 |
|
$ |
23,574 |
|
$ |
22,002 |
|
$ |
11,491 |
|
$ |
10,249 |
|
$ |
10,396 |
|
44
PLAN ASSUMPTIONS
|
|
U.S. PENSION BENEFITS |
|
INTERNATIONAL
|
|
U.S. POSTRETIREMENT
|
|
||||||||||||
|
|
2006 |
|
2005 |
|
2004 |
|
2006 |
|
2005 |
|
2004 |
|
2006 |
|
2005 |
|
2004 |
|
Weighted-average actuarial assumptions used to determine benefit obligations as of December 31: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate |
|
5.79 |
% |
5.57 |
% |
5.75 |
% |
4.65 |
% |
4.54 |
% |
5.22 |
% |
5.79 |
% |
5.57 |
% |
5.75 |
% |
Projected salary increase |
|
4.32 |
|
4.30 |
|
4.30 |
|
3.27 |
|
3.15 |
|
3.13 |
|
|
|
|
|
|
|
Weighted-average actuarial assumptions used to determine net cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate |
|
5.57 |
|
5.75 |
|
6.25 |
|
4.56 |
|
5.18 |
|
5.37 |
|
5.57 |
|
5.75 |
|
6.25 |
|
Expected return on plan assets |
|
8.75 |
|
8.75 |
|
9.00 |
|
5.80 |
|
5.68 |
|
5.75 |
|
8.75 |
% |
8.75 |
% |
9.00 |
% |
Projected salary increase |
|
4.30 |
% |
4.30 |
% |
4.30 |
% |
3.21 |
% |
3.12 |
% |
3.07 |
% |
|
|
|
|
|
|
The expected long-term rate of return is generally based on the pension plans asset mix, assumptions of equity returns based on historical long-term returns on asset categories, expectations for inflation, and estimates of the impact of active management of the assets.
For postretirement benefit measurement purposes as of December 31, 2006, 10 percent (for pre-age 65 retirees) and 11 percent (for post-age 65 retirees) annual rates of increase in the per capita cost of covered health care were assumed. The rates were assumed to decrease by 1 percent each year until they reach 5 percent in 2012 for pre-age 65 retirees and 5 percent in 2013 for post-age 65 retirees and remain at those levels thereafter. Health care costs which are eligible for subsidy by the company are limited to a maximum 4 percent annual increase beginning in 1996 for certain employees.
Assumed health care cost trend rates have a significant effect on the amounts reported for the companys U.S. postretirement health care benefits plan. A one-percentage point change in the assumed health care cost trend rates would have the following effects:
|
|
1-PERCENTAGE POINT |
|
||||
THOUSANDS |
|
INCREASE |
|
DECREASE |
|
||
Effect on total of service and interest cost components |
|
$ |
509 |
|
$ |
(453 |
) |
Effect on postretirement benefit obligation |
|
9,597 |
|
(8,531 |
) |
||
The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) introduces a prescription drug benefit under Medicare as well as a federal subsidy to sponsors of retiree health care benefit plans. The companys U.S. postretirement health care benefits plan offers prescription drug benefits. The company amended its plan effective January 1, 2005 in order to obtain the benefits provided under the Act. In accordance with FSP No. 106-2 Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, the company began recording favorable benefits of the Act in the third quarter of 2004, using the prospective transition method consistent with this guidance. The after-tax benefit for 2004 was approximately $1.0 million. The company recognized an actuarial gain and a reduction in its postretirement benefit obligation of $15.5 million at July 1, 2004 related to the Act.
SAVINGS PLAN AND ESOP
The company provides a 401(k) savings plan for substantially all U.S. employees. Employee before-tax contributions of up to 3 percent of eligible compensation are matched 100 percent by the company and employee before-tax contributions between 3 percent and 5 percent of eligible compensation are matched 50 percent by the company. The match is 100 percent vested immediately. Effective January 2003, the plan was amended to provide that all employee contributions which are invested in Ecolab stock will be part of the employees ESOP account while so invested. The companys contributions are invested in Ecolab common stock and amounted to $18.9 million in 2006, $17.4 million in 2005 and $15.8 million in 2004. Effective January 1, 2006, the plan was amended to allow employees to immediately re-allocate company matching contributions in Ecolab common stock to other investment funds within the plan.
16. OPERATING SEGMENTS
The companys thirteen operating segments have been aggregated into three reportable segments.
The United States Cleaning & Sanitizing reportable segment provides cleaning and sanitizing products to United States markets through its Institutional, Food & Beverage, Kay, Textile Care, Healthcare, Vehicle Care and Water Care Services operating segments. The companys Professional Products operating segment has been combined with Institutional to leverage Institutionals sales force, delivering the professional products line to customers in the hospitality, healthcare and commercial markets. These operating segments exhibit similar products, manufacturing processes, customers, distribution methods and economic characteristics.
The United States Other Services reportable segment includes all other U.S. operations of the company. This segment provides pest elimination and kitchen equipment repair and maintenance through its Pest Elimination and GCS Service operating segments. These two operating segments are primarily fee for service businesses. Since the primary focus of these segments is service, they have not been combined with the companys United States Cleaning & Sanitizing reportable segment. These operating segments are combined and disclosed as an all other category in accordance with SFAS 131. Total service revenue for this segment was $334 million, $300 million and $269 million for 2006, 2005 and 2004, respectively.
45
The companys International reportable segment includes four operating segments; Europe/Middle East/Africa (EMEA), Asia Pacific, Latin America and Canada. These segments provide cleaning and sanitizing products as well as pest elimination service. International operations are managed by geographic region and exhibit similar products, manufacturing processes, customers, distribution methods and economic characteristics. Total service revenue for international pest elimination was $169 million, $161 million and $146 million for 2006, 2005 and 2004, respectively.
Information on the types of products and services of each of the companys operating segments is included on the inside front cover under Services/Products Provided of the Ecolab Overview section of this Annual Report.
The company evaluates the performance of its International operations based on fixed management currency exchange rates. All other accounting policies of the reportable segments are consistent with accounting principles generally accepted in the United States of America and the accounting policies of the company described in Note 2 of these notes to consolidated financial statements. The profitability of the companys operating segments is evaluated by management based on operating income.
Financial information for each of the companys reportable segments is as follows:
THOUSANDS |
|
U.S.
|
|
U.S.
|
|
TOTAL
|
|
INTERNATIONAL |
|
FOREIGN
|
|
CORPORATE |
|
CONSOLIDATED |
|
|||||||
NET SALES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2006 |
|
$ |
2,152,330 |
|
$ |
410,480 |
|
$ |
2,562,810 |
|
$ |
2,261,414 |
|
$ |
71,590 |
|
|
|
$ |
4,895,814 |
|
|
2005 |
|
1,952,220 |
|
375,234 |
|
2,327,454 |
|
2,136,664 |
|
70,714 |
|
|
|
4,534,832 |
|
|||||||
2004 |
|
1,796,355 |
|
339,305 |
|
2,135,660 |
|
2,037,907 |
|
11,366 |
|
|
|
4,184,933 |
|
|||||||
OPERATING INCOME (LOSS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2006 |
|
329,155 |
|
38,943 |
|
368,098 |
|
233,587 |
|
9,957 |
|
|
|
611,642 |
|
|||||||
2005 |
|
279,960 |
|
36,012 |
|
315,972 |
|
219,104 |
|
7,344 |
|
|
|
542,420 |
|
|||||||
2004 |
|
266,072 |
|
20,447 |
|
286,519 |
|
209,490 |
|
(1,758 |
) |
$ |
(4,361 |
) |
489,890 |
|
||||||
DEPRECIATION & AMORTIZATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2006 |
|
132,030 |
|
6,416 |
|
138,446 |
|
117,911 |
|
4,522 |
|
7,690 |
|
268,569 |
|
|||||||
2005 |
|
123,644 |
|
5,460 |
|
129,104 |
|
113,564 |
|
7,595 |
|
6,672 |
|
256,935 |
|
|||||||
2004 |
|
119,831 |
|
5,254 |
|
125,085 |
|
112,726 |
|
3,644 |
|
5,499 |
|
246,954 |
|
|||||||
TOTAL ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2006 |
|
1,301,916 |
|
174,970 |
|
1,476,886 |
|
2,237,915 |
|
171,091 |
|
533,473 |
|
4,419,365 |
|
|||||||
2005 |
|
1,348,706 |
|
154,870 |
|
1,503,576 |
|
2,100,205 |
|
(30,983 |
) |
223,830 |
|
3,796,628 |
|
|||||||
CAPITAL EXPENDITURES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
2006 |
|
165,324 |
|
5,855 |
|
171,179 |
|
113,050 |
|
3,656 |
|
|
|
287,885 |
|
|||||||
2005 |
|
149,100 |
|
7,246 |
|
156,346 |
|
108,245 |
|
4,192 |
|
|
|
268,783 |
|
|||||||
2004 |
|
153,503 |
|
4,993 |
|
158,496 |
|
117,698 |
|
(323 |
) |
|
|
275,871 |
|
|||||||
Consistent with the companys internal management reporting, corporate operating income includes special charges included on the consolidated statement of income for 2004. Corporate assets are principally cash and cash equivalents and short-term investments.
The company has two classes of products within its United States Cleaning & Sanitizing and International operations which comprise 10 percent or more of consolidated net sales. Sales of warewashing products were approximately 21 percent, 21 percent and 22 percent of consolidated net sales in 2006, 2005 and 2004, respectively. Sales of laundry products were approximately 10 percent, 11 percent and 10 percent of consolidated net sales in 2006, 2005 and 2004, respectively.
Property, plant and equipment of the companys United States and International
DECEMBER 31 (THOUSANDS) |
|
2006 |
|
2005 |
|
||
United States |
|
$ |
599,153 |
|
$ |
532,430 |
|
International |
|
332,200 |
|
338,117 |
|
||
Effect of foreign currency translation |
|
20,216 |
|
(2,494 |
) |
||
Consolidated |
|
$ |
951,569 |
|
$ |
868,053 |
|
46
17. QUARTERLY FINANCIAL DATA (UNAUDITED)
THOUSANDS, EXCEPT PER SHARE |
|
FIRST
|
|
SECOND
|
|
THIRD
|
|
FOURTH
|
|
YEAR |
|
|||||
2006 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
$ |
513,447 |
|
$ |
544,477 |
|
$ |
561,707 |
|
$ |
532,699 |
|
$ |
2,152,330 |
|
United States Other Services |
|
93,233 |
|
104,902 |
|
108,297 |
|
104,048 |
|
410,480 |
|
|||||
International |
|
510,088 |
|
561,800 |
|
584,273 |
|
605,253 |
|
2,261,414 |
|
|||||
Effect of foreign currency translation |
|
3,307 |
|
14,705 |
|
24,578 |
|
29,000 |
|
71,590 |
|
|||||
Total |
|
1,120,075 |
|
1,225,884 |
|
1,278,855 |
|
1,271,000 |
|
4,895,814 |
|
|||||
Cost of sales |
|
552,491 |
|
608,003 |
|
625,554 |
|
630,010 |
|
2,416,058 |
|
|||||
Selling, general and administrative expenses |
|
436,127 |
|
464,754 |
|
471,937 |
|
495,296 |
|
1,868,114 |
|
|||||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
79,525 |
|
86,118 |
|
98,976 |
|
64,536 |
|
329,155 |
|
|||||
United States Other Services |
|
8,009 |
|
10,625 |
|
12,466 |
|
7,843 |
|
38,943 |
|
|||||
International |
|
43,238 |
|
55,145 |
|
66,221 |
|
68,983 |
|
233,587 |
|
|||||
Effect of foreign currency translation |
|
685 |
|
1,239 |
|
3,701 |
|
4,332 |
|
9,957 |
|
|||||
Total |
|
131,457 |
|
153,127 |
|
181,364 |
|
145,694 |
|
611,642 |
|
|||||
Interest expense, net |
|
10,328 |
|
11,014 |
|
11,219 |
|
11,857 |
|
44,418 |
|
|||||
Income before income taxes |
|
121,129 |
|
142,113 |
|
170,145 |
|
133,837 |
|
567,224 |
|
|||||
Provision for income taxes |
|
43,243 |
|
48,934 |
|
59,786 |
|
46,646 |
|
198,609 |
|
|||||
Net income |
|
$ |
77,886 |
|
$ |
93,179 |
|
$ |
110,359 |
|
$ |
87,191 |
|
$ |
368,615 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income per common share |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
0.31 |
|
$ |
0.37 |
|
$ |
0.44 |
|
$ |
0.35 |
|
$ |
1.46 |
|
Diluted |
|
$ |
0.30 |
|
$ |
0.36 |
|
$ |
0.43 |
|
$ |
0.34 |
|
$ |
1.43 |
|
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
253,540 |
|
252,152 |
|
251,573 |
|
251,263 |
|
252,132 |
|
|||||
Diluted |
|
258,055 |
|
256,692 |
|
256,657 |
|
256,639 |
|
257,144 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
2005 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
$ |
467,179 |
|
$ |
496,808 |
|
$ |
510,476 |
|
$ |
477,757 |
|
$ |
1,952,220 |
|
United States Other Services |
|
85,810 |
|
96,328 |
|
98,315 |
|
94,781 |
|
375,234 |
|
|||||
International |
|
483,997 |
|
536,454 |
|
550,197 |
|
566,016 |
|
2,136,664 |
|
|||||
Effect of foreign currency translation |
|
32,894 |
|
29,074 |
|
5,785 |
|
2,961 |
|
70,714 |
|
|||||
Total |
|
1,069,880 |
|
1,158,664 |
|
1,164,773 |
|
1,141,515 |
|
4,534,832 |
|
|||||
Cost of sales |
|
526,975 |
|
571,066 |
|
572,862 |
|
577,928 |
|
2,248,831 |
|
|||||
Selling, general and administrative expenses |
|
424,918 |
|
449,346 |
|
429,464 |
|
439,853 |
|
1,743,581 |
|
|||||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|||||
United States Cleaning & Sanitizing |
|
71,605 |
|
72,660 |
|
85,933 |
|
49,762 |
|
279,960 |
|
|||||
United States Other Services |
|
7,534 |
|
10,287 |
|
11,124 |
|
7,067 |
|
36,012 |
|
|||||
International |
|
36,503 |
|
52,431 |
|
64,212 |
|
65,958 |
|
219,104 |
|
|||||
Effect of foreign currency translation |
|
2,345 |
|
2,874 |
|
1,178 |
|
947 |
|
7,344 |
|
|||||
Total |
|
117,987 |
|
138,252 |
|
162,447 |
|
123,734 |
|
542,420 |
|
|||||
Interest expense, net |
|
11,190 |
|
12,184 |
|
11,529 |
|
9,335 |
|
44,238 |
|
|||||
Income before income taxes |
|
106,797 |
|
126,068 |
|
150,918 |
|
114,399 |
|
498,182 |
|
|||||
Provision for income taxes |
|
37,371 |
|
44,667 |
|
52,960 |
|
43,703 |
|
178,701 |
|
|||||
Net income |
|
$ |
69,426 |
|
$ |
81,401 |
|
$ |
97,958 |
|
$ |
70,696 |
|
$ |
319,481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income per common share |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
$ |
0.27 |
|
$ |
0.32 |
|
$ |
0.38 |
|
$ |
0.28 |
|
$ |
1.25 |
|
Diluted |
|
$ |
0.27 |
|
$ |
0.31 |
|
$ |
0.38 |
|
$ |
0.27 |
|
$ |
1.23 |
|
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic |
|
256,272 |
|
255,474 |
|
255,817 |
|
255,402 |
|
255,741 |
|
|||||
Diluted |
|
260,626 |
|
259,594 |
|
259,911 |
|
259,723 |
|
260,098 |
|
Per share amounts do not necessarily sum due to changes in the calculation of shares outstanding for each discrete period and rounding.
47
REPORTS OF MANAGEMENT
To our Shareholders:
MANAGEMENTS RESPONSIBILITY FOR FINANCIAL STATEMENTS
Management is responsible for the integrity and objectivity of the consolidated financial statements. The statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, include certain amounts based on managements best estimates and judgments.
The Board of Directors, acting through its Audit Committee composed solely of independent directors, is responsible for determining that management fulfills its responsibilities in the preparation of financial statements and maintains financial control of operations. The Audit Committee recommends to the Board of Directors the appointment of the companys independent registered public accounting firm, subject to ratification by the shareholders. It meets regularly with management, the internal auditors and the independent auditors.
The independent registered public accounting firm has audited the consolidated financial statements included in this annual report and have expressed their opinion regarding whether these consolidated financial statements present fairly in all material respects our financial position and results of operation and cash flows as stated in their report presented separately herein.
MANAGEMENTS REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the principal executive officer and principal financial officer, an evaluation of the design and operating effectiveness of internal control over financial reporting was conducted based on the framework in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the evaluation under the framework in Internal Control Integrated Framework, management concluded that internal control over financial reporting was effective as of December 31, 2006.
Managements assessment of the effectiveness of the companys internal control over financial reporting as of December 31, 2006 has been audited by PricwaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included herein.
/s/ Douglas M. Baker, Jr. |
|
Douglas M. Baker, Jr. |
|
Chairman of the Board, President and Chief Executive Officer |
/s/ Steven L. Fritze |
|
Steven L. Fritze |
|
Executive Vice President and Chief Financial Officer |
48
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Directors of Ecolab Inc.:
We have completed integrated audits of Ecolab Inc.s consolidated financial statements and of its internal control over financial reporting as of December 31, 2006, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Our opinions, based on our audits, are presented below.
CONSOLIDATED FINANCIAL STATEMENTS
In our opinion, the accompanying consolidated balance sheet and the related consolidated statements of income, of cash flows, of comprehensive income and shareholders equity present fairly, in all material respects, the financial position of Ecolab Inc. and its subsidiaries at December 31, 2006 and 2005, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2006 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of Ecolab Inc.s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit of financial statements includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.
As discussed in Note 2 to the consolidated financial statements, Ecolab Inc. changed the manner in which it accounts for defined benefit pension and other postretirement plans effective December 31, 2006.
INTERNAL CONTROL OVER FINANCIAL REPORTING
Also, in our opinion, managements assessment, included in the accompanying Managements Report on Internal Control Over Financial Reporting, that Ecolab Inc. maintained effective internal control over financial reporting as of December 31, 2006 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), is fairly stated, in all material respects, based on those criteria. Furthermore, in our opinion, Ecolab Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2006, based on criteria established in Internal Control - Integrated Framework issued by the COSO. Ecolab Inc.s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express opinions on managements assessment and on the effectiveness of Ecolab Inc.s internal control over financial reporting based on our audit. We conducted our audit of internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. An audit of internal control over financial reporting includes obtaining an understanding of internal control over financial reporting, evaluating managements assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we consider necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.
A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the companys assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Minneapolis, Minnesota
February 23, 2007
49
SUMMARY OPERATING AND FINANCIAL DATA
DECEMBER 31 (THOUSANDS, EXCEPT PER SHARE) |
|
2006 |
|
2005 |
|
2004 |
|
2003 |
|
||||
OPERATIONS |
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
|
|
|
|
|
|
|
|
||||
United States |
|
$ |
2,562,810 |
|
$ |
2,327,454 |
|
$ |
2,135,660 |
|
$ |
2,014,767 |
|
International (at average rates of currency exchange during the year) |
|
2,333,004 |
|
2,207,378 |
|
2,049,273 |
|
1,747,052 |
|
||||
Total |
|
4,895,814 |
|
4,534,832 |
|
4,184,933 |
|
3,761,819 |
|
||||
Cost of sales (including special charges (income) of $(106) in 2004, $(76) in 2003 and $8,977 in 2002, $(566) in 2001 and $1,948 in 2000) |
|
2,416,058 |
|
2,248,831 |
|
2,033,492 |
|
1,846,584 |
|
||||
Selling, general and administrative expenses |
|
1,868,114 |
|
1,743,581 |
|
1,657,084 |
|
1,459,818 |
|
||||
Special charges, sale of business and merger expenses |
|
|
|
|
|
4,467 |
|
408 |
|
||||
Operating income |
|
611,642 |
|
542,420 |
|
489,890 |
|
455,009 |
|
||||
Gain on sale of equity investment |
|
|
|
|
|
|
|
11,105 |
|
||||
Interest expense, net |
|
44,418 |
|
44,238 |
|
45,344 |
|
45,345 |
|
||||
Income from continuing operations before income taxes, equity earnings and changes in accounting principle |
|
567,224 |
|
498,182 |
|
444,546 |
|
420,769 |
|
||||
Provision for income taxes |
|
198,609 |
|
178,701 |
|
161,853 |
|
160,179 |
|
||||
Equity in earnings of Henkel-Ecolab |
|
|
|
|
|
|
|
|
|
||||
Income from continuing operations |
|
368,615 |
|
319,481 |
|
282,693 |
|
260,590 |
|
||||
Gain from discontinued operations |
|
|
|
|
|
|
|
|
|
||||
Changes in accounting principle |
|
|
|
|
|
|
|
|
|
||||
Net income, as reported |
|
368,615 |
|
319,481 |
|
282,693 |
|
260,590 |
|
||||
Adjustments |
|
|
|
|
|
|
|
|
|
||||
Adjusted net income |
|
$ |
368,615 |
|
$ |
319,481 |
|
$ |
282,693 |
|
$ |
260,590 |
|
Income per common share, as reported |
|
|
|
|
|
|
|
|
|
||||
Basic - continuing operations |
|
$ |
1.46 |
|
$ |
1.25 |
|
$ |
1.10 |
|
$ |
1.00 |
|
Basic - net income |
|
1.46 |
|
1.25 |
|
1.10 |
|
1.00 |
|
||||
Diluted - continuing operations |
|
1.43 |
|
1.23 |
|
1.09 |
|
0.99 |
|
||||
Diluted - net income |
|
1.43 |
|
1.23 |
|
1.09 |
|
0.99 |
|
||||
Adjusted income per common share |
|
|
|
|
|
|
|
|
|
||||
Basic - continuing operations |
|
1.46 |
|
1.25 |
|
1.10 |
|
1.00 |
|
||||
Basic - net income |
|
1.46 |
|
1.25 |
|
1.10 |
|
1.00 |
|
||||
Diluted - continuing operations |
|
1.43 |
|
1.23 |
|
1.09 |
|
0.99 |
|
||||
Diluted - net income |
|
$ |
1.43 |
|
$ |
1.23 |
|
$ |
1.09 |
|
$ |
0.99 |
|
Weighted-average common shares outstanding basic |
|
252,132 |
|
255,741 |
|
257,575 |
|
259,454 |
|
||||
Weighted-average common shares outstanding diluted |
|
257,144 |
|
260,098 |
|
260,407 |
|
262,737 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
SELECTED INCOME STATEMENT RATIOS |
|
|
|
|
|
|
|
|
|
||||
Gross profit |
|
50.7 |
% |
50.4 |
% |
51.4 |
% |
50.9 |
% |
||||
Selling, general and administrative expenses |
|
38.2 |
|
38.4 |
|
39.6 |
|
38.8 |
|
||||
Operating income |
|
12.5 |
|
12.0 |
|
11.7 |
|
12.1 |
|
||||
Income from continuing operations before income taxes |
|
11.6 |
|
11.0 |
|
10.6 |
|
11.2 |
|
||||
Income from continuing operations |
|
7.5 |
|
7.0 |
|
6.8 |
|
6.9 |
|
||||
Effective income tax rate |
|
35.0 |
% |
35.9 |
% |
36.4 |
% |
38.1 |
% |
||||
|
|
|
|
|
|
|
|
|
|
||||
FINANCIAL POSITION |
|
|
|
|
|
|
|
|
|
||||
Current assets |
|
$ |
1,853,557 |
|
$ |
1,421,666 |
|
$ |
1,279,066 |
|
$ |
1,150,340 |
|
Property, plant and equipment, net |
|
951,569 |
|
868,053 |
|
866,982 |
|
769,112 |
|
||||
Investment in Henkel-Ecolab |
|
|
|
|
|
|
|
|
|
||||
Goodwill, intangible and other assets |
|
1,614,239 |
|
1,506,909 |
|
1,570,126 |
|
1,309,466 |
|
||||
Total assets |
|
$ |
4,419,365 |
|
$ |
3,796,628 |
|
$ |
3,716,174 |
|
$ |
3,228,918 |
|
Current liabilities |
|
$ |
1,502,730 |
|
$ |
1,119,357 |
|
$ |
939,547 |
|
$ |
851,942 |
|
Long-term debt |
|
557,058 |
|
519,374 |
|
645,445 |
|
604,441 |
|
||||
Postretirement health care and pension benefits |
|
420,245 |
|
302,048 |
|
270,930 |
|
249,906 |
|
||||
Other liabilities |
|
259,102 |
|
206,639 |
|
262,111 |
|
201,548 |
|
||||
Shareholders equity |
|
1,680,230 |
|
1,649,210 |
|
1,598,141 |
|
1,321,081 |
|
||||
Total liabilities and shareholders equity |
|
$ |
4,419,365 |
|
$ |
3,796,628 |
|
$ |
3,716,174 |
|
$ |
3,228,918 |
|
|
|
|
|
|
|
|
|
|
|
||||
SELECTED CASH FLOW INFORMATION |
|
|
|
|
|
|
|
|
|
||||
Cash provided by operating activities |
|
$ |
627,564 |
|
$ |
590,136 |
|
$ |
570,908 |
|
$ |
523,932 |
|
Depreciation and amortization |
|
268,569 |
|
256,935 |
|
246,954 |
|
228,103 |
|
||||
Capital expenditures |
|
287,885 |
|
268,783 |
|
275,871 |
|
212,035 |
|
||||
Cash dividends declared per common share |
|
$ |
0.4150 |
|
$ |
0.3625 |
|
$ |
0.3275 |
|
$ |
0.2975 |
|
|
|
|
|
|
|
|
|
|
|
||||
SELECTED FINANCIAL MEASURES/OTHER |
|
|
|
|
|
|
|
|
|
||||
Total debt |
|
$ |
1,066,036 |
|
$ |
746,301 |
|
$ |
701,577 |
|
$ |
674,644 |
|
Total debt to capitalization |
|
38.8 |
% |
31.2 |
% |
30.5 |
% |
33.8 |
% |
||||
Book value per common share |
|
$ |
6.69 |
|
$ |
6.49 |
|
$ |
6.21 |
|
$ |
5.13 |
|
Return on beginning equity |
|
22.4 |
% |
20.0 |
% |
21.4 |
% |
23.3 |
% |
||||
Dividends per share/diluted net income per common share |
|
29.0 |
% |
29.5 |
% |
30.0 |
% |
30.1 |
% |
||||
Net interest coverage |
|
13.8 |
|
12.3 |
|
10.8 |
|
10.0 |
|
||||
Year end market capitalization |
|
$ |
11,360,426 |
|
$ |
9,217,763 |
|
$ |
9,047,445 |
|
$ |
7,045,490 |
|
Annual common stock price range |
|
$ |
46.40-33.64 |
|
$ |
37.15-30.68 |
|
$ |
35.59-26.12 |
|
$ |
27.92-23.08 |
|
Number of employees |
|
23,130 |
|
22,404 |
|
21,338 |
|
20,826 |
|
Property, plant and equipment amounts have been restated to include capital software which was previously classified in other assets. Results for 2004 through 1996 have been restated to reflect the effect of retroactive application of SFAS No. 123R, Share-Based Payment. The former Henkel-Ecolab joint venture is included as a consolidated subsidiary effective November 30, 2001. Adjusted results for 1996 through 2001 reflect the pro forma effect of the discontinuance of the amortization of goodwill as if SFAS No. 142 had been in effect since January 1, 1996. All per share, shares outstanding and market price data reflect the two-for-one stock splits declared in 2003 and 1997. Return on beginning equity is net income divided by beginning shareholders equity.
50
2002 |
|
2001 |
|
2000 |
|
1999 |
|
1998 |
|
1997 |
|
1996 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
$ 1,923,500 |
|
$ |
1,821,902 |
|
$ |
1,746,698 |
|
$ |
1,605,385 |
|
$ |
1,429,711 |
|
$ |
1,251,517 |
|
$ |
1,127,281 |
|
1,480,085 |
|
498,808 |
|
483,963 |
|
444,413 |
|
431,366 |
|
364,524 |
|
341,231 |
|
||||||
3,403,585 |
|
2,320,710 |
|
2,230,661 |
|
2,049,798 |
|
1,861,077 |
|
1,616,041 |
|
1,468,512 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
1,688,710 |
|
1,121,133 |
|
1,056,899 |
|
963,900 |
|
875,102 |
|
745,437 |
|
694,909 |
|
||||||
1,304,239 |
|
898,159 |
|
864,072 |
|
804,436 |
|
730,170 |
|
655,726 |
|
590,641 |
|
||||||
37,031 |
|
824 |
|
(20,736 |
) |
|
|
|
|
|
|
|
|
||||||
373,605 |
|
300,594 |
|
330,426 |
|
281,462 |
|
255,805 |
|
214,878 |
|
182,962 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
43,895 |
|
28,434 |
|
24,605 |
|
22,713 |
|
21,742 |
|
12,637 |
|
14,372 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
329,710 |
|
272,160 |
|
305,821 |
|
258,749 |
|
234,063 |
|
202,241 |
|
168,590 |
|
||||||
131,277 |
|
110,453 |
|
124,467 |
|
106,412 |
|
99,340 |
|
83,911 |
|
69,840 |
|
||||||
|
|
15,833 |
|
19,516 |
|
18,317 |
|
16,050 |
|
13,433 |
|
13,011 |
|
||||||
198,433 |
|
177,540 |
|
200,870 |
|
170,654 |
|
150,773 |
|
131,763 |
|
111,761 |
|
||||||
1,882 |
|
|
|
|
|
|
|
38,000 |
|
|
|
|
|
||||||
(4,002 |
) |
|
|
(2,428 |
) |
|
|
|
|
|
|
|
|
||||||
196,313 |
|
177,540 |
|
198,442 |
|
170,654 |
|
188,773 |
|
131,763 |
|
111,761 |
|
||||||
|
|
18,471 |
|
17,762 |
|
16,631 |
|
14,934 |
|
11,195 |
|
10,683 |
|
||||||
$ 196,313 |
|
$ |
196,011 |
|
$ |
216,204 |
|
$ |
187,285 |
|
$ |
203,707 |
|
$ |
142,958 |
|
$ |
122,444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
$ 0.77 |
|
$ |
0.70 |
|
$ |
0.79 |
|
$ |
0.66 |
|
$ |
0.58 |
|
$ |
0.51 |
|
$ |
0.43 |
|
0.76 |
|
0.70 |
|
0.78 |
|
0.66 |
|
0.73 |
|
0.51 |
|
0.43 |
|
||||||
0.76 |
|
0.68 |
|
0.76 |
|
0.63 |
|
0.56 |
|
0.49 |
|
0.42 |
|
||||||
0.75 |
|
0.68 |
|
0.75 |
|
0.63 |
|
0.70 |
|
0.49 |
|
0.42 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
0.77 |
|
0.77 |
|
0.86 |
|
0.72 |
|
0.64 |
|
0.55 |
|
0.47 |
|
||||||
0.76 |
|
0.77 |
|
0.85 |
|
0.72 |
|
0.79 |
|
0.55 |
|
0.47 |
|
||||||
0.76 |
|
0.75 |
|
0.83 |
|
0.70 |
|
0.62 |
|
0.53 |
|
0.46 |
|
||||||
$ 0.75 |
|
$ |
0.75 |
|
$ |
0.82 |
|
$ |
0.70 |
|
$ |
0.76 |
|
$ |
0.53 |
|
$ |
0.46 |
|
258,147 |
|
254,832 |
|
255,505 |
|
259,099 |
|
258,314 |
|
258,891 |
|
257,983 |
|
||||||
261,574 |
|
259,855 |
|
263,892 |
|
268,837 |
|
268,095 |
|
267,643 |
|
265,634 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
50.4% |
|
51.7 |
% |
52.6 |
% |
53.0 |
% |
53.0 |
% |
53.9 |
% |
52.7 |
% |
||||||
38.3 |
|
38.7 |
|
38.7 |
|
39.2 |
|
39.2 |
|
40.6 |
|
40.2 |
|
||||||
11.0 |
|
13.0 |
|
14.8 |
|
13.7 |
|
13.7 |
|
13.3 |
|
12.5 |
|
||||||
9.7 |
|
11.7 |
|
13.7 |
|
12.6 |
|
12.6 |
|
12.5 |
|
11.5 |
|
||||||
5.8 |
|
7.7 |
|
9.0 |
|
8.3 |
|
8.1 |
|
8.2 |
|
7.6 |
|
||||||
39.8% |
|
40.6 |
% |
40.7 |
% |
41.1 |
% |
42.4 |
% |
41.5 |
% |
41.4 |
% |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
$ 1,015,937 |
|
$ |
929,583 |
|
$ |
600,568 |
|
$ |
577,321 |
|
$ |
503,514 |
|
$ |
509,501 |
|
$ |
435,507 |
|
716,095 |
|
668,413 |
|
512,581 |
|
454,376 |
|
423,941 |
|
400,537 |
|
336,314 |
|
||||||
|
|
|
|
199,642 |
|
219,003 |
|
253,646 |
|
239,879 |
|
285,237 |
|
||||||
1,133,875 |
|
943,400 |
|
411,871 |
|
341,966 |
|
293,528 |
|
267,731 |
|
151,403 |
|
||||||
$ 2,865,907 |
|
$ |
2,541,396 |
|
$ |
1,724,662 |
|
$ |
1,592,666 |
|
$ |
1,474,629 |
|
$ |
1,417,648 |
|
$ |
1,208,461 |
|
$ 853,828 |
|
$ |
827,952 |
|
$ |
532,034 |
|
$ |
470,674 |
|
$ |
399,791 |
|
$ |
404,464 |
|
$ |
327,771 |
|
539,743 |
|
512,280 |
|
234,377 |
|
169,014 |
|
227,041 |
|
259,384 |
|
148,683 |
|
||||||
207,596 |
|
183,281 |
|
117,790 |
|
97,527 |
|
85,793 |
|
76,109 |
|
73,577 |
|
||||||
144,993 |
|
121,135 |
|
72,803 |
|
86,715 |
|
67,829 |
|
124,641 |
|
138,415 |
|
||||||
1,119,747 |
|
896,748 |
|
767,658 |
|
768,736 |
|
694,175 |
|
553,050 |
|
520,015 |
|
||||||
$ 2,865,907 |
|
$ |
2,541,396 |
|
$ |
1,724,662 |
|
$ |
1,592,666 |
|
$ |
1,474,629 |
|
$ |
1,417,648 |
|
$ |
1,208,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
$ 412,697 |
|
$ |
358,508 |
|
$ |
309,813 |
|
$ |
290,098 |
|
$ |
233,727 |
|
$ |
234,126 |
|
$ |
253,819 |
|
220,635 |
|
158,785 |
|
143,212 |
|
129,240 |
|
117,646 |
|
97,449 |
|
86,791 |
|
||||||
212,757 |
|
157,937 |
|
150,009 |
|
145,622 |
|
147,631 |
|
121,667 |
|
111,518 |
|
||||||
$ 0.2750 |
|
$ |
0.2625 |
|
$ |
0.2450 |
|
$ |
0.2175 |
|
$ |
0.1950 |
|
$ |
0.1675 |
|
$ |
0.1450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
$ 699,842 |
|
$ |
745,673 |
|
$ |
370,969 |
|
$ |
281,074 |
|
$ |
295,032 |
|
$ |
308,268 |
|
$ |
176,292 |
|
38.5% |
|
45.4 |
% |
32.6 |
% |
26.8 |
% |
29.8 |
% |
35.8 |
% |
25.3 |
% |
||||||
$ 4.31 |
|
$ |
3.51 |
|
$ |
3.02 |
|
$ |
2.97 |
|
$ |
2.68 |
|
$ |
2.14 |
|
$ |
2.01 |
|
21.9% |
|
23.1 |
% |
25.8 |
% |
24.6 |
% |
34.1 |
% |
25.3 |
% |
24.5 |
% |
||||||
36.7% |
|
38.6 |
% |
32.7 |
% |
34.5 |
% |
27.9 |
% |
34.2 |
% |
34.5 |
% |
||||||
8.5 |
|
10.6 |
|
13.4 |
|
12.4 |
|
11.8 |
|
17.0 |
|
12.7 |
|
||||||
$ 6,432,035 |
|
$ |
5,147,980 |
|
$ |
5,492,072 |
|
$ |
5,063,409 |
|
$ |
4,685,512 |
|
$ |
3,579,240 |
|
$ |
2,450,258 |
|
$ 25.20-18.27 |
|
$ |
22.10-14.25 |
|
$ |
22.85-14.00 |
|
$ |
22.22-15.85 |
|
$ |
19.00-13.07 |
|
$ |
14.00-9.07 |
|
$ |
9.88-7.28 |
|
20,417 |
|
19,326 |
|
14,250 |
|
12,870 |
|
12,007 |
|
10,210 |
|
9,573 |
|
51
EXHIBIT (21)
Registrant
ECOLAB INC.
Name of Affiliate |
|
State or Other
|
|
Percentage
|
|
|
|
|
|
Ecolab (Antigua) Ltd. |
|
Antigua |
|
100 |
|
|
|
|
|
Ecolab S.A. |
|
Argentina |
|
100 |
|
|
|
|
|
Ecolab Australia Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
Ecolab Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
Ecolab Water Care Services Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
Gibson Chemical Industries Pty Ltd. |
|
Australia |
|
100 |
|
|
|
|
|
Gibson Chemicals (NSW) Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
Gibson Chemicals Fiji Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
Gibson Chemicals Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
Robust Chemicals Pty Limited |
|
Australia |
|
100 |
|
|
|
|
|
Vessey Chemicals (Holdings) Pty Limited |
|
Australia |
|
95 |
|
|
|
|
|
Vessey Chemicals Pty Limited |
|
Australia |
|
95 |
|
|
|
|
|
Vessey Chemicals (Vic.) Pty Limited |
|
Australia |
|
95 |
|
|
|
|
|
Vessey Chemicals (WA) Pty Limited |
|
Australia |
|
95 |
|
|
|
|
|
Ecolab Ges.m.b.H |
|
Austria |
|
100 |
|
|
|
|
|
Ecolab Holding Europe GmbH |
|
Austria |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
Bahamas |
|
100 |
|
|
|
|
|
Ecolab (Barbados) Limited |
|
Barbados |
|
100 |
|
|
|
|
|
Ecolab B.V.B.A./S.P.R.L. |
|
Belgium |
|
100 |
|
|
|
|
|
Kay N.V. |
|
Belgium |
|
100 |
|
|
|
|
|
Ecolab Emprecendimentos E Participacoes Ltda. |
|
Brazil |
|
100 |
|
|
|
|
|
Ecolab Quimica Ltda. |
|
Brazil |
|
100 |
|
|
|
|
|
Ecolab EOOD |
|
Bulgaria |
|
100 |
|
|
|
|
|
Ecolab Co. |
|
Canada |
|
100 |
|
|
|
|
|
Ecolab S.A. |
|
Chile |
|
100 |
|
|
|
|
|
Ecolab Colombia S.A. |
|
Colombia |
|
100 |
|
|
|
|
|
Ecolab, Sociedad Anonima |
|
Costa Rica |
|
100 |
|
|
|
|
|
Ecolab d.o.o. |
|
Croatia |
|
100 |
|
|
|
|
|
Ecolab Holding (Cyprus) Limited |
|
Cyprus |
|
100 |
|
|
|
|
|
Ecolab Hygiene s.r.o. |
|
Czech Republic |
|
100 |
|
|
|
|
|
Ecolab ApS |
|
Denmark |
|
100 |
|
|
|
|
|
Ecolab Holding Denmark ApS |
|
Denmark |
|
100 |
|
|
|
|
|
Ecolab, S.A. de C.V. |
|
El Salvador |
|
100 |
|
|
|
|
|
Oy Ecolab AB |
|
Finland |
|
100 |
|
|
|
|
|
Ecolab Pest IDF SAS |
|
France |
|
100 |
|
|
|
|
|
Artois Chimie SAS |
|
France |
|
100 |
|
|
|
|
|
Alpha Holding SAS |
|
France |
|
100 |
|
|
|
|
|
Amboile Services SAS |
|
France |
|
100 |
|
|
|
|
|
Amperia SARL |
|
France |
|
100 |
|
|
|
|
|
Biophyte SARL |
|
France |
|
100 |
|
|
|
|
|
Centre Régional de Désinfectisation et de Dératisation SAS |
|
France |
|
100 |
|
|
|
|
|
Ecolab SAS |
|
France |
|
100 |
|
|
|
|
|
Ecolab SNC |
|
France |
|
100 |
|
|
|
|
|
Hygiene Champenoise SAS |
|
France |
|
100 |
|
|
|
|
|
Hygiene de LEst SAS |
|
France |
|
100 |
|
|
|
|
|
Lorillou Hygiene SAS |
|
France |
|
100 |
Multiser SA |
|
France |
|
100 |
|
|
|
|
|
Nigiko SAS |
|
France |
|
100 |
|
|
|
|
|
Omniser SARL |
|
France |
|
100 |
|
|
|
|
|
SCI Aphomia |
|
France |
|
100 |
|
|
|
|
|
SCI Dugard |
|
France |
|
100 |
|
|
|
|
|
SCI Dumoulin |
|
France |
|
100 |
|
|
|
|
|
SCI Eliomys |
|
France |
|
100 |
|
|
|
|
|
SCI Erebia |
|
France |
|
100 |
|
|
|
|
|
SCI Louvette |
|
France |
|
100 |
|
|
|
|
|
SCI Marco |
|
France |
|
100 |
|
|
|
|
|
SCI Orly |
|
France |
|
100 |
|
|
|
|
|
Shield Medicare sarl |
|
France |
|
100 |
|
|
|
|
|
Bionagro Natureprodukte GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Beteiligungs GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Deutschland GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Export GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Holding GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab GmbH & Co. OHG |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Management GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab NFK Beteilgungen Management GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab NFK R&D GmbH & Co. OHG |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab NFK R&D Verwaltungs GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab Technologies GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Lang Apparatebau GmbH |
|
Germany |
|
100 |
Lang Engineering GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Lang Hygiene Systeme GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Shield Medicare GmbH |
|
Germany |
|
100 |
|
|
|
|
|
Ecolab A.E.B.E. |
|
Greece |
|
100 |
|
|
|
|
|
Ecolab (Guam) LLC |
|
Guam |
|
100 |
|
|
|
|
|
Ecolab, Sociedad Anonima |
|
Guatemala |
|
100 |
|
|
|
|
|
Peter Cox Insurance Co. Limited |
|
Guernsey |
|
100 |
|
|
|
|
|
Quimicas Ecolab, S.A. |
|
Honduras |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
Hong Kong |
|
100 |
|
|
|
|
|
Ecolab Holding Hungary Ltd. |
|
Hungary |
|
100 |
|
|
|
|
|
Ecolab Hygiene Kft. |
|
Hungary |
|
100 |
|
|
|
|
|
P.T. Ecolab Indonesia |
|
Indonesia |
|
100 |
|
|
|
|
|
Eclab Export Limited |
|
Ireland |
|
100 |
|
|
|
|
|
Ecolab Co. |
|
Ireland |
|
100 |
|
|
|
|
|
Ecolab Finance Company Limited |
|
Ireland |
|
100 |
|
|
|
|
|
Ecolab (Holdings) Limited |
|
Ireland |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
Ireland |
|
100 |
|
|
|
|
|
Ecolab JVZ Limited |
|
Israel |
|
100 |
|
|
|
|
|
Ecolab-Zohar Dalia L.P. |
|
Israel |
|
51 |
|
|
|
|
|
Ecolab-Zohar Dalia Management Company Ltd. |
|
Israel |
|
51 |
|
|
|
|
|
Ecolab Holding Italy Srl |
|
Italy |
|
100 |
|
|
|
|
|
Ecolab Srl |
|
Italy |
|
100 |
|
|
|
|
|
Elton Chemical Srl |
|
Italy |
|
100 |
|
|
|
|
|
Findesadue Srl |
|
Italy |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
Jamaica |
|
100 |
|
|
|
|
|
Ecolab K.K. |
|
Japan |
|
100 |
Ecolab East Africa (Kenya) Limited |
|
Kenya |
|
100 |
|
|
|
|
|
Ecolab Korea Ltd. |
|
Korea |
|
100 |
|
|
|
|
|
Ecolab SIA |
|
Latvia |
|
100 |
|
|
|
|
|
Ecolab-Importacao E Exportacao Limitada |
|
Macau |
|
100 |
|
|
|
|
|
Ecolab Sdn Bhd |
|
Malaysia |
|
100 |
|
|
|
|
|
Ecolab, S. de R.L. de C.V. |
|
Mexico |
|
100 |
|
|
|
|
|
Ecolab Holdings Mexico, S.A. de C.V. |
|
Mexico |
|
100 |
|
|
|
|
|
Ecolab Maroc S. A. |
|
Morocco |
|
100 |
|
|
|
|
|
Ecolab (Proprietary) Limited |
|
Namibia |
|
100 |
|
|
|
|
|
Ecolab Finance N.V. |
|
Netherlands Antilles (Curacao) |
|
100 |
|
|
|
|
|
Ecolabone B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
Ecolabtwo B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
Ecolab Holdings B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
Ecolab B.V. |
|
Netherlands |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
New Zealand |
|
100 |
|
|
|
|
|
Ecolab Nicaragua, S.A. |
|
Nicaragua |
|
100 |
|
|
|
|
|
Ecolab A/S |
|
Norway |
|
100 |
|
|
|
|
|
Ecolab S.A. |
|
Panama |
|
100 |
|
|
|
|
|
Ecolab Chemicals Ltd. |
|
Peoples Republic of China |
|
100 |
|
|
|
|
|
Ecolab China Ltd. |
|
Peoples Republic of China |
|
100 |
|
|
|
|
|
Ecolab (GZ) Chemicals Limited |
|
Peoples Republic of China |
|
100 |
|
|
|
|
|
Ecolab Perú Holdings S.R.L. |
|
Peru |
|
100 |
|
|
|
|
|
Ecolab Philippines Inc. |
|
Philippines |
|
100 |
|
|
|
|
|
Ecolab Sp.z o.o. |
|
Poland |
|
100 |
Ecolab S.R.L. |
|
Romania |
|
100 |
|
|
|
|
|
ZAO Ecolab |
|
Russia |
|
100 |
|
|
|
|
|
Ecolab Hygiene d.o.o. |
|
Serbia |
|
100 |
|
|
|
|
|
Ecolab Pte. Ltd. |
|
Singapore |
|
100 |
|
|
|
|
|
Ecolab s.r.o. |
|
Slovakia |
|
100 |
|
|
|
|
|
Ecolab d.o.o. |
|
Slovenia |
|
100 |
|
|
|
|
|
Ecolab (Proprietary) Ltd. |
|
South Africa |
|
100 |
|
|
|
|
|
Ecolab Hispano-Portuguesa, S.A. |
|
Spain |
|
100 |
|
|
|
|
|
Ecolab (St. Lucia) Limited |
|
St. Lucia |
|
100 |
|
|
|
|
|
Ecolab AB |
|
Sweden |
|
100 |
|
|
|
|
|
Ecolab GmbH |
|
Switzerland |
|
100 |
|
|
|
|
|
Ecolab Ltd. |
|
Taiwan |
|
100 |
|
|
|
|
|
Ecolab East Africa (Tanzania) Limited |
|
Tanzania |
|
100 |
|
|
|
|
|
Ecolab Ltd. |
|
Thailand |
|
100 |
|
|
|
|
|
Ecolab Temizleme Sistemleri Limited Sirketi |
|
Turkey |
|
100 |
|
|
|
|
|
Ecolab East Africa (Uganda) Limited |
|
Uganda |
|
100 |
|
|
|
|
|
Ecolab LLC |
|
Ukraine |
|
100 |
|
|
|
|
|
Ecolab Gulf FZE |
|
UAE |
|
100 |
|
|
|
|
|
Ecolab Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Ecolab (U.K.) Holdings Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Peter Cox Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Shield Holdings Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Shield Medicare Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Shield Salvage Associates Limited |
|
United Kingdom |
|
100 |
Sterishield Systems Limited |
|
United Kingdom |
|
100 |
|
|
|
|
|
Ecolab S. A. |
|
Uruguay |
|
100 |
|
|
|
|
|
Ecolab Foreign Sales Corp. |
|
U.S. Virgin Islands |
|
100 |
|
|
|
|
|
Ecolab S.A. |
|
Venezuela |
|
74 |
|
|
|
|
|
United States |
|
|
|
|
|
|
|
|
|
Daydots Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabone LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabtwo LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabthree LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabfour LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabfive LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabsix LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolabseven LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab AP Holdings LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Finance Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Holdings Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Holdings (Europe) Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Investment Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Israel Holdings LLC |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Manufacturing Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
Ecolab Marketing LLC |
|
Delaware |
|
100 |
|
|
|
|
|
GCS Service, Inc. |
|
Delaware |
|
100 |
|
|
|
|
|
ETAC Inc. |
|
Minnesota |
|
100 |
|
|
|
|
|
Kay Chemical Company |
|
North Carolina |
|
100 |
Kay Chemical International, Inc. |
|
North Carolina |
|
100 |
|
|
|
|
|
Wabasha Leasing LLC |
|
Delaware |
|
100 |
Certain additional subsidiaries, which are not significant in the aggregate, are not shown.
Exhibit (24)
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS , That the undersigned, a director of Ecolab Inc., a Delaware corporation, does hereby make, nominate and appoint LAWRENCE T. BELL and SARAH Z. ERICKSON, and each of them, to be my attorney-in-fact, with full power and authority to sign his or her name to the Annual Report on Form 10-K of Ecolab Inc. for the fiscal year ended December 31, 2006, and all amendments thereto, provided that the Annual Report and any amendments thereto, in final form, be approved by said attorney-in-fact; and his or her name, when thus signed, shall have the same force and effect as though I had manually signed said document.
IN WITNESS WHEREOF , I have hereunto affixed my signature this 23 rd day of February, 2007.
|
|
/s/Les S. Biller |
|
|
|
|
Les S. Biller |
|
|
|
|
/s/Richard U. De Schutter |
|
|
|
|
Richard U. De Schutter |
|
|
|
|
/s/Jerry A. Grundhofer |
|
|
|
|
Jerry A. Grundhofer |
|
|
|
|
/s/Stefan Hamelmann |
|
|
|
|
Stefan Hamelmann |
|
|
|
|
/s/Joel W. Johnson |
|
|
|
|
Joel W. Johnson |
|
|
|
|
/s/Jerry W. Levin |
|
|
|
|
Jerry W. Levin |
|
|
|
|
/s/Robert L. Lumpkins |
|
|
|
|
Robert L. Lumpkins |
|
|
|
|
/s/Beth M. Pritchard |
|
|
|
|
Beth M. Pritchard |
|
|
|
|
/s/Kasper Rorsted |
|
|
|
|
Kasper Rorsted |
|
|
|
|
/s/John J. Zillmer |
|
|
|
|
John J. Zillmer |
|
|
EXHIBIT (31)
CERTIFICATIONS
I, Douglas M. Baker, Jr., certify that:
1. I have reviewed this annual report on Form 10-K of Ecolab Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: February 28, 2007
/s/Douglas M. Baker, Jr. |
|
Douglas M. Baker, Jr. |
|
Chairman of the Board, |
|
President and Chief Executive Officer |
|
I, Steven L. Fritze, certify that:
1. I have reviewed this annual report on Form 10-K of Ecolab Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: February 28, 2007
/s/Steven L. Fritze |
|
Steven L. Fritze |
|
Executive Vice President and |
|
Chief Financial Officer |
|
EXHIBIT (32)
SECTION 1350 CERTIFICATIONS
Pursuant to 18 U.S.C. Section 1350, each of the undersigned officers of Ecolab Inc. does hereby certify that:
(a) the Annual Report on Form 10-K of Ecolab Inc. for the year ended December 31, 2006 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ecolab Inc.
Dated: February 28, 2007 |
|
/s/Douglas M. Baker, Jr. |
|
|
Douglas M. Baker, Jr. |
|
|
Chairman of the Board, President and |
|
|
Chief Executive Officer |
|
|
|
|
|
|
|
|
|
Dated: February 28, 2007 |
|
/s/Steven L. Fritze |
|
|
Steven L. Fritze |
|
|
Executive Vice President and |
|
|
Chief Financial Officer |